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One of the most intriguing mysteries of human cognition 
is the capacity for judgment, reasoning, decision-making and 
planning. This capacity allow us to face problems that need to be 
solved immediately and make decisions quickly and appropriately 
by monitoring the information of the external world continuously. 
Executive functions are considered the key that allows human high-
order cognitive processes. They coordinate operations of various 
processes to accomplish a particular goal in a flexible manner 
(Miyake & Shah, 1999; Roberts, Robbins, & Weiskrantz, 1998). The 
mechanism or system responsible for the coordination of 
operations is called ‘cognitive control’.  
Cognitive control is a construct from contemporary 
cognitive neuroscience that refers to processes that coordinate and 
combine information from different cognitive systems. This control 
is reached through the adaptive selection and execution of 
information processing strategies. These strategies may vary from 
moment to moment depending on current goals, avoiding a rigid 
and inflexible cognitive system. A number of theoretical models 
have been proposed for how the control of cognition is achieved 
(Baddeley, 1996; Botvinick, Braver, Barch, Carter, & Cohen, 2001; 
Cohen, Dunbar, & McClelland, 1990; Miyake et al., 2000; Norman 
& Shallice, 1986) and progress has been made towards identifying 
its neuroanatomical substrates (Cohen & O’Reilly, 1996; Goldman-
Rakic, 1996; Luria, 1973; Posner & Petersen, 1989; see Niendam et 
al., 2012 for a review). The widely accepted Miyake's (2000) 
framework of cognitive control describes it as a set of general-
purpose control mechanisms, often linked to the prefrontal cortex 
(PFC) of the brain, that regulate the dynamics of human cognition 
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and action. This model proposes that cognitive control emerges 
from three distinct cognitive processes: switching between mental 
sets or task sets (mental flexibility), monitoring and updating of 
information in working memory (WM updating), and inhibiting 
automatic or prepotent responses (inhibitory control). These 
processes have been studied in different contexts, such as 
development (Jones, Rothbart, & Posner, 2003), healthy aging (see 
Braver & Barch, 2002 for a review), bilingualism (Bialystok, Klein, 
& Viswanathan, 2004), psychiatric disorders (see Millan et al., 2012 
for a review), and drug abuse (see Gould, 2010 for a review), 
providing useful insights into the nature, organization and role of 
individual differences in executive functions. 
In spite of a prolonged effort, the understanding of this 
complex cognitive control and its neural foundations continues to 
evolve. There has been substantial progress in the last few decades 
regarding the research on the neural basis and architecture of 
cognitive control. The majority of research efforts have focused on 
the PFC, which subserves a range of cognitive control processes. 
Namely, the organization of lateral prefrontal cortex (LPFC) 
(Fletcher & Henson, 2001; Fuster, 2008; Miller, 2000; Shallice & 
Burgess, 1996) and its influence through top-down interactions 
between LPFC regions and premotor or posterior associative 
cortices are the main brain substrates that enable our constant 
adaptation to changing environments (see Badre, 2008 for a 
review). One outstanding question in this area is the relative role of 
dopamine (DA) as a gating signal in the basal ganglia and PFC. 
Some models focus on the role of DA in training a selective gating 
signal in the PFC that is capable of manipulating new information 
into some regions of the PFC, while leaving others to actively 
maintain older information (O’Reilly, Herd, & Pauli, 2010). In 
addition, during information processing, the phenomenon of 
conflict is likely to occur and it needs to be overcome by selecting 
the relevant information and suppressing the processing of 
irrelevant information. DA plays an important role in the 
modulation of information processing (Cools & Robbins, 2004). 
Cognitive control results from the ability of DA (Cools & Robbins, 
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2004; Robbins & Arnsten, 2009) to modulate the flow of 
information processing and the high sensibility of PFC to 
neurochemical environment alterations (Arnsten & Robbins, 2002). 
This interaction between the dopaminergic system and the PFC 
may serve as a gating function that regulates and protects from 
interference during information processing. Several factors like 
severe periods of stress and fatigue may alter this particular 
relationship (Chaudhuri & Behan, 2000; Lorist, Boksem, & 
Ridderinkhof, 2005; Lorist & Tops, 2003), but central for the aim 
of this thesis we focused on the stimulant drugs’ ability to produce 
a core failure between neurotransmission and adapting behaviour to 
changing environmental demands (Dalley, Everitt, & Robbins, 
2011; Ersche et al., 2012; Garavan & Hester, 2007; Jentsch & 
Taylor, 1999; Volkow et al., 2010). 
Cognitive processes on drug abuse 
Psychoactive drugs have the ability to alter mood state or 
behaviour by acting directly on mechanisms of brain function. 
Thus, it is not surprising that these drugs act in a similar manner to 
natural chemicals found in the brain, like neurotransmitters or 
hormones that regulate mood and behavior. However, beyond the 
biological role that drugs play in the body, drug abuse is commonly 
characterized by an affective, emotional, or social phenomenon, 
given the psychological factors and processes that sustain this 
behavior, such as reward, reinforcement, craving, and stress. 
Research on drug abuse and addiction has yielded important 
insights into abusers’ desire to use drugs, and the process of 
addiction shows that it largely depends on altered brain function 
(Ersche et al., 2012; Hyman & Malenka, 2001; Leshner, 1997; Rácz, 
2014). Drugs of abuse are known to produce their acute 
psychoactive effect by a multitude of neurochemical actions on 
nucleus accumbens and prefrontal cortical areas (Goldstein & 
Volkow, 2002; Koob, Sanna, & Bloom, 1998; Koob, 1992; Volkow, 
Wang, Fowler, Tomasi, & Telang, 2011). However, the continuous 
use of the drug leads to feelings of craving and dependence, which 
are the results of a dysregulation of the brain’s neurochemistry and 
abnormal cortical structures such as striatal tissues and prefrontal 
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cortices (Goldstein & Volkow, 2002; Koob & Le Moal, 2001; 
Nader et al., 2002; Rácz, 2014; Smith, Jones, Bullmore, Robbins, & 
Ersche, 2013; Volkow et al., 1993; Volkow et al., 2010).  
Although hedonic and pleasant feelings might be at the 
center of motivation for the drive to seek and take drugs, certain 
cognitive processes such as memory likely contribute to obeying 
the drive, whereas others, like inhibitory control, contribute to the 
individual’s effort to resist it. From this point of view, cognitive 
processes may be of significance in understanding the resisting to 
take the drugs, the transition from recreational use to chronic drug 
abuse, and the relapse so typical of those attempting abstinence or 
recovery when the drug use ceases. A core deficit in drug abuse is 
the failure to regulate behavior in response to changing 
environmental demands, leading to mental inflexibility, impulsivity, 
and/or compulsivity, therefore making the cognitive system more 
vulnerable to the intrusion of distracting information (Bolla et al., 
2003; Colzato, Ruiz, van den Wildenberg, Bajo, & Hommel, 2011; 
Colzato, Ruiz, van den Wildenberg, & Hommel, 2012; Colzato, van 
den Wildenberg, & Hommel, 2007; Colzato, Ruiz, van den 
Wildenberg, & Hommel, 2011; Crean, Crane, & Mason, 2011; 
Fillmore & Rush, 2002; Fishbein et al., 2005; Hester & Garavan, 
2004; Kelley, Yeager, Pepper, & Beversdorf, 2005; Kenney & 
Gould, 2008; Lyvers & Yakimoff, 2003; Moriyama, Muramatsu, 
Kato, Mimura, & Kashima, 2006; Ornstein et al., 2000; Solowij 
et al., 2002; Verdejo-García, Perales, & Pérez-García, 2007). 
Thesis Question 
Khat, an amphetamine-like compound from the khat plant 
(Catha Edulis), and cocaine, an alkaloid derivative extracted from 
coca plant (Erythroxylon coca), are two drugs that are abused for their 
stimulant properties. Over the past few decades, the growing 
number of individuals using cocaine has increased the number of 
studies researching impaired cognitive processes during and after 
cocaine abuse. However, although khat is very popular in East 
Africa countries, it continues being a world-wide less known drug, 
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and there is still a lack of studies researching the possible cognitive 
impairment of khat users.  
Both drugs are powerful stimulants of the central nervous 
system, acting on catecholaminergic synapses by releasing DA in 
the synaptic cleft and/or blocking the re-uptake action of dopamine 
transporters (DAT). Cathinone and cocaine also potentiate the 
neurotransmission of serotonin, epinephrine, and norepinephrine. 
Although these neurotransmitters are not mainly responsible for 
the rewarding properties of the drugs, they do have an effect on the 
central and peripheral nervous system. In any case, the major part 
of this research is concerned with the rewarding, reinforcing, and 
addicting properties of khat and cocaine that occur through their 
effect on DA and its transporters (Banjaw, Mayerhofer, & Schmidt, 
2003; Kalix, 1990; Kuhar, Ritz, & Boja, 1991; Ritz, Lamb, 
Goldberg, & Kuhar, 1987). 
The chewing of khat is a cultural, world-wide phenomenon 
that receives less attention than other stimulant drugs of abuse. 
Khat consumption in East Africa has increased during the last 
decades and has spread to ethnic communities in the rest of the 
world, such as in the Netherlands, United Kingdom, Canada, and 
the United States. Khat leaves have been chewed on since ancient 
times to alleviate fatigue, enhance work capacity, stay alert, reduce 
hunger, and induce euphoria and enhanced self-esteem. Studies 
addressing the neurobiological mechanisms underlying the use of 
khat are still very scarce, as are studies that have systematically 
investigated the acute and long-term cognitive effects of khat use. 
With regards to this last statement, this thesis shows the first 
findings in the research of khat and its impact on cognitive control 
functions through a series of experiments assessing inhibitory 
control, WM monitoring, mental flexibility and resolution of 
response conflict. In addition, this thesis reviews what is known 
about the pharmacological mechanisms, effects, toxicity, and 
withdrawal symptoms of khat and the synthetic cathinone 
mephedrone (4-methcathinone).  
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Regarding the stimulant drug cocaine, the available studies 
on chronic cocaine abuse still produce inconsistent results when 
comparing the performance of different types of cocaine users with 
cocaine-free controls (Goldstein et al., 2004; Jovanovski, Erb, & 
Zakzanis, 2005; Rogers & Robbins, 2001). Although certain studies 
have found deficits in memory, attention abstraction, decision-
making and visuospatial abilities, others have failed to find deficits 
in some of the same functions (see Spronk et al., 2013 for a review). 
A common executive dysfunction that researchers in this field agree 
upon is related to inhibitory function (Bolla, Rothman, & Cadet, 
1999; Colzato & Hommel, 2009; Colzato et al., 2007; Fillmore & 
Rush, 2002; Rosselli & Ardila, 1996; Verdejo-García, López-
Torrecillas, Aguilar de Arcos, & Pérez-García, 2005). We 
investigated if this dysfunction extends to the performance of 
inhibition in the field of memory and language production. This 
thesis shows a set of studies in which chronic and recreational 
cocaine users were tested through a blocked-cycled naming task 
and a directed forgetting procedure. The performance on these 
tasks requires inhibition of word representations in virtue of their 
semantic-relatedness, and inhibition of prepotent memories in 
episodic memory, respectively. 
Outline of thesis 
This thesis contains six chapters reporting empirical work 
on the impact of khat and cocaine abuse on cognitive control and a 
review about the pharmacokinetics and pharmacodynamics of khat 
and mephedrone. 
Chapter 2 reviews the behavioral and physiological effects 
of the natural psychomotor stimulants khat and the cathinone-
derived designer drug mephedrone. This chapter describes their 
diverse historical and geographical background, their variety, their 
mechanisms of action, and their potential for producing abuse and 
dependence. 
Chapter 3 investigates, in an experiment, the ability to 
inhibit and execute behavioral responses in adult khat and khat-free 
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users. Response inhibition and response execution were measured 
in a stop-signal paradigm. The results show that users and non-
users are comparable in terms of response execution, but users 
need significantly more time to inhibit responses than non-users. 
Chapter 4 reports two experiments studying whether khat 
use is associated with changes in working memory (WM) and 
cognitive flexibility in adult khat and khat-free users. The results 
show that khat users perform significantly worse than controls on 
tasks tapping into cognitive flexibility and monitoring of 
information in WM. The inability to monitor information in WM, 
and to adjust behavior rapidly and flexibly may have repercussions 
on daily life activities. 
Chapter 5 presents an experiment on the impact of khat on 
the emergence and resolution of response conflict. Khat users and 
khat-free controls were tested on response conflict, as measured 
through a Simon task. Khat users show a general slowing and less 
efficient resolution of response conflicts, which is likely to impair 
decision making in everyday life situations. 
Chapter 6 investigates the possible impairment of 
inhibitory control in language production among recreational and 
chronic cocaine polydrug users. Two experiments were carried out 
with chronic and recreational cocaine polydrug users using a 
blocked-cycled naming task, an index of semantic interference. 
Chronic and recreational users show bigger semantic interference 
than cocaine-free controls, as indicated by a deficit in inhibiting 
interfering information. We propose that the consumption of 
cocaine impacts the inhibitory processes that suppress the 
overactive lexical representations in the semantic context. 
Chapter 7 reports two experiments that test the ability of 
intentional forgetting in chronic and recreational cocaine users. 
Chronic and recreational cocaine users were matched to a control 
group and were compared in their performance on a directed 
forgetting task. Results showed that chronic and recreational 
cocaine users are not able to inhibit irrelevant memories. We 
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attribute the inability to exert memory inhibition in chronic and 
recreational cocaine users to cocaine consumption.  
Chapters 2 to 7 are published, under revision, or submitted 
in international psychological journals. They have been inserted in 
this thesis in their original, submitted, or published form. To 
acknowledge the important contributions of several co-authors to 
each of these articles, a list of references is presented here. 
Chapter 2: Ruiz, M. J. & Colzato, L. S. (2014). 
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writing: Manuel J. Ruiz and Lorenza S. Colzato. 
Chapter 3: Colzato, L. S., Ruiz, M. J., van den Wildenberg, 
W. P. M., Bajo, M. T., & Hommel, B. (2011). Long-Term Effects of 
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Conceived and designed the experiments: Lorenza S. 
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Chapter 2 
Pharmacokinetics and pharmacodynamics 
of khat and mephedrone 
Abstract 
This chapter considers the behavioral and physiological 
effects of the natural psychomotor stimulants khat (Catha Edulis) 
and the cathinone-derived designer drug mephedrone. These 
natural and synthetic stimulants increase alertness, arousal, energy, 
talkativeness and motor excitement. This chapter describes their 
diverse historical and geographical background, their variety, their 
mechanisms of action, and their potential for producing abuse and 
dependence. 
Khat  
Background and History  
Khat is the transliteration of an Arabic word that indicates 
the leaves and shoots of Catha Edulis. This is a plant of the 
Celastraceae family endemic in countries around the Red Sea and 
East Africa. Its leaves are chewed on since ancient times as part of 
cultural tradition. The khat chewing habit is deeply rooted in 
African countries, such as Sudan, Eritrea, Ethiopia, Djibouti, 
Kenya, and Tanzania, and in the southwestern countries of the 
Arabia Peninsula, such as Yemen, which is a country with a major 
population of chewers (United Nations and United Nations Office 
on Drugs and Crime, 2013). This drug is abused for its stimulant 
effect, and the acute consumption is associated with optimism, 
euphoria, excitation, talkativeness and increased energy. The effects 
are long-lasting and may prevent fatigue. Recently, due to air 
transportation improvement and the influx of immigrants from 
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East Africa and the Arabian Peninsula have spread the use of khat 
leaves around the world. Fresh khat is usually wrapped in banana 
leaves for transportation to preserve its moisture. The vast majority 
of those ingesting khat do it by chewing. Only a small number 
ingest it by making a “tea” from dried leaves, or, even more rarely 
by smoking dried leaves. The chewer fills his mouth with fresh 
leaves and young stalks, and chews them slowly and intermittently 
to release the active components in the juice, which is swallowed 
along with saliva. When khat leaves and stalks are chewed, 
cathinone is absorbed through the buccal mucosa and the stomach. 
In a single khat session, approximately 100-500 g of fresh khat is 
chewed for several hours (Feyissa and Kelly, 2008). 
Mechanisms of Khat action 
Since one characteristic property of khat is stimulation of 
the central nervous system, the pharmacodynamics aspects of khat 
constituents is of particular interest. The chemical similarity 
between cathinone and amphetamine, and the amphetamine-like 
effects, lead cathinone to be called a “natural amphetamine” (Kalix, 
1992). Experimental studies conducted to investigate khat’s central 
and peripheral effects have determined that cathinone and 
amphetamine share a common pharmacological activity. Khat 
alkaloids comprise two groups. The first group is the cathamines, 
and the second is cathaedulines. Cathamines are more abundant 
and widely known than cathaedulines. Khat contains more than 
forty compounds, such as alkaloids, glycosides, tannins, amino 
acids, vitamins and minerals. But three phenylalkylamine alkaloids 
are responsible for its psychoactive effects. These are (−)-S-
cathinone α-aminopropriophenone (cathinone), (+)-
norpseudoephedrine (cathine) and norephedrine (Szendrei, 1980), 
which are phenylpropylamines structurally related to amphetamine 
and noradrenaline. The major active constituent in fresh khat is 
(−)-S-cathinone. The plant contains the (−)-enantiomer only, the 
(+)-enantiomer has not been found (Kalix & Braenden, 1985), 
which has the same molecular configuration as S-(+)-amphetamine 
(Kohli and Goldberg, 1982). Given its potency and high 
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liposolubility (Kalix and Braenden, 1985), it facilitates access into 
the central nervous system (CNS) (Zelger et al., 1980). So, it can be 
assumed that khat-induced symptoms are mainly due to cathinone 
(Kalix, 1990). Cathinone, mainly increases levels of dopamine and 
norepinephrine in the brain by acting on catecholaminergic 
synapses, delaying the reuptake and/or enhancing the release of 
those neurotransmitters. Cathinone is relatively unstable and during 
maturation it is enzymatically degraded to cathine and norephedrine 
(Al-Obaid et al., 1998) within a few days after harvesting. These 
molecules are less lipophilic and act at a peripheral level, provoking 
the sympathomimetic effects. Thus, only fresh picked leaves have 
full efficacy, while cathine and norpseudoephedrine occur mainly 
just in older leaves and/or by degradation of cathinone (Sporkert et 
al., 2003). The phenylalkylamine content of khat leaves varies 
within wide limits. Other phenylalkylamine alkaloids found in khat 
leaves are the phenylpentenylamines merucathinone, 
pseudomerucathine and merucathine. However, they seem to 
contribute less to the stimulant effects of khat (Geisshüsler and 
Brenneisen, 1987).  
In view of its peripheral action, cathinone is accompanied 
by sympathomimetic syndrome. Several studies have looked into 
the cardiac effect of khat. Cathinone provokes increases in blood 
pressure and heart rate, characterized by transient hypertension and 
tachycardia (Brenneisen et al., 1990; Halbach, 1972; Hassan et al., 
2005, 2000). These effects seem to be mediated by the stimulant 
effect of cathinone on β-adrenoceptors in the heart (Kennedy et al., 
1983). Other peripheral effects include dry mouth, hyperthermia, 
mydriasis and anorexia (Nencini et al., 1984). These effects are 
thought to result from the ability of cathinone to release 
noradrenaline from sympathetic nerve terminals with an effect and 
potency similar to those of amphetamines (Kalix, 1992; Kohli and 
Goldberg, 1982). The main effects of cathinone are relief of fatigue, 
hyperactivity, increased alertness, euphoria, loquacity, improved 
ability to communicate, and restlessness. Khat chewing is thought 
to exert its effects by increasing concentrations of stimulant 
neurotransmitters, such as dopamine, serotonin and/or 
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noradrenaline in specific regions of the brain. The animal model of 
psychostimulation has been widely used to observe the action of 
khat alkaloids on the CNS. The acute effect of khat alkaloids on 
neurotransmission is comparable to that induced by amphetamines: 
Cathinone and cathine interact with the dopaminergic pathways, 
increasing dopamine and serotonin, and preventing reuptake of 
noradrenaline and dopamine (Kalix, 1984, 1983; Pehek et al., 1990). 
Cathinone inhibits MAO more strongly than amphetamine 
(nencini, 1984) and is more selective toward the iso-enzyme MAO-
B (Nencini et al., 1984; Osorio-Olivares et al., 2004), provoking a 
synaptic accumulation of this catecholamine due to a decrease in 
dopamine degradation. Cathinone is not considered a direct 
dopamine agonist but rather a presynaptic releaser and inhibitor of 
dopamine. The major metabolites of cathinone, i.e. cathine and 
norephedrine, have weaker effects on the CNS due to their less 
lipophilic properties. The pharmacology of cathinone has not been 
well characterized in the CNS (Kite et al., 2003), however there are 
enough experimental results that suggest that khat’s 
psychostimulant effect is primarily mediated via meso-cortico-
limbic dopaminergic pathways (Banjaw et al., 2003; Kalix, 1990). 
There is evidence from animal studies that cathinone releases 5-HT 
in rat striatal tissue (Kalix, 1984) and repeated administration of 
khat to rats led to a depletion of the 5-HT neurotransmitter and its 
metabolite 5-Hydroxyindoleacetic acid in anterior and posterior 
striatum. However the relevance of 5-HT pathways to the 
behavioral action of cathinone is less studied and defined than that 
of dopamine. Since both cathinone and amphetamine have shown 
to reduce the uptake of 5-HT in animal models of 
psychostimulation, a possible involvement of 5-HT in mediating 
the euphoric action of cathinone cannot be ruled out (Al-Motarreb 
et al., 2002).  
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Basic Pharmacology of Khat  
Absorption  
Khat alkaloids plasma concentration-time data are usually 
described using a two-compartment model with two segment 
absorption (Toennes et al., 2003). Khat is used predominantly by 
oral route. Cathinone and cathine are rapidly and completely 
absorbed by this route with nearly 100% bioavailability. There are 
considerable differences in cathinone content in khat leaves from 
different origins and type. The scientific studies consider that 
cathinone alkaloid is present at around 36-343 mg, cathine 86-120 
mg and norephedrine 8-47 mg per 100 g of fresh leaves (Al-
Motarreb et al., 2002; Geisshüsler and Brenneisen, 1987; Toennes 
et al., 2003; Widler et al., 1994). One of the reasons for this 
difference in cathinone concentration is that cathinone is unstable, 
and it is rapidly transformed by enzymatic reduction into cathine 
and norephedrine once the leaves have been harvested. The 
psychostimulant effects induced by khat appear after approximately 
half an hour of chewing, and last about 3h (Brenneisen et al., 1990; 
Kalix, 1996). Cathinone and cathine are isolated from the leaves of 
Catha edulis by enzymes present in saliva. The absorption of the 
constituents of khat is said to have two phases, the first being at the 
buccal mucosa, which plays an important role in the absorption of 
alkaloids; and a second phase is after swallowing of the extract, at 
the lining of the stomach or small intestine (Arunotayanun and 
Gibbons, 2012; Feyissa and Kelly, 2008; Toennes et al., 2003). In 
one study four naïve non-drug users chewed an average of 44g of 
khat for an hour, and they showed, on average, a maximum plasma 
concentration of cathinone occurring at 2.3h for cathinone, 2.5h 
for cathine and 2.8 h for norephedrine (Toennes et al., 2003); 8h 
later, amount of cathinone was reported to be 245±49 µg min ml-1. 
In a study by Wilder et al. (1994) six subjects chewing a single 
amount of khat corresponding to 0.8 mg/kg body weight, showed 
maximum plasma concentration of cathine to be at 2h, and the 
total cathinone absorbed in the body after 9h was 25±13 µg min 
ml-1. In a study by Halket et al. (1995a), maximum peak plasma 
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levels were on average 83 µg ml-1 after one hour of chewing 60 
grams of fresh khat leaves.  
Distribution 
The active ingredients are not extracted rapidly by chewing 
and thus do not have a fast onset of action. Little is known about 
the distribution of khat psychoactive alkaloids in the human body, 
and a consistent pharmacokinetic model of action has not been 
developed. Plasma concentration curves vary between studies due 
to differences in the alkaloids doses, however these studies show a 
good agreement in results (Halket, Karasu, & Murray-Lyon, 1995; 
Widler et al, 1994; Toennes, Harder, Schramm, Niess, & Kauert, 
2003). In the study by Toennes et al. (2003) the plasma 
concentration-time was described using a two-compartment model 
with two segment absorption. The time until the compound 
appeared in the central compartment (tlag 1) was between 0.1-0.2 h 
for the three alkaloids, whereas the lag time for the second segment 
(tlag 2) was more than 1.2 h.  Maximum plasma concentrations 
were reached, on average, after 2.3h for cathinone (58±18.8 µg L-1), 
after 2.6h for cathine (58±18.8 µg L-1), and after 2.8 h for 
norephedrine (72±12.2 µg L-1). Cathinone in the central 
compartment had an average half-life of 1.50±0.8 h. The apparent 
volume of distribution from central compartment was 2.7±1.6 L 
kg-1 for cathinone and 0.7±0.4 L kg-1 for cathine. Cathinone is a 
more lipophilic alkaloid than cathine, and its more rapid and 
intense action is explained by its higher lipid solubility, which 
facilitates access into the CNS (Zelger et al., 1980). 
Metabolism and Excretion 
The psychostimulant effects appear 15-30 min after one 
starts chewing, and they last for three hours. During this time, 
nearly 90% of alkaloids are released. There is a rapid 
biotransformation due to the steroselective metabolism of (-)-S-
cathinone to cathine and norephedrine. First-pass metabolism of 
cathinone by liver microsomal enzymes reduces the β-keto group to 
an alcohol, resulting in cathine and norephedrine (Brenneisen et al., 
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1986; Guantai and Maitai, 1983). The principal stereoisomer S-(−)-
cathinone is metabolized to norephedrine and cathine. Both 
metabolites remain active in plasma concentrations for no less than 
9h, when cathinone is no longer found in plasma. Cathine is 
excreted unaltered for nearly 24 hours (Maitai and Mugera, 1975; 
Widler et al., 1994). Since both norephedrine and cathine are 
pharmacologically active compounds, they may contribute to the 
general effects of khat chewing (Graziani et al., 2008). Less than 7% 
of cathinone is excreted unchanged in the urine (Brenneisen et al., 
1986; Toennes and Kauert, 2002). Since norephedrine is both a 
khat alkaloid and a cathinone metabolite, it is difficult to determine 
its metabolism and excretion. There is evidence of higher amounts 
of norephedrine being excreted in urine than is ingested due to a 
combination of absorbed norephedrine and the product of 
cathinone metabolism (Mathys and Brenneisen, 1992; Toennes and 
Kauert, 2002). Brenneisen et al. (1986) found that 21-50% of 
cathinone was recovered mainly as aminoalcohol metabolites in 24 
hour urine samples. The elimination half-life of cathinone is 
1.5±0.8 hours, and that of cathine is 5.2 ± 3.4 hours. In the study 
of Toennes et al. (2002) the maximum concentrations of cathinone, 
cathine and norephedrine in urine samples were 2.5, 20 and 30 mg 
L-1, respectively. The metabolite cathine has been found in both 
urine and breast-milk of lactating women who habitually chewed 
khat. As a result, breast-fed infants will ingest a sympathomimetic 
and anorectic compound, such as cathine (Kristiansson et al., 1987). 
Behavioral and Neural Effects of Khat: Abuse 
and Dependence 
Chronic khat use is commonly associated with cardiac, 
psychological, neurological and gastrointestinal complications. 
Increased blood pressure and heart rate have been associated with a 
higher risk of ischemic and myocardial infarction (Al-Motarreb et 
al., 2005; Kalix, 1981). Also, tannins from khat plant produce 
esophagitis, gastritis, oral keratosis, periodontal diseases and 
grastroduodenal ulcers. Tannins and norpseudoephedrine 
contribute to constipation, the most common complaint of khat 
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users. Khat use also affects nutrition and absorption of nutrients, 
which leads to malnutrition. (Al-Habori, 2005). There is evidence 
for a strong association between the development of buccal cancer 
and cirrhosis and khat use (Chapman et al., 2010; Fasanmade et al., 
2007; Kassie et al., 2001), especially when combined with alcohol 
and tobacco. Habitual use of khat is known to seriously impair male 
sexual functions leading to a high incidence of spermathorrea and a 
permanent impotence (el-Shoura et al., 1995; Halbach, 1972; 
Mwenda et al., 2003). 
Khat is known to produce paranoid psychosis, auditory 
hallucinations and hypomanic illness with grandiose delusions, fear 
and anxiety (Kalix, 1988). These effects are exceptional and 
associated with chewing high amounts of khat, moreover these 
effects disappear spontaneously within 1-2 days of cessation of khat 
use.  Depression often appears during withdrawal, but in nearly all 
cases that report this symptom, it disappears after khat cessation as 
well (Hassan et al., 2002; Kalix and Braenden, 1985; Pantelis et al., 
1989). The administration of benzodiazepine and antipsychotic 
medication is often necessary. To date there are no sufficient 
scientific reports and large-scale studies, excepting clinical cases, 
that associate the effects of khat use and psychiatric disorders 
(Warfa et al., 2007). However, literature suggests that the adverse 
psychiatric sequelae may relate to traumatic experiences such as war 
or combat, and the lack of social support of immigrants, which 
favors the experience of negative effects of the drug in vulnerable 
subjects. 
Cathinone is a reinforcing drug and it maintains very high 
rates of responding in animal experiments (Kalix, 1984), but there 
are conflicting opinions regarding the existence of a withdrawal 
syndrome. Accumulating evidence demonstrates withdrawal 
symptoms and low tolerance in humans. Withdrawal symptoms 
after long-term use of khat have been described as and include 
lethargy, mild depression, trembling and nightmares (Corkery et al., 
2011).  The development of tolerance is still a debated issue due to 
the variable conclusion of clinical trials and research. Development 
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of tolerance should be similar to amphetamine tolerance, however, 
it is improbable that khat users ingest enough cathinone to develop 
dependence, because the bulk volume of khat self-limits 
consumption (Nencini and Ahmed, 1989).  Nevertheless, khat-
induced changes appear to be less pronounced in chronic users, 
which would indicate that tolerance may develop for the acute 
sympathomimetic and neuroendocrine effects of khat, such as 
increased levels in blood pressure, heart rate, respiratory rate and 
body temperature (Kalix and Braenden, 1985). The reinforcing 
properties of khat are weaker than amphetamines or cocaine; thus 
development of dependence is unlikely to be similar in extent and 
severity to amphetamines. In fact, there are very few cases of khat 
dependence and khat users do not have serious problems when 
they stop using it. 
Cognitive Effects of Khat Exposure 
Long-term cognitive deficit 
Several studies have systematically looked into the 
detrimental effect of chronic use of khat on cognition. First, 
Colzato, Ruiz, van den Wildenberg, Bajo, and Hommel (2011a) 
reported that chronic khat users compared to khat-free controls, in 
a stop-signal paradigm, exhibit impairments in the inhibition of 
behavioral responses when they had to refrain from responding to 
a red arrow (stop-signal). Second, Colzato, Ruiz, van den 
Wildenberg, and Hommel (2011b) showed that chronic khat users 
performed significantly worse than controls in a task-switching 
paradigm (an index of cognitive flexibility) and on the N-back task 
(an index of working memory updating). In the task-switching 
paradigm participants were supposed to switch between two 
different tasks: responding to the global or to the local target 
dimension of hierarchical geometrical figures. Chronic khat users 
showed more pronounced switching costs (i.e., a greater difference 
in reaction times between when the task was alternated compared 
when it was repeated) than khat-free controls, an indication of 
decreased cognitive flexibility. In the N-back task, participants were 
confronted with a stream of letters and had to indicate whether the 
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present letter matched the one that was presented directly before 
(1-back) or in the second-to-last trial (2-back). Chronic khat users 
made significantly more errors in both the 1-back and 2-back 
conditions, an indication of more deficient WM updating. 
Third, Colzato, Ruiz, van den Wildenberg, and Hommel 
(2012) showed that chronic khat users displayed less efficient 
resolution of response conflicts in the Simon task in which 
participants had to respond, by pressing left and right response 
buttons, to the color of visual stimuli while disregarding their 
irrelevant location. Moreover, the amount of hours chewing khat 
positively correlated with the size of the Simon effect, indicating 
that longer chewing was associated with increased response 
conflict. 
Acute Cognitive Effects 
So far, only one study has investigated the acute effect of 
khat on cognition. Colzato and colleagues (2013) explored how 
acute khat use affects the emergence and resolution of response 
conflict as measured by the Simon task. In one single session, 
participants worked through two task blocks: the khat group 
chewed exclusively khat whereas the khat-free group chewed solely 
a gum. Results showed that in the second block, which reflects the 
acute impact of khat, the khat group was better than controls in 
resolving stimulus-induced response conflict. These results suggest 
that the acute intake of khat may improve participants’ ability to 
handle response conflict. 
Mephedrone (4-methcathinone) 
Background and History 
In recent years, a new class of designer drugs has appeared 
on the drug of abuse market in many countries. It has risen in 
popularity in European countries, especially in the UK, as well in 
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the South–East Asia, Australia and North America. These are the 
so-called beta-keto designer drugs. They come from synthetic ring-
substituted phenylethylamines with substitution of a ketone group 
at the β-carbon position (Gibbons and Zloh, 2010; Gibbons, 2012). 
Various R-group substitutions give rise to approximately 30 known 
synthetic cathinones, many of them identical except for the β-
carbon ketone group (European Monitoring Centre for Drugs and 
Drug Addiction, 2012).The most widely abused synthetic 
cathinones are 4-methcathinone (mephedrone), 3,4-
methylenedioxymethcathinone (methylone) and 3,4-
methylenedioxypyrovalerone (MDPV). Mephedrone is the most 
abused synthetic drug in Europe, while methylone and MDPV are 
the most frequently abused synthetic cathinones within the US. The 
first most popular synthetic cathinone in EU countries was 
mephedrone (4-methcathinone, 4-MMC), and it was seen as an 
alternative to MDMA (3,4-methylenedioxymethylamphetamine). 
It is a derivative from the psychoactive alkaloid cathinone 
occurring naturally in the plant khat (Catha Edulis). Mephedrone is 
abused for its stimulant effect, which is similar to the psychoactive 
and sympathomimetic effects exerted by cocaine and MDMA. It 
appeared for the first time on the internet in 2007 (Walsh, 2011), 
and it has several street names, such as “meaow-meaow”, “drone”, 
“meph”, “bubles” or “Ronzio”. This substance was synthesized by 
Roger Adams for the first time in the late 1920’s (Hyde et al., 1928), 
was then used as a neuroleptic (“Methylaminopropiophenone 
compounds and methods for producing the same,” 1957), and was 
examined as a locomotor stimulant by van der Schoot et al. (1962). 
Prior to the banning, it was sold under its name, then after 
becoming a controlled substance it was marketed as “bath salt” in 
Europe or “plant food” in the US, commonly labeled “not for 
human consumption” to circumvent the legislation of drug of 
abuse (EMCDDA, 2011; Kelly, 2011; National Drug Intelligence 
Center [U.S.], 2011; Schifano et al., 2010a). In the 2000’s, 
mephedrone had received a renewed popularity as a synthetic drug, 
particularly in young people. The synthesis of synthetic cathinones 
is relatively simple and can be carried out with similar equipment 
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and knowledge as amphetamines (Camilleri et al., 2010). Synthetic 
cathinones are usually produced in countries such as China, India 
or Pakistan by rogue chemists, and it is then shipped directly to 
distributors. Mephedrone was controlled as a Class B substance 
under Misuse of Drug acts, 1971 in the UK. The substance is 
available from a number of different sources, including drug-
dealers, headshops, and most importantly via the internet. Before 
the UK legislation in 2010, there were more than 50 websites that 
sold mephedrone and other cathinones. Since the banning, the 
number of websites decreased, and people started to sell 
replacements called “legal highs”. In May 2010 the Council of the 
European Union decided that mephedrone should be controlled in 
all EU countries based on a risk assessment by a scientific 
committee (EMCDDA, 2011). There are little data about the 
prevalence of use of mephedrone. The available data are from self-
reported surveys of particular demographics, showing that it was a 
very popular “party drug” frequently used in nightclubs, discos and 
dance parties (Dick and Torrance, 2010; Schifano et al., 2010a; 
Winstock, 2011). However, the use of mephedrone has declined, 
primarily due to the banning of the substance, the increasing 
difficulty in gaining access to it, and the increased price of the drug. 
In the absence of epidemiological data on prevalence, an internet-
based cross-sectional survey in 2012 of over 22,000 world-wide 
clubbers showed that 13.9% of the UK subgroup reported to have 
used mephedrone in the last 12 months (MixMag’s Global Drug 
Survey, 2013). 
Mephedrone is typically sold to users in powder form, and 
it is generally described as being a white crystalline powder with a 
light yellow color (EMCDDA, 2011; Newcombe, 2009; Schifano et 
al., 2010a). The most common routes of use are insufflation 
(snorting), oral ingestion, diluted in drinks or wrapped in smoking 
paper (known as “bombing”); and intramuscular or intravenous 
injections. Smoked and rectal insertions are rare methods of 
administration, but they are commonly used as well (Measham, 
Moore, Newcombe, & Smith, 2010; Winstock et al., 2011; Wood 
et al., 2010). Mephedrone and other synthetic cathinones have been 
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regularly used in conjunction with other drug of abuse including 
GHB, alcohol, cannabis, opiates, cocaine, MDMA, ketamine and 
amphetamine (Dargan et al., 2011). 
Basic Pharmacology and Mechanisms of 
Mephedrone action  
Very little information is available about the 
pharmacokinetic processes of the synthetic drug mephedrone. 
Recent studies used animal models to figure out the 
pharmacokinetic parameters (Martínez-Clemente et al., 2013). Most 
mephedrone data come from the internet, population surveys and 
case reports, and the amount of used mephedrone widely varies 
from 5-125 mg via nasal route to 15-250 mg by oral route (“Erowid 
4-Methylmethcathinone Vault : Dose/Dosage”). Users commonly 
report re-dosing to maintain the desired effects for an average of 
six hours, showing that mephedrone usage often does not comprise 
a single dose, using an amount of 300-700 mg per session (James et 
al., 2011; Regan et al., 2010; Winstock et al., 2011; Wood et al., 
2010a, 2010b). The effects have a rapid onset, appearing within 
minutes and lasting at least for an hour when the substance is 
insufflated; or having an onset time of nearly 45 min and lasting for 
2-4 hours by oral route. Given the affiliation of mephedrone to 
beta-ketoamphetamines, it is expected to act on the central nervous 
system by promoting the release of monoamine neurotransmitters 
and likely inhibiting their reuptake (Feyissa and Kelly, 2008; Kalix, 
1990). In vitro studies showed that mephedrone’s main mechanism 
of action is very similar to that of amphetamines (Cozzi et al., 
1999). The cathinone derivatives often have an amphetamine 
analogue; cathinone and methylone are structurally comparable to 
amphetamine and MDMA, respectively. However, there is no 
common amphetamine analogue of mephedrone. Particularly in 
mephedrone, the presence of the ring substituent on the 
phenethylamine core modifies its pharmacological properties, 
giving the compound some MDMA-like effects. Mephedrone has a 
chiral center, so it exists in two forms, the S(−) and R(−) 
mephedrone. Like the alkaloid cathinone, mephedrone’s S(−) 
Chapter 2 ─ 44 
 
 
stereoisomer is thought to be more potent than (R). Mephedrone is 
less lipophilic than amphetamines, therefore it shows a reduced 
ability to cross the blood-brain barrier due to the presence of the 
beta group (Gygi et al., 1996; Nagai et al., 2007). At present, the 
pharmacokinetics of synthetic cathinones in humans is poorly 
documented and it is compared to traditional amphetamines 
pharmacokinetics. However, animal studies and the action of 
natural cathinones show insights in the action of these drugs. 
Absorption and distribution 
There are no studies examining mephedrone absorption in 
humans. The results are drawn from users that reported the 
consumption of the substance, user surveys or clinical reports. The 
absorption of mephedrone depends on the route of use, with the 
onset of desired effects occurring a few minutes after nasal 
insufflation or intravenous injection, and between 15-45 min after 
oral ingestion (“Erowid 4-Methylmethcathinone Vault : 
Dose/Dosage”, “Erowid 4-Methylmethcathinone Vault : Effects”). 
In a typical session a low dose of mephedrone is used (15-150 mg 
orally and 5-125 mg for insufflation), and usually no more than 1 g 
is used (“Erowid 4-Methylmethcathinone Vault : Dose/Dosage”; 
Newcombe, 2009). The majority of users prefer to combine 
different administration routes, (e.g insufflation and ingestion) and 
repeated doses, rather than a single use, to maintain the desired 
effects (DeLuca, 2009).  A study investigating plasma parameters 
was carried by Wright et al. (2012) in Wistar and Sprague-Dawley 
rats. In this study a subcutaneous injection of 5.6 mg/kg of 
mephedrone was administered, resulting in a peak plasma 
concentration of 868 µg·ml-1 and 1206 µg·ml-1 for the Wistar and 
Sprague-Dawley rats respectively; peak plasma concentrations were 
reached after 15 minutes. A rapid reduction of plasma 
concentration, probably due to the rapid clearing of mephedrone, 
was found in both animal models, with an area under the curve 
(AUC) of 870 µg ml-1 and 1170 µg ml-1 in Wistar and Sprague-
Dawley rats, respectively. In a study of forensic traffic cases, blood 
concentrations ranged from 1 to 51 µg/kg in mephedrone users. In 
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a more recent study carried out by Martínez-Clemente and 
colleagues (2013) mephedrone was administered intravenously (10 
mg/kg) and orally (30 and 60 mg/kg) to Sprague-Dawley rats. 
Results fitted a two compartment model, showing that after oral 
administration mephedrone achieved a peak concentration between 
0.5-1 hours and declined to undetectable levels after 9 hours. The 
bioavailability of mephedrone was about 10% and the percentage 
of mephedrone protein binding was 21.59±3.67%. 
The effects of cathinone when taken by insufflation start 
within 10-20 min and last 1-2 hours, with oral effects taking longer 
to peak, at around 20-40 min and lasting 2-4 hours. This may vary 
in association with the amount of food present in the stomach 
(Wright et al., 2012). 
Metabolism and excretion  
Synthetic cathinones metabolites have been detected using 
gas/liquid chromatography-mass spectrometry. All cathinone 
derivatives have been shown to pass phase I metabolism. The first 
study that looked into mephedrone metabolism was conducted by 
Meyer et al. (2010b). They administered a single dose of 20 mg/kg 
of mephedrone by gastric intubation to rats, and urine samples 
were collected during 24 hours after the drug administration. They 
showed that synthetic cathinone undergoes three overlapping phase 
I metabolism pathways in rat and human urine samples, with seven 
metabolites being identified in human samples and six in rat urine. 
Mephedrone can be N-demethylated to a primary amine, 
responsible for the metabolites nor-mephedrone, nor-dihydro 
mephedrone and nor-hydroxytolyl mephedrone; subsequently, 
ketone moieties can be reduced to alcohols, producing nor-dihydro 
mephedrone and 4-carboxy-dihydro mephedrone; or finally, tolyl 
groups are oxidized to the corresponding alcohol and carboxylic 
acid, giving as metabolites hydroxytolyl mephedrone and nor-
hydroxytolyl mephedrone. Further phase II metabolites can be 
found, resulting from glucuronidation and/or sulfation reactions 
(Khreit et al., 2013; Meyer et al., 2010c). A recent in vitro study 
conducted by Khreit et al. (2013) used rat liver hepatocytes, and 
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they found 17 metabolites from Phase I and Phase II, and a half-
life of 61.9 min for the active substance mephedrone. 
In an in vitro study by Pedersen et al. (2013) using cDNA-
expressed CYP enzymes and human liver microsomal preparations, 
it was demonstrated that the cytochrome P450 (CYP) 2D6  is the 
main responsible enzyme for the phase I metabolism of 
mephedrone, with some minor contribution from other NAPDH-
dependent enzymes. The majority of cathinone derivatives are 
eliminated by metabolites via urine, which can be detected with 
appropriate urine testing technology (Meyer and Maurer, 2010). 
However, there is still a lack of studies that look into the time 
course detection and/or the major metabolites in blood. 
Behavioral and Neural Effects of Mephedrone: Abuse, 
Dependence and Toxicity 
There are very few data about the human 
pharmacodynamics processes of mephedrone and few studies on 
the pharmacological targets have been published (Hadlock et al., 
2011; Kehr et al., 2011; Martínez-Clemente et al., 2012; Motbey et 
al., 2012a). The desired effects looked for by the users are those 
similar to cocaine-like stimulant effects or MDMA-like 
hallucinogenic effects: increased alertness, increased energy and 
motivation, euphoria, excitement, improved mood, empathogenic 
effects, sociability, enhanced appreciation for music, reduced 
appetite, mild-sexual stimulation and insomnia (Kapitány-Fövény et 
al., 2013; Schifano et al., 2010a; Winstock et al., 2011; Zawilska and 
Wojcieszak, 2013). Many of these effects can be ascribed to general 
sympathomimetic activation, with several effects on the peripheral 
and central nervous systems being similar to those described in khat 
users, but greatly enhanced due to the higher consumed amount of 
the psychoactive compound. Few studies have evaluated the effect 
of mephedrone on the PNS, but they agree on profound changes in 
peripheral organs systems, such as the cardiovascular and digestive 
system (Baumann et al., 2013a, 2012; Meng et al., 2012; Varner et 
al., 2013). Different animal models show the effects of mephedrone 
on monoamine neurotransmission in the CNS, and one may 
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postulate that the stimulant and empathogenic effect may be 
exerted by increasing concentrations of catecholamines such as 
dopamine (DA), serotonin (5-HT) and norepinephrine (NE), with 
similar releasing potencies in each neurotransmitter (Baumann et 
al., 2012; Cameron et al., 2013; Cozzi et al., 1999; Kehr et al., 2011; 
Martínez-Clemente et al., 2012; Motbey et al., 2012b; Ramoz et al., 
2012). An animal model study conducted by Hadlock (2011) 
revealed that mephedrone has a DA-releasing capability in striatal 
tissue resembling methamphetamines, but this does not cause 
dopaminergic deficits. Repeated administrations rapidly decreased 
DA and 5HT transporter functions by 20% in rat striatal and 
hippocampal synaptosomes, causing serotonergic, but not 
dopaminergic deficits. Hadlock also observed reduced DAT and 
SERT function by approximately 20% in the striatal and 
hippocampal synaptosomes, respectively. In addition, in vivo 
mycrodialisys studies in rats demonstrated that mephedrone 
produces increased extracellular DA levels in the nucleus 
accumbens (Baumann et al., 2013a, 2012; Kehr et al., 2011). 
Acute and long-term exposure to amphetamines has been 
associated with a loss of transporter function in the DA and 5-HT 
systems (Fleckenstein et al., 1999), so it seem plausible that 
synthetics cathinones follow the same pattern of DA and 5-HT 
neurotoxicity, and DAT and SERT activity. However, there are a 
number of other studies that report no loss of DA and 5-HT, or 
transporter alterations following several mephedrone doses at 
different administrations (Angoa-Perez et al., 2012; Baumann et al., 
2012; den Hollander et al., 2013; Motbey et al., 2012b). All synthetic 
cathinones also inhibit NE transporters (NET; Eshleman et al., 
2013; Iversen et al., 2013). Increased NE levels in the brain are not 
known to correlate with the intoxicating effects of the drug, but 
this feature is likely to contribute importantly to peripheral 
sympathomimetic effects (Iversen et al., 2014). 
Recently, several studies of animal models have displayed 
the behavioral effects and neurotoxicity of mephedrone and other 
synthetic cathinones, especially highlighting impacts on locomotor 
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activity, learning and memory, thermoregulation and abuse liability 
(Shawn M Aarde et al., 2013; Angoa-Perez et al., 2012; Baumann et 
al., 2012; den Hollander et al., 2013; Gregg and Rawls, 2014; Lisek 
et al., 2012; López-Arnau et al., 2012; Marusich et al., 2012; Motbey 
et al., 2012b; Wright et al., 2012; Shortall et al., 2013; Dargan and 
Wood, 2013). 
There is a variety of sources of information about the acute 
effects of mephedrone, which include self-reported toxicity on 
internet discussion fora, data from sub-population user surveys, 
data from regional and national poisons information services and 
published case reports and case series of mephedrone intoxication. 
Despite the different origin of intoxication information, a general 
acute toxic effect pattern can be observed (Wood and Dargan, 
2012), and the clinical presentations of intoxicated humans coincide 
with the monoamine dysfunctions observed in animal studies. Most 
of the effects seem to be similar to those already documented for 
amphetamine, methamphetamine and MDMA (Schifano et al., 
2010a).  
The most common adverse symptoms following the use of 
mephedrone are those related to the CNS (seizures hyperthermia, 
insomnia, agitation, hallucination/delusion, confusion) and 
peripheral (tachycardia, hypertension, hyperthermia, hyponatremia, 
nausea, vomiting and chest pain) (Dargan et al., 2010; Winstock et 
al., 2011; Wood et al., 2010b). Psychotic disturbances may appear 
after high and multiple doses during one session, or in users with 
an underlying psychobiological vulnerability (Winstock et al., 2011). 
Synthetic cathinone hallucinations are frequently auditory and long 
lasting, they may appear after cessation and persist for several days 
thereafter while receiving treatment. The anxiolytic and 
antipsychotic drugs lorazepam, haloperidol, diazepam and 
risperidone have been used alone or in combination to successfully 
treat synthetic cathinone induced psychiatric disorders (Kasick et 
al., 2012; Lusthof et al., 2011; Stoica and Felthous, 2013). Synthetic 
cathinones produced serious physical problems that require 
substantial and prolonged medical treatment, including liver failure, 
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kidney failure, rhabdomyolysis, and the developments of 
compartment syndrome (Adebamiro and Perazella, 2012; Borek 
and Holstege, 2012; Levine et al., 2013; Stoica and Felthous, 2013). 
There have been numerous, well-documented deaths associated 
with mephedrone and other synthetic cathinones, some linked to 
self-reported use, others with post-mortem toxicological analysis 
(Aromatario et al., 2012; Cosbey et al., 2013; Dickson et al., 2010; 
European Monitoring Centre for Drugs and Drug Addiction, 2011, 
2012; Ghodse et al., 2010; Marinetti and Antonides, 2013; Maskell 
et al., 2011; Schifano et al., 2012; Torrance and Cooper, 2010; 
Wood et al., 2010a). However, the data must be interpreted with 
caution due to the concomitant consumption of synthetic 
cathinones and other recreational drugs such as alcohol, cannabis, 
cocaine, amphetamine or opioids (Dargan et al., 2011). 
The potential abuse liability of mephedrone has received 
limited investigation in comparison with others stimulants. 
However, the studies on animal models using drug-discrimination, 
place preference or self-administrations indicate a significant abuse 
liability for synthetic cathinones (Aarde et al., 2013; Hadlock et al., 
2011; Lisek et al., 2012). These models are thought to reflect the 
positive reinforcing, or rewarding, effects of drugs and subjective 
effects in human users, and these may be comparable to 
mephedrone users who report significantly increased desire and 
craving for the drug, paired with the development of withdrawal 
effects and tolerance (Freeman et al., 2012; Winstock et al., 2011). 
Effects during withdrawal period have been observed to include 
nasal congestion, tiredness, insomnia, irritability and an inability to 
concentrate (Winstock et al., 2011). There is not a described 
withdrawal treatment, so primarily supportive treatment is 
comprised of low benzodiazepine doses and antipsychotics for 
agitation and paranoia. Mephedrone seems to have the potential to 
induce tolerance, therefore a quick progression to regular drug use 
is possible (Schifano et al., 2010a). Users may feel a strong urge to 
use and keep using despite problems, prompting a potential abuse 
liability. Of particular interest is mephedrone related dependence. 
Mephedrone users reported addictive potential of several synthetic 
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cathinones, which is likely related to the increase in extracellular 
dopamine in the nucleus accumbens that has been demonstrated in 
animals models (Kehr et al., 2011). There is strong evidence for 
craving responses elicited in mephedrone users that reveal an 
intense compulsion to self-administer the drug on repeated 
occasions (Bajaj et al., 2010; Dargan et al., 2011; EMCDDA, 2011; 
Newcombe, 2009). 
Cognitive Effects of Mephedrone Exposure 
Only few studies have investigated cognitive deficits 
associated with mephedrone exposure in humans. Freeman and 
colleagues (2012) have assessed working memory (WM), 
phonological and semantic fluency, psychomotor speed and 
executive control in mephedrone users. Compared to controls, they 
showed only a significant deficit in working memory performance, 
but not in the other domains. Herzig and colleagues (2013) 
speculated that “mephedrone consumption does not necessarily 
exert a negative impact on cognitive functioning by itself. Instead, 
mephedrone users are likely to be those individuals who are prone 
to consuming other psychoactive drugs in conjunction with 
mephedrone”.  
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Chapter 3 
Long-term effects of chronic khat use: 
impaired inhibitory control 
Abstract 
So far no studies have systematically looked into cognitive 
impairments in khat users. This study compared the ability to 
inhibit and execute behavioral responses in adult khat users and in 
khat-free-matched sample controlled for age, race, gender 
distribution, level of intelligence, and alcohol and cannabis 
consumption. Response inhibition and response execution were 
measured by a stop-signal paradigm. Results show that users and 
non-users are comparable in terms of response execution but users 
need significantly more time to inhibit responses to stop-signals 
than non-users. The inability to stop on time may have 
repercussions for daily life activities as driving a car. 
Introduction 
Leaves from the flowering evergreen khat tree have been 
chewed in East-Africa since ancient times to alleviate fatigue, stay 
alert, reduce hunger and induce euphoria. Khat consumption has 
increased during the last decades in Eastern Africa and has become 
a global phenomenon spreading to ethnic communities in the rest 
of the world, such as in The Netherlands, United Kingdom, Canada 
or United States (United Nations Office on Drugs and Crime, 
2010). The airport of Amsterdam and London, where arrived 
weekly a big amount of khat, have become the European 
distribution points (Beckerleg, 2008; Pennings, Opperhuizen, & van 
Amsterdam, 2008). In particular, in The Netherlands, it is legal to 
buy and sell khat bundles compared to other countries as Canada, 
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U.S.A., France, Norway, Poland where the use, sell and possess of 
khat is considered illegal. 
The acute consumption of khat is associated with 
optimism, mild euphoria, excitation, talkativeness, increased energy 
and enhanced self-esteem (Brenneisen, Fisch, Koelbing, 
Geisshusler, & Kalix, 1990; Kalix, 1996). The half-life is about 4 
hours, depending on the amount of chewed khat. When the acute 
effects vanish, users experience feeling of depletion, insomnia, 
numbness, depression, lack of energy and mental fatigue. At a long 
term, chronic (i.e. daily) use of khat is associated with increased 
blood pressure, development of gastrointestinal tract problems, 
cytotoxic effects on liver and kidneys and keratotic lesions at the 
side of chewing).  
Cathine (Norpseudoephedrine) and cathinone 
(Benzoylethanamine), the active ingredients of khat, are similar in 
structure and pharmacological activity to amphetamines (Wagner et 
al., 1982). The two alkaloids act by increasing dopamine (DA), 
serotonin and noradrenalin (Kalix & Braenden, 1985). For this 
reason khat is also called “natural amphetamines”. Cathinone 
increases levels of DA in the brain by acting on the 
cathecholaminergic synapses, retarding DA reuptake inactivation 
and/or enhancing DA release (Patel, 2000; Wagner et al., 1982), in 
particular in the striatum (Zelger & Carlini, 1981).  
Studies addressing the neurobiological mechanism 
underlying the use of khat are still lacking as well as studies that 
have systematically looked into the long-term cognitive effects of 
chronic khat use. Nevertheless, given the similarity of khat and 
amphetamine in structure and pharmacological activity, it makes 
sense to assume that the long-term use of khat affects the same 
neurotransmitter and brain structures as the chronic use of 
amphetamine (see Berman et al., 2008). At a structural level, one 
may thus expect white matter abnormalities, lower cortical gray 
matter volume, and higher striatal volume. In particular, higher 
striatal volumes might reflect a compensation for toxicity in the 
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dopamine-rich basal ganglia. At a functional level, in turn, chronic 
khat use is likely to be associated with reduced functioning of 
dopamine D2 (DAD2) receptors in the striatum and dysfunctions 
in prefrontal cortex (PFC) and orbitofrontal cortex (OFC) – areas 
that have been shown to play major roles in the control of goal-
directed action (Miller, 2000). 
Interestingly, DA has a key role in inhibitory action control 
(Colzato et al., 2010; Colzato et al., 2009). Behavioral inhibitory 
efficiency is commonly assessed by means of the stop-signal task 
(Logan & Cowan, 1984). In this task, participants are first presented 
with a stimulus (i.e., a go signal) prompting them to execute a 
particular manual response, and this stimulus may or may not be 
followed by a stop signal calling for the immediate abortion of that 
response. Based on the mathematical considerations formulated by 
Logan and Cowan (1984), the stop-signal paradigm provides a 
direct behavioral assessment of the individual ability to stop a 
planned or ongoing motor response in a voluntary fashion and a 
quantitative estimate of the duration of the covert response-
inhibition process (i.e., stop-signal reaction time or SSRT; see 
Figure 1). Parkinson’s patients, who suffer from loss of 
dopaminergic neurons in the basal ganglia, showed longer SSRTs 
(Gauggel, Rieger, & Feghoff, 2004) and impaired suppression of 
conflicting responses (Wylie et al., 2009; Wylie, Ridderinkhof, 
Bashore, & van den Wildenberg, 2010)  compared to matched 
controls. Consistent with this picture, spontaneous eyeblink rate 
(EBR), a marker of dopaminergic functioning, reliably predicts the 
efficiency in inhibiting unwanted action tendencies in a stop-signal 
task (Colzato et al., 2009; see Logan, 1994, for a review). Along the 
same lines Colzato and colleagues observed that recreational users 
of cocaine, who are likely to suffer from reduced dopamine D2 
receptors in the striatum (Volkow, Fowler, & Wang, 1999), need 
significantly more time to inhibit responses to stop-signals than 
non-users. Very recently, Colzato et al. (2010) found that DA D2 
receptor (DRD2) C957T T/T homozygotes were also less efficient 
in inhibiting prepotent responses. 
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So far, surprisingly, no studies have systematically looked 
into cognitive impairments in khat users. In the present study we 
tested, by means of the stop-signal task (Logan & Cowan, 1984), 
whether khat use produces deficiencies of inhibitory control. Given 
the above mentioned links between DA and inhibitory action 
control on the one hand and between DA and khat on the other 
hand, we expected impairments of inhibitory control among khat 
users. 
Material and Method 
Participants 
Forty young healthy adults (36 men and 4 women) were 
compensated for their collaboration. They constituted the two 
groups of khat users and khat-free controls. The sample was drawn 
from 50 adults in the Leiden and The Hague metropolitan area, 
who volunteered to participate in studies of behavioral 
pharmacology. Participants were recruited via ads posted on 
community bulletin boards and by word of mouth. We made sure 
that the users met the following criteria: (1) last month 
consumption by chewing route for a minimum 1 year; (2) no 
clinically significant medical disease and (3) no use of medication 
criteria. All khat users met more than four of the seven criteria that 
according to the American psychiatric Association DSM-IV and the 
World Health Organization (ICD-10) define addiction: tolerance, 
withdrawal, difficulty controlling the use, negative consequences for 
job, family and health, significant time or emotional energy spent in 
searching/consuming the drug, put off or neglected activities 
because of the use, and desire to cut down the use. Khat-free 
controls met the same criteria except that no one reported any 
history of past or current khat use. 
Participants were asked to refrain from taking all 
psychoactive drugs for at least 24 hours before the test, not to 
consume alcohol on the night before the experimental session, and 
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to have a normal night rest. Participant’s compliance with the 
instruction was encouraged by taking a (no further analyzed) saliva 
sample test at the beginning of the session. In 
psychopharmacological research this deceptive method is often 
used and considered effective in studies addressing acute effects 
(Colzato, Erasmus, & Hommel, 2004; Ridderinkhof et al., 2002) 
and long-term effects of drugs (Alting von Geusau, Stalenhoef, 
Huizinga, Snel, & Ridderinkhof, 2004; Colzato et al., 2009). 
Participants in two groups were matched for ethnicity 
(100% African), age, sex, IQ, (measured by Raven’s Standard 
progressive matrices (SPM); Raven, 1988) and alcohol and cannabis 
consumption. Even if khat was the preferred drug of use for the 
participants, some of them drunk alcohol (7) on a weekly base and 
used cannabis (3) monthly base. All khat users (and non-users) 
reported to have never used LSD, MDMA, cocaine, amphetamine, 
barbiturates, ketamine, GHB or speed. Demographic and drug use 
statistics are provided in Table 1. Written informed consent was 
obtained from all participants after the nature of the study was 
explained to them. The protocol and the remuneration 
arrangements of 25 Euro were approved by institutional review 
board (Leiden University, Institute for Psychological Research). 
  




Table 1. Demographic characteristics and self-reported use of khat and 
other psychoactive drugs. Standard deviations are presented within 
parentheses. 
Notes. IQ: measured by means of the Raven’s Standard Progressive 
Matrices, 
Bundles used:  number of khat bundles consumed in a typical day/session 
Hours chewing khat: amount of time the users spend chewing khat in a 
typical day/session 
Monthly drinks: monthly number of standard alcoholic drinks 
ns Nonsignificant group difference 
* Significant group difference, p<0.05 
** Significant group difference, p<0.01 
  
Sample Khat users  Khat-free controls 
N (M:F)ns 20 (18:2)  20 (18:2) 
Age (years)  ns 31.3 (6.5)  30.7 (5.8) 
IQ  ns 110 (3.3)  112 (3.0) 
Khat exposure (years) ** 10.5 (6.5)  0 
Khat times in a week ** 3.1 (1.8)  0 
Bundles used (khat shrubs) ** 3.0 (1.2)  0 
Bundles used in one session 1.0 (1.9)  0 
Hours chewing khat ** 5.8 (1.7)  0 
Monthly exposure (joints)  ns 2.0 (0.4)  2.1 (0.3) 
Monthly drinks (units)  ns 8.4 (0.5)  6.4 (0.6) 
Lifetime cocaine (grams)  ns 0  0 
Lifetime amphetamines 
(grams)  ns 
0  0 
Lifetime ketamine (grams)  ns 0  0 
Lifetime Speed (grams)  ns 0  0 
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Apparatus and stimuli 
The experiment was controlled by a ACPI uniprocessor 
PC running on an Intel Celeron 2.8 gHz processor, attached to a 
Philips 109B6 17 inch monitor (LightFrame 3, 96 dpi with a refresh 
rate of 120 Hz). Responses were made by pressing the “Z” or “?” 
of the QWERTY computer keyboard with the left and right index 
finger, respectively. Participants were required to react quickly and 
accurately by pressing the left and right key in response to the 
direction of a left- or right-pointing green arrow (go trials) of about 
3.5 X 2.0 cm with the corresponding index finger.  
Procedure 
All participants were tested individually. Participants 
completed the SPM (Raven et al., 1988) and performed the stop-
signal task for about 30-min. Participants were allowed to take a 
short break (up to 5 minutes) between task blocks.  
IQ 
Individual IQs were determined by means of a 30-min 
reasoning-based intelligence test (Raven Standard Progressive 
Matrices: SPM). The SPM assesses the individual's ability to create 
perceptual relations and to reason by analogy independent of 
language and formal schooling; it is a standard, widely-used test to 
measure Spearman's g factor as well as fluid intelligence (Raven 
et al., 1988). Participants completed the SPM and subsequently 
performed on the behavioral task measuring inhibitory control. 
  




The experimental session consisted of a 30-min session in 
which participants completed a version of the stop-signal 
task adopted from Colzato et al., (2007); see also Colzato 
et al., 2009; Colzato et al., 2010). Each trial began with the 
presentation of an arrow (pseudo-randomly) pointing to 
the left of right (with a probability of 50% each). Arrows 
were presented pseudo-randomly for maximal 1500 ms, 
with the constraint that they signaled left- and right-hand 
responses equally often. Arrow presentation was response-
terminated. Intervals between subsequent go signals varied 
randomly but equiprobably, from 1250 to 1750 ms in steps 
of 125 ms. During these interstimulus intervals, a white 
fixation point (3 mm in diameter) was presented. The green 
arrow changed to red on 30 % of the trials, upon which the 
choice response had to be aborted (stop trials). A staircase-
tracking procedure dynamically adjusted the delay between 
the onset of the go signal and the onset of the stop signal 
to control inhibition probability (Levitt, 1971). After a 
successfully inhibited stop trial, stop-signal delay in the 
next stop trial increased by 50 ms, whereas the stop-signal 
delay decreased by 50 ms in the next stop trial when the 
participant was unable to stop. This algorithm ensured that 
motor actions were successfully inhibited in about half of 
the stop trials, which yielded accurate estimates of SSRT 
and compensates for differences in choice RT between 
participants (Band, van der Molen, & Logan, 2003; see 
Figure 1). The stop task consisted of five blocks of 104 
trials each, the first of which served as a practice block to 
obtain stable performance. 
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Figure 1. Calculation of stop-signal RT (SSRT) according to a race 
model. The curve depicts the distribution of RTs on go trials (trials 
without a stop signal) representing the finishing times of the response 
processes. Assuming independence of go and stop processes, the 
finishing time of the stop process bisects the go RT distribution. Given 
that the button-press response could be withheld in 50% of all stop 
trials, stop-signal RT (200 ms) is calculated by subtracting the mean stop-
signal delay (100 ms) from the median go RT (300 ms). 
Statistical analysis 
First, independent samples t-tests were performed for 
analyses of age, sex, IQ differences between genotype groups. 
Second, individual SSRTs for stop-signal trials were calculated to 
index response inhibition for all participants. SSRTs were analyzed 
separately by means of univariate ANOVAs with Group (Khat 
users vs. Khat-free controls) as between-subject factor. Third, to 
test whether the magnitude of inhibitory efficiency is proportional 
to the degree of exposure to khat, we computed Pearson 
correlation coefficients between the amount of cocaine consumed 
and SSRT. A significance level of p<.05 was adopted for all 
statistical tests. 





No significant group differences were obtained for age, 
t(38)= 0.306, p=0.761, intelligence, t(38)= -0.973, p=0.337, alcohol 
consumption, t(38)= 0.478, p=0.521, or cannabis consumption, 
t(38)= 0.169, p=1.00. Table 1 shows drug-use profiles for the two 
groups. 
Stop-Signal Task  
Analyses of mean RT to go-signals showed that khat users 
(530 ms) did not react significantly faster than khat-free controls 
(480 ms). SSRTs were computed for each participant and for each 
group separately. All participants were able to stop their responses 
on stop-signal trials successfully in about half of the time a stop 
signal instructed them to do so (51.9 % in Khat users and 49.7 % in 
Khat-free controls), indicating that the dynamic tracking algorithm 
worked well in both groups. The percentage of choice errors to go-
signals was low and did not discriminate between Khat users (1.8 
%) and Khat-free users (1.0%). Most importantly, SSRTs were 
significantly longer for users (236 ms) than for non-users (192 ms), 
F(1,38) = 33.21, p< 0.001, MSE = 584.624, η2p = 0.47, see Figure 
1. To test whether the magnitude of cognitive impairments is 
proportional to the amount of Khat consumed, we computed 
Pearson correlation coefficients between the individual lifetime 
khat exposure, hours chewing and number of bundles used in a 
khat session and SSRT. No significant correlations were obtained, 
probably due to the limited distribution of the data. 
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Figure 2. Calculation of stop-signal RT (SSRT) according to a race 
model. The curve depicts the distribution of RTs on go trials (trials 
without a stop signal) representing the finishing times of the response 
processes. Assuming independence of go and stop processes, the 
finishing time of the stop process bisects the go RT distribution. Given 
that the button-press response could be withheld in 50% of all stop 
trials, stop-signal RT (200 ms) is calculated by subtracting the mean stop-
signal delay (100 ms) from the median go RT (300 ms). 
Discussion 
This study tested, for the first time, whether the use of 
khat is associated with a detectable selective impairment in the 
ability to inhibit responses. As expected, we found that khat users 
were roughly comparable to khat free controls in Go RT but khat 
users showed significantly elevated SSRTs. In other words, chronic 
khat use is associated with impaired inhibitory control. We attribute 
this deficit to the possibility that, at long-term use, cathinone, the 
active ingredient of khat, is associated to dysfunctions in PFC and a 
reduced DA level in the striatum – the neurotransmitter that plays a 
crucial role in response inhibition (Colzato et al., 2010; Colzato & 
Hommel, 2009; Colzato et al., 2007; Gauggel et al., 2004). 
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It may be important to note that the group difference in 
response execution was unreliable but approached the statistical 
significance level, suggesting that a larger sample might have 
rendered this effect reliable. On the one hand, this means that it 
would be premature to exclude a general performance deficit in 
chronic khat users until converging evidence is available. On the 
other hand, however, the staircase method that we used allowed 
separating SSRT from the general RT level, which ensures that the 
former cannot be explained on the basis of the latter. That is, the 
SSRT effect does indicate a specific impairment in inhibitory 
processes in khat users over and beyond a possible general 
performance deficit. 
Even though the empirical connection between inhibitory 
control functions and khat use is considerable, the causal relation 
between the two may not be straightforward. Indeed, we cannot 
exclude that preexisting neuro-developmental factors may play a 
mediating role and that khat users may suffer preexisting problems 
in inhibitory control and impulsivity, as it is already the case for 
cocaine users (Bechara, 2005; Verdejo-García, Lawrence, & Clark, 
2008). Notwithstanding this caveat, the connection between 
inhibitory efficiency and khat use seems rather strong – the more 
so as a number of possible confounds were controlled for in this 
study: the khat users that participated in the current study were 
barely exposed to other drugs and the two groups were well 
matched in terms of age, IQ, sex, race, and alcohol and cannabis 
consumption. Especially the matching of age was essential: while 
inhibitory control seems not to be related to general intelligence, 
there is evidence that cognitive inhibitory processes decline in 
efficacy throughout the life span (Williams, Ponesse, Schachar, 
Logan, & Tannock, 1999). 
The present findings raise the question whether 
recreational khat users also show impairments in other cognitive 
control functions, such as the shifting between tasks and mental 
sets, and the updating and monitoring of working memory (Miyake 
et al., 2000). The direct effects of khat use on the brain need to be 
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explored as well. It remains to be demonstrated, for instance, that 
the use of khat produces changes at neuromodulatory level (DA), 
cortical functioning (decreased neural activity in the striatum and 
prefrontal cortex), genetic vulnerability and changes in expression 
of genes. For instance, it would be informative to investigate 
whether, among khat users, there is also a genetic association with 
the Taq A1 of the DRD2 polymorphism as in the case of alcohol 
dependence (Blum et al., 1990) and cocaine addiction (Noble et al., 
1993). This association would be useful as marker for a genetic 
vulnerability. 
Of particular interest would be to look into the acute 
effects of khat. Previous research addressing the acute effect of 
other psychostimulant drugs – as cocaine – has shown a drug-
induced facilitation of inhibitory control (Fillmore, Rush, & Hays, 
2006). Interestingly, in this study, stop-signal performance revealed 
a quadratic dose–response function suggesting that the 
improvement of inhibitory control is limited to a range of 
intermediate doses, while with lower and higher doses performance 
deficits are more likely. It also remains to be seen whether the long-
term use of khat has similar effects and after-effects (after periods 
of abstinence) on receptor characteristics, DA sensitivity, etc., as 
have been observed with the long-term use of other 
psychostimulant drugs like cocaine (Kreek, Nielsen, Butelman, & 
LaForge, 2005). 
The findings of this study are rather worrying because, 
first, many real-life situations require the active inhibition of pre-
potent actions, as in the case of traffic lights turning red or of 
criminal actions. Consistent with this idea, the increasing number of 
traffic accidents in the Eastern Africa countries has been related to 
the chewing khat habit (Toennes & Kauert, 2004). Chronic khat use 
may indeed lead to a marked deterioration of psychophysical 
functions (as inhibitory control) implicated in driving behaviour. 
Second, this impairment of inhibitory control has serious 
implications for personal or societal functioning. This reduced level 
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of inhibitory control may even be involved in the emergence of 
addiction: the more a drug is used, the less able users are to prevent 
themselves from using it. In fact, socioeconomic and familiar 
problems are common among khat consumers. Many men secure 
their daily portion of khat at the expense of vital needs, indicating 
dependence. Family life is harmed because of neglect, dissipation of 
family income and inappropriate behaviour and in countries like 
Ethiopia or Kenya, khat addicts are the main group among persons 
treated for drug problems (UNODC: World Drug Report, 2010).  
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Chapter 4 
Khat use is associated with impaired 
Working Memory and Cognitive 
Flexibility 
Abstract 
Khat consumption has increased during the last decades in 
Eastern Africa and has become a global phenomenon spreading to 
ethnic communities in the rest of the world, such as in The 
Netherlands, United Kingdom, Canada, and the United States. Very 
little is known, however, about the relation between khat use and 
cognitive control functions in khat users. We studied whether khat 
use is associated with changes in working memory (WM) and 
cognitive flexibility, two central cognitive control functions. Khat 
users and khat-free controls were matched in terms of sex, 
ethnicity, age, alcohol and cannabis consumption, and IQ (Raven’s 
progressive matrices). Groups were tested on cognitive flexibility, 
as measured by a Global-Local task, and on WM using an N-back 
task. Khat users performed significantly worse than controls on 
tasks tapping into cognitive flexibility as well as monitoring of 
information in WM. The present findings suggest that khat use 
impairs both cognitive flexibility and the updating of information in 
WM. The inability to monitor information in WM and to adjust 
behavior rapidly and flexibly may have repercussions on daily life 
activities. 
Introduction 
The khat plant (Catha Edulis) is a flowering evergreen tree 
that grows at high altitudes. It is cultivated especially in East-Africa 
and the south west of the Arabian Peninsula, in countries such as 
Somalia, Kenya, Djibouti, Yemen, or Ethiopia. In those countries 
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the chewing of khat is also very common; it is consumed as qat and 
kat in Yemen; eschat in Ethiopia; miraa, kijiti, gomba, mbachu or 
veve in Kenya; and as mairungi in Uganda. 
Historically, khat leaves have been chewed since ancient 
times to alleviate fatigue, enhance work capacity, stay alert, reduce 
hunger, and to induce euphoria and enhanced self-esteem 
(Brenneisen, Fisch, Koelbing, Geisshusler, & Kalix, 1990; Kalix, 
1996). Khat has been appreciated for medical purposes too 
(Carrier, 2008), and even for its aphrodisiac effects, but it is also 
used for recreational purposes (Krikorian, 1984). It is habitually 
used in informal meetings (khat sessions) in which the participants 
are engaged in discussions and maintain social contact. During khat 
sessions, the leaves and the tender younger stalks of the plant are 
chewed slowly over several hours and they are kept in the side of 
the cheek until the mouth is filled with fresh leaves. The users then 
chew intermittently to release the active components and then spit 
out the residues (Al-Habori, 2005). 
The half-life of khat is about 4 hours, depending on the 
amount of chewed khat. When the acute effects disappear, 
consumers experience feelings of depletion, insomnia, numbness, 
depression, lack of energy, and mental fatigue. Long-term, chronic 
(i.e. daily) use of khat is associated with increased blood pressure, 
development of gastrointestinal tract problems, cytotoxic effects on 
liver and kidneys, and keratotic lesions at the side of chewing (Al-
Habori, 2005). 
Many authors have argued about the causal role of khat in 
exacerbating psychotic reactions. In psychotic patients, khat may 
aggravate thought disturbances (hallucinations and delusions), 
induce aggressive behavior, and create difficulties in treating these 
patients (Hassan, Gunaid, & Murray-Lyon, 2007; Kalix & 
Braenden, 1985). Regular users with a predisposition to psychotic 
symptoms, including schizotypal or schizoid traits and family 
disorders, also have an increased risk of khat-induced psychosis. 
The psychotic symptoms are abated rapidly when khat is withdrawn 
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(Hoffman & al’ Absi, 2010; Pantelis, Hindler, & Taylor, 1989). 
However, recently, Odenwald, (2007) challenged this assumption 
concluding that the causal relationship between general 
psychopathology and khat use remains unclear and that people with 
preexisting vulnerability should avoid using khat. Socio-economic 
and familiar problems may also arise in khat consumers (Balint, 
Falkay, & Balint, 2009; Cox, 2003; Pennings, Opperhuizen, & van 
Amsterdam, 2008). Many men secure their daily portion of khat at 
the expense of vital needs, indicating dependence. Family life is 
harmed because of neglect, dissipation of family income, and 
inappropriate behaviour. In countries like Ethiopia or Kenya, khat-
dependent individuals are the main group among those treated for 
drug problems (UNODC, 2010). 
The active ingredients of Catha Edulis are cathine 
(norpseudoephedrine) and cathinone (Benzoylethanamine). These 
alkaloids are similar in structure and pharmacological activity to 
amphetamines (Wagner, Preston, Ricaurte, Schuster, & Seiden, 
1982). The acute effects of cathinone and cathine on 
neurotransmitters are basically comparable to amphetamines 
effects: both stimulate the CNS and suppress appetite. However, 
cathinone has a more rapid onset and a shorter half-life than 
amphetamine. The two alkaloids act by increasing dopamine (DA), 
serotonin and noradrenaline (Kalix & Braenden, 1985). For this 
reason khat is called a “natural amphetamine”. Even though the 
literature on the effect of Catha Edulis compounds on humans is 
scarce, khat is considered to increase blood pressure and heart rate, 
and is associated with euphoregenic and psychostimulants effects 
(Brenneisen et al., 1990). 
Cathinone is probably the main contributor to the 
stimulant effect of khat. Cathinone is an unstable molecule that 
rapidly transforms into cathine. Cathine is a less powerful stimulant 
and the pharmacological conversion from cathinone to cathine 
causes the decrease of stimulating properties of khat leaves over 
time. Fresh leaves have a greater ratio of cathinone to cathine than 
dried ones (Chappell & Lee, 2010). Therefore, the fresh leaves have 
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more psychoactive effects and a number of techniques are in use to 
slow down the degradation process (e.g., wrapping the khat in 
banana leaves). To provide consumers with fresh leaves, khat is 
delivered by air around the world, commonly no later than five days 
after been harvested. When the leaves are chewed, cathinone is 
absorbed through the buccal mucosa and the stomach. After 
absorption it is metabolically transformed into norephedrine 
(Feyissa & Kelly, 2008). The effects of oral administration of 
cathinone occur more rapidly than the effects of amphetamine; 
roughly 15 minutes as compared to 30 minutes in amphetamine. 
Cathinone increases levels of DA in the brain by acting on the 
cathecholaminergic synapses, delaying DA reuptake inactivation 
and/or enhancing DA release (Patel, 2000; Zelger & Carlini, 1981), 
in particular in the striatum (Zelger & Carlini, 1981). However, it is 
important to note that the consumption of cathinone in pure form 
is not entirely comparable with chewing khat leaves. 
Studies addressing the neurobiological mechanism 
underlying the use of khat are still missing as well as studies that 
have systematically investigated the long-term cognitive effects of 
chronic khat use. Nevertheless, given the similarity of khat and 
amphetamine in structure and pharmacological activity, it makes 
sense to assume that the long-term use of khat affects the same 
neurotransmitter and brain structures as the chronic use of 
amphetamine (see Berman, O’Neill, Fears, Bartzokis, & London, 
2008). At a structural level, one may thus expect white matter 
abnormalities, lower cortical gray matter volume, and higher striatal 
volume. In particular, higher striatal volumes might reflect a 
compensation for toxicity in the dopamine-rich basal ganglia. At a 
functional level, in turn, chronic khat use is likely to be associated 
with reduced functioning of Dopamine D2 (DAD2) receptors in 
the striatum and dysfunctions in prefrontal cortex (PFC) and 
orbitofrontal cortex (OFC)—areas that have been shown to play 
major roles in cognitive control (Miller, 2000). 
Interestingly, DA has a key role in WM processes (Braver 
& Cohen, 2000; Sawaguchi & Goldman-Rakic, 1991) and in the 
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ability to flexibly alter cognitive representations (Cools, Gibbs, 
Miyakawa, Jagust, & D’Esposito, 2008). According to Moustafa et 
al.(2008), the striatum serves as a gate to modulate when and when 
not to update information into PFC. Consistent with this idea, 
Siessmeier et al. (2006) found that administering DA agents to 
healthy subjects leads to a correlation between DA uptake in the 
striatum and dorso-lateral PFC (DLPFC) BOLD activity, 
suggesting that the striatum might drive activity in the PFC. 
Moreover, a PET study showed that working memory capacity 
predicts dopamine synthesis capacity in the striatum (Cools et al., 
2008). Consistent with these findings, previous studies on chronic 
amphetamine users and mice provided evidence for impairment on 
WM due to amphetamine use (Baicy & London, 2007; Berman 
et al., 2008; Daumann, Fischermann, Heekeren, Thron, & 
Gouzoulismayfrank, 2004; Daumann et al., 2003). Similarly, studies 
investigating patients with Parkinson's disease (PD), a 
neurodegenerative disorder characterized by severe DA depletion 
in the striatum, showed decrements for the flexible alteration of 
cognitive representations (Roshan Cools & Robbins, 2004). Along 
the same lines, there is evidence of decreasing mental flexibility due 
to amphetamine use (van der Plas, Crone, van den Wildenberg, 
Tranel, & Bechara, 2009). 
Khat consumption in Eastern Africa has increased during 
the last decades and has become a global phenomenon spreading to 
ethnic communities in the rest of the world, such as in the 
Netherlands, United Kingdom, Canada, and the United States 
UNODC, 2010). Amsterdam airport, where a large amount of khat 
arrives weekly, has become a European distribution point 
(Beckerleg, 2008; Pennings et al., 2008). In the Netherlands, khat 
bundles are commonly sold in restaurants, grocery stores and 
smartshops, which makes this country a suitable platform to 
investigate the effects of the drug. 
Surprisingly, only one study has systematically looked into 
cognitive impairments in khat users so far. Colzato et al. (2011) 
reported that khat users exhibit impairments in the inhibition of 
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overt manual responses assumed to rely on proper dopaminergic 
functioning (Colzato, van den Wildenberg, Van der Does, & 
Hommel, 2010). The ability to inhibit unwanted thoughts and 
actions is commonly considered an important part of executive 
control, but it represents just one of a larger set of cognitive control 
functions. In an attempt to categorize the available concepts and 
measures in a coherent fashion, Miyake and colleagues have 
investigated the psychometric relationships between the tests and 
tasks that are commonly used to assess cognitive control (Friedman 
& Miyake, 2004; Friedman et al., 2006; Miyake et al., 2000). Their 
findings suggest the existence of three major, separable control 
functions: the “inhibition” of unwanted responses, the “shifting” 
between tasks and mental sets (also called “flexibility”), and the 
“updating” (and monitoring of) working memory (WM) 
representations. Miyake and colleague’s model has been previously 
used to investigate cognitive impairments among recreational users 
of cocaine and MDMA (Alting von Geusau, Stalenhoef, Huizinga, 
Snel, & Ridderinkhof, 2004; Colzato, Huizinga, & Hommel, 2009). 
Given the link between khat use and impaired inhibitory 
control, the current study focused on the two remaining cognitive 
control functions; flexibility and updating. Importantly for the 
current study, the above mentioned links between DA and 
“updating” (and monitoring of) WM representations and mental 
flexibility on the one hand, and between DA and khat on the other, 
suggest that WM monitoring and mental flexibility are impaired in 
khat users. We tested both hypotheses by comparing khat users and 
matched khat-free controls in a task assessing the efficiency of 
monitoring information in WM and a task that taps into cognitive 
flexibility. 
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Material and Method 
Participants 
Forty young healthy adults (36 men and 4 women) were 
compensated for their participation. They constituted the two 
groups of 20 khat users and 20 khat-free controls. The sample was 
drawn from 50 adults in the Leiden and The Hague metropolitan 
area, who volunteered to participate in studies of behavioral 
pharmacology. Participants were recruited via ads posted on 
community bulletin boards and by word of mouth. Participants 
were selected via a phone interview. Based on the interview, we 
excluded 10 of the 50 potential participants because of current 
medication use. 
We made sure that the users met the following criteria: (1) 
khat consumption by chewing route for a minimum of 1 year; (2) 
no clinically significant medical disease and (3) no use of 
medication. All khat users met more than four of the seven criteria 
that according to the American psychiatric Association DSM-IV 
and the World Health Organization (ICD-10) define addiction: 
tolerance, withdrawal, difficulty controlling the use, negative 
consequences for job, family and health, significant time or 
emotional energy spent in searching/consuming the drug, put off 
or neglected activities because of the use, and desire to cut down 
the use. None of the khat-free controls reported any history of past 
or current khat use. 
Participants were asked to refrain from taking any 
psychoactive drugs for at least 24 hours before the test, not to 
consume alcohol on the night before the experimental session, and 
to have a normal night rest. Participant's compliance with the 
instruction was encouraged by taking a (not further analyzed) saliva 
sample test at the beginning of the session (cf. Colzato et al., 2009; 
Colzato, Erasmus, & Hommel, 2004). 
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The two groups were matched for ethnicity (100% 
African), age, sex, IQ, (measured by Raven's Standard progressive 
matrices (SPM); Raven, Court, & Raven, 1988) and alcohol and 
cannabis consumption. Even though khat was the preferred drug 
for users, some of them drink alcohol (7) on a weekly base and 
used cannabis (3) on a monthly base. Khat users and non-users 
reported to have never used LSD, MDMA, cocaine, amphetamine, 
barbiturates, ketamine, GHB or speed. Demographic and drug use 
information are provided in Table 1. Written informed consent was 
obtained from all participants after the nature of the study was 
explained to them. The protocol and the remuneration 
arrangements of 25 Euro were approved by the institutional review 
board (Leiden University, Institute for Psychological Research). 
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Sample Khat users  Khat-free controls 
N (M:F) ns 20 (18:2)  20 (18:2) 
Age (years) ns 31.3 (6.5)  30.7 (5.8) 
Raven IQ ns 110 (3.3)  112 (3.0) 
Khat exposure (years) ** 10.5 (6.5)  0 
Khat times in a week ** 3.1 (1.8)  0 
Bundles used (khat shrubs) ** 3.0 (1.2)  0 
Bundles used in one session 1.0 (1.9)  0 
Hours chewing khat ** 5.8 (1.7)  0 
Monthly exposure (joints) ns 2.0 (0.4)  2.1 (0.3) 
Monthly drinks (units) ns 8.4 (0.5)  6.4 (0.6) 
Lifetime cocaine (grams) ns 0  0 
Lifetime amphetamines 
(grams) ns 
0  0 
Lifetime ketamine (grams) ns 0  0 
Lifetime Speed (grams) ns 0  0 
Table 1. Demographic characteristics and self-reported use of khat and 
other psychoactive drugs. Standard deviations are presented within 
parentheses. 
 
Notes. Raven IQ: IQ measured by means of the Raven’s Standard 
Progressive Matrices, 
Bundles used:  number of khat bundles consumed in a typical day/session 
Hours chewing khat: amount of time the users spend chewing khat in a 
typical day/session 
Monthly drinks: monthly number of standard alcoholic drinks 
ns Nonsignificant group difference 
* Significant group difference, p<0.05 
** Significant group difference, p<0.01 




The tasks used in this study have been previously 
employed to systematically investigate the neurotoxic effects of 
recreational MDMA use (Alting von Geusau et al., 2004; Daumann 
et al., 2004) and recreational use of cocaine (Colzato et al., 2009; 
Colzato, van den Wildenberg, & Hommel, 2007). Similar to these 
studies and following Miyake et al., we defined cognitive flexibility 
as the ability to adapt and restructure cognitive representations in 
response to changing situational demands (cf., Monsell, 1996). We 
used the N-back task (see, Kane, Conway, Miura, & Colflesh, 
(2007), for a recent review) to assess the operational component of 
WM and a task-switching design (Colzato, van Leeuwen, van den 
Wildenberg, & Hommel, 2010) to assess flexibility. 
All participants were tested individually. Individual IQs 
were determined by means of a 30-min reasoning-based intelligence 
test (SPM). The SPM assesses the individual's ability to create 
perceptual relations and to reason by analogy independent of 
language and formal schooling; it is a standard, widely-used test to 
measure Spearman's g factor and of fluid intelligence in particular 
(Raven et al., 1988). Participants provided a saliva sample, 
completed the SPM, and subsequently performed the behavioral 
tasks measuring cognitive flexibility and WM capacity. Participants 
were allowed to take a short break (maximal 10 minutes) between 
task blocks. The experiment was controlled by a PC attached to a 
17-inch monitor with a refresh rate of 120 Hz. Participants were 
seated approximately 0.5 m from the screen. 
N-Back task (WM monitoring) 
Participants performed two N-back tasks consisting of the 
sequential visual presentation (stimulus onset asynchrony 2000 ms; 
duration of presentation 1000 ms) of single letters (B, C, D, G, P, 
T, F, N, L). Participants had to press the left or right shift-key of 
the computer-keyboard when the target or the non-target appeared, 
respectively. Target definition differed with respect to the 
experimental condition. In the 1-back condition, targets were 
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defined as stimuli within the sequence that were identical to the 
immediately preceding one. In the 2-back condition, participants 
had to respond if the presented letter matched the one that was 
presented two trials before. The 1-back, and 2-back tasks differ in 
their amount of memory load and demands on executive control 
for the processing of information within working memory. Each 
block consisted of four cycles of the same task. 
Task switching (flexibility) 
Participants responded to randomly presented rectangles 
or squares by pressing a left or right response button, respectively. 
The target stimuli contained a global dimension (i.e., the overall 
shape was either a rectangle or a square) and a local dimension (the 
overall shape consisted either of small squares or small rectangles). 
Three blocks of trials were administered, two training blocks in 
which the instruction (global or local) was constant across all trials, 
followed by the experimental block in which participants switched 
between the global and the local task. In one of the two training 
blocks, participants responded to the local figure, in the other block 
they responded to the global figure. The order of the training 
blocks was randomized across participants and each block 
consisted of 50 trials. In the third block consisting of 160 trials, 
participants alternated between predictable sequences of four 
“local” and four “global” trials). A cue indicated to which 
dimension (global or local) the participants should respond. Cues 
that related to the global (local) dimension consisted of a big (small) 
square, presented at one side of the target stimulus, and a big 
(small) rectangle, presented at the other side of the target stimulus. 
The color of cues and target was red. Both remained on the screen 
until a response was given or 2500 ms had passed. The time interval 
between presentation of the cue and of the target stimulus varied 
between 400 ms and 500 ms and the interval between responses 
and the next presentation of the cue varied between 900 ms and 
1100 ms. 
  




We adopted a significance level of p<.05 for all statistical 
tests. Independent samples t-tests were used to analyze binary 
comparisons and ANOVAs otherwise. 
T-tests were performed for Group analysis of age, sex, IQ 
and alcohol, and cannabis consumption and in the N-back task to 
assess differences between khat users and khat-free controls. For 
switching performance mean RTs and proportions of errors (PE) 
were analyzed by means of ANOVAs using Target level (global vs. 
local), the Congruency between the stimuli on the two levels 
(congruent vs. incongruent), and Task switch (i.e., same vs. 
different target level as in previous trial: task repetition vs. 
alternation) as within-participants factor and Group (khat users vs. 
khat-free controls) as between-participants factor. Spearman 
correlation coefficients were computed between the degree of 
exposure to khat and cognitive performance in order to test 
whether the magnitude of cognitive impairments is proportional to 
the amount of khat consumed. Effect magnitudes were assessed by 




No significant group differences were obtained for age, 
t(38) = 0.306, p = 0.761, intelligence, t(38) = −0.973, p = 0.337, 
alcohol consumption, t(38) = 0.478, p = 0.521, or cannabis 
consumption, t(38) = 0.169, p = 1.00. Table 1 shows drug-use 
profiles for the two groups. 
Task  
The results per cognitive task are summarized below and in 
Table 2. The data of two male khat-users were excluded in both 
tasks because of their excessive error rates in the task-switching 
paradigm (PE>45%). 
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Task Switching 
Analyses of Mean RT showed three reliable main effects 
(see Table 2). First, the effect of Task switch, F(1,36) = 38.30, 
p<.0001, MSE = 7916.15, η2p = 0.52, was due to that repeating the 
task allowed for faster responding than switching between target 
levels (475 vs. 537 ms). Second, the effect of Target level, F(1,36) = 
23.52, p<.0001, MSE = 8728.09, η2p = 0.39, reflected the well-
known global preference (Navon, 1977), that is, faster responses to 
globally than locally defined targets (480 vs. 532 ms). Third, the 
Congruency effect, F(1,36) = 7.46, p<.01, MSE = 10881.70, η2p = 
0.17, indicated interference from the non-target level, that is, faster 
responses if the stimulus at the currently irrelevant level was 
congruent (e.g., a global square shape consisting of local squares) 
with the present target than if that stimulus was incongruent (e.g., a 
global square consisting of local rectangles; 489 vs. 522 ms, 
respectively). 
More important for present purposes, the size of the 
Switch effect varied by Group, F(1,36) = 5.68, p<.05, MSE = 
8073.45, η2p = 0.14: khat users showed more pronounced switching 
costs (i.e., a greater difference in RT between alternation trials and 
repetition trials) than khat-free controls. No other interaction was 
reliable. 
Analyses of error rates revealed three reliable main effects. 
First, an effect of Group, F(1,36) = 73.91, p<.0001, MSE = 
3065.69, η2p = 0.67: khat users committed significantly more errors 
than khat-free controls (21.3% vs. 4.0%). Second, the effect of 
Congruency, F(1,36) = 83.49, p<.0001, MSE = 322.34, η2p = 0.70, 
reflecting the interference of the irrelevant target level, as indicated 
by a smaller proportion of errors on congruent as compared to 
incongruent trials (3.3% vs. 22.1%). Third, the effect of Target 
level, F(1,36) = 5.17, p<.05, MSE = 686.91, η2p = 0.13, suggesting 
less errors to globally than locally defined targets (10.1% vs. 
15.2%). No other effect was significant. 
  




Mean RTs and accuracy—with the latter commonly being 
the more reliable measure in this task—were submitted to 
independent t-tests, see Table 2 for means. As expected, khat users 
committed significantly more errors in both the 1-back, t(36) = 
4.72, p = 0.001, and 2-back conditions, t(36) = .75, p = 0.001, see 
Table 2. RTs revealed no significant group differences in the 1-
back, t(36) = 0.53, p = 0.59, and 2-back conditions, t(36) = 1.37, p 
= 0.18. 
Task Khat users Khat-free 
controls 
N-BACK (WM monitoring)   
1-back   
      Reaction Times (ms) 494 (55) 504 (62) 
      Accuracy (%) 70 (17.5)* 91 (7.9)* 
2-back   
      Reaction Times (ms) 497 (68) 523 (50) 
      Accuracy (%) 62 (12.9)* 81 (11.4)* 
TASK SWITCHING (flexibility)   
Repetition   
      Reaction Times (ms) 494 (25) 455 (24) 
      Error Rates (%) 20.7 (1.6) 3.8 (1.5) 
Alternation   
      Reaction Times (ms) 581 (27) 492 (25) 
      Error Rates (%) 21.8 (1.7) 4.2 (1.6) 
Switch Costs   
      Reaction Times (ms)   87*   37* 
      Error Rates (%) 0.1 0.1 
Table 2. Means responses latencies (in ms), error rates (in percent), and 
standard deviations of measures for the N-back task and task switching. 
Switch Costs Reaction Times: difference in RT between alternation trials 
and repetition trials 
Switch Costs Error Rates: difference in error rates between alternation 
trials and repetition trials 
* Significant group difference, p<0.05 (referring to the interaction effect 
reported in the text) 
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Correlations 
To test whether the magnitude of cognitive impairments is 
proportional to the amount of khat consumed, we computed 
Pearson correlation coefficients between the individual life time 
khat exposure, hours chewing and number of bundles used in a 
khat session and switching costs, as well as accuracy in the n-back 
task. No significant correlations were obtained, probably due to the 
limited variability across users. 
Discussion 
This study tested, for the first time, whether khat use is 
associated with a detectable selective impairment in cognitive 
flexibility and WM. As expected, khat users showed increased 
switching costs, suggesting that recreational use is associated with 
impaired cognitive flexibility. Performance in khat users differed 
from performance in non-users also with respect to WM updating 
(the executive component of WM). We attribute these deficits to 
the possibility that long-term use of cathinone, the active ingredient 
of khat, is associated with dysfunctions in PFC and a reduced DA 
level in the striatum—the neurotransmitter that plays a crucial role 
in cognitive flexibility and updating of WM (Colzato, Waszak, 
Nieuwenhuis, Posthuma, & Hommel, 2010; Cools, 2006; Moustafa 
et al., 2008). Bearing in mind the similarity between cathinone and 
amphetamine, our results are also consistent with previous studies 
in humans showing impairments in WM (Baicy & London, 2007; 
Daumann et al., 2004;  Daumann et al., 2003; Nordahl, Salo, & 
Leamon, 2003) and cognitive flexibility (van der Plas et al., 2009) as 
consequences of long-term amphetamine and methamphetamine 
use. 
Given that khat users committed significantly more errors 
also in the 1-back task, a condition that requires hardly any active 
maintenance of information, we suggest that khat use may be 
associated with impairment of the updating rather than the 
maintenance component of WM. Khat users may thus not 
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necessarily process or store fewer items than khat-free controls but, 
rather, are less selective with regard to what they store (Vogel, 
McCollough, & Machizawa, 2005). In an N-back task, this would 
imply that khat users are less efficient in discriminating targets from 
non-targets, which means that non-targets are more likely to enter 
WM and interfere with target information. 
Bearing in mind the similarity between cathinone and 
amphetamine, our results are also consistent with previous studies 
in humans showing impairments in WM (Baicy & London, 2007; 
Daumann et al., 2004; Daumann et al., 2003; Nordahl et al., 2003) 
and cognitive flexibility (van der Plas et al., 2009) as consequences 
of long-term amphetamine and methamphetamine use. Together 
with our previous observation of impaired inhibitory control in 
khat users (Colzato et al., 2011), this suggests that khat use may be 
associated with a general decrement in cognitive control. Another, 
not necessarily exclusive possibility is that the impairments on tasks 
measuring mental flexibility and WM were the result of transitory 
khat-induced withdrawal symptoms. Indeed, chronic khat users 
experience withdrawal symptoms during the first days, especially 
sleeping problems, depressive states, attentional problems, and 
intense cravings (Al-Habori, 2005). Moreover, given that cathine 
stays longer than 24 hours in the body, it cannot be excluded that 
our pattern of results is due to possible acute effects potentially 
masking or potentiating longer-term effects (Al-Habori, 2005). 
It is important to emphasize that the causal relation 
between cognitive impairment and the regular use of khat is not 
necessarily straightforward. For instance, we cannot exclude that 
pre-existing genetic or neurodevelopmental factors may play a 
mediating role. What we can exclude are contributions from other 
drugs, to which our khat users were barely exposed, and from 
individual characteristics as age or intelligence, which do impact 
performance on working-memory tasks (Ackerman, Beier, & Boyle, 
2005; Colzato, van Wouwe, Lavender, & Hommel, 2006; Hartman 
& Warren, 2005; Kray, Li, & Lindenberger, 2002) but were 
controlled in this study. 
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Although data on the density of DA receptors in khat users 
are not yet available, one may speculate that khat users suffer from 
the impaired functioning of dopaminergic receptors in the 
frontostriatal circuit. Indeed, the striatum is assumed to underlie the 
ability to flexibly alter cognitive representations (Roshan Cools, 
2006) and to serve as a gate to modulate when to update 
information in the PFC structures subserving WM (Moustafa et al., 
2008). 
The present findings raise the question whether khat users 
also show impairments in other cognitive control functions, such as 
strategic planning and decision making (Hoffman & al’ Absi, 2010). 
The acute effect of khat on cognitive functions needs to be 
investigated as well. Moreover, it would very useful to explore the 
direct effect of khat use on the brain. It remains to be 
demonstrated, for instance, that khat use produces changes at the 
neuromodulatory (reduced functioning of DAD2 receptors) and 
functional level (dysfunction in PFC and striatum) that may be 
proportional to the degree of behavioural performance deficits. Of 
particular interest would be to investigate whether khat users suffer 
from impulsive behaviour—given that cathinone has been found to 
enhance aggressive behavior in isolated rats (Banjaw & Schmidt, 
2005) and that dysfunctional impulsivity has been associated with 
genetic markers of striatal dopamine (Colzato et al., 2010). 
As pointed out, the observations that khat use is apparently 
associated with all three major functions of cognitive control (WM 
monitoring/updating, flexibility, and inhibition: (Miyake et al., 
2000) suggest a broad and general impact of khat use on human 
cognition. Accordingly, using khat can be expected to affect a 
broad range of everyday behavior, ranging from car driving to work 
performance and social behavior. 
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Khat use is associated with increased 
response conflict in humans 
Abstract 
Khat consumption has become a worldwide phenomenon 
broadening from Eastern Africa and the south west of the Arabian 
Peninsula to ethnic communities in the rest of the world. Only few 
studies have systematically looked into cognitive impairments in 
khat users. We studied whether khat use is associated with changes 
in the emergence and resolution of response conflict, a central 
cognitive control function. Khat users (n = 16) and khat-free 
controls (n = 16) were matched in terms of sex, ethnicity, socio-
economic situation, age, alcohol and cannabis consumption, and IQ 
(Raven's Progressive Matrices). Groups were tested on response 
conflict, as measured by the Simon task. Khat users performed 
significantly slower than controls and were more strongly affected 
by stimulus-induced response conflict. Khat use is associated with 
specific impairments in behavioral control: general slowing and less 
efficient resolution of response conflicts, which is likely to impair 
decision making in everyday life. 
Introduction 
The khat plant (Catha edulis) is a flowering evergreen. Its 
leaves have been chewed in East-Africa and the south west of the 
Arabian Peninsula since ancient times to ease exhaustion, increase 
alertness and self-esteem, decrease hunger, and induce euphoria 
and feelings of well-being (Brenneisen, Fisch, Koelbing, 
Geisshusler, & Kalix, 1990; Kalix, 1996). Khat has been used for 
medical purposes as an appetite suppressant and an anti-ulcer agent 
(Carrier, 2008) and even for its aphrodisiac effects and to treat 
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premature ejaculation. It is also used for recreational purposes 
(Krikorian, 1984) during casual meetings (so called khat sessions) in 
which individuals actively engage in discussions and develop 
and/or preserve social contact. During those sessions, the leaves 
and the tender younger stalks of khat are chewed slowly, but 
intermittently to release the active components, over several hours 
(Al-Habori, 2005). 
However, once the positive acute effects vanish, users 
undergo feelings of exhaustion, sleeplessness, apathy, depression, 
lethargy, mental fatigue, and concentration difficulties. In humans, 
chronic (i.e., daily) long-term use of khat is associated with several 
adverse effects, such as blood vessel constriction, prolonged 
malnutrition, increased blood pressure, development of 
gastrointestinal tract problems, cytotoxic effects on liver and 
kidneys, and keratotic lesions at the side of chewing (Al-Habori, 
2005). 
The active ingredients of Catha edulis are cathine 
(norpseudoephedrine) and cathinone (benzoylethanamine), the 
latter is the main contributor of the stimulant effect of khat. These 
alkaloids are similar in structure and pharmacological activity to 
amphetamines (Wagner, Preston, Ricaurte, Schuster, & Seiden, 
1982): both stimulate the central nervous system and suppress 
appetite. For this reason, khat is also called a “natural 
amphetamine.” However, cathinone has a more rapid onset 
(roughly 15 min) and a shorter half-life (about 4 h) than 
amphetamine. Cathinone increases levels of dopamine (DA) and 
norepinephrine in the brain by acting on the cathecholaminergic 
synapses, delaying the reuptake and/or enhancing the release of 
those neurotransmitters (Patel, 2000; Wagner et al., 1982). 
Nevertheless, it is important to note that the consumption of 
cathinone in pure form is not entirely comparable with chewing 
khat leaves. Interestingly, synthetic cathinones, in particular 
mephedrone, has replaced MDMA (3,4-
methylenedioxymethamphetamine or “ecstasy”) as one of the 
favorite recreational drugs among individuals who go clubbing, at 
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least in the UK (Wood, Greene, & Dargan, 2011). However, the 
use of mephedrone has been associated with unpleasant side 
effects, such as sweating, headache, palpitations, nausea, and 
vomiting. 
The neurobiological underpinnings underlying the acute 
effect of khat and the long-term cognitive effects of chronic khat 
use are still unclear and understudied (Hoffman & al’ Absi, 2010). 
However, given the chemical similarity of khat and amphetamine in 
structure and pharmacological activity, long-term use of khat likely 
affects the same neurotransmitter and brain structures as the 
chronic use of amphetamine (Berman, O’Neill, Fears, Bartzokis, & 
London, 2008; Salo, Nordahl, Galloway, et al., 2009a). At an 
anatomical level, one may suspect a lower level of structural 
connectivity as indication of decreased myelination of the fibers 
and a lower cortical gray matter volume that might underlie the 
possible cognitive impairments associated with chronic khat use. At 
a neuromodular level, instead, chronic khat use is likely to be 
associated with dopaminergic dysfunctions in prefrontal cortex 
(PFC) and dorsal anterior cingulate cortex (ACC)—circuits 
innervated by DA and that have been shown to play major roles in 
the way we control our thoughts and goal-directed behavior (Miller, 
2000). 
Khat use in Eastern Africa and in the south west of the 
Arabian Peninsula has gained popularity during the last 10 years 
and—mainly because of the Somali diaspora caused by the Somali 
civil war—has become a worldwide phenomenon broadening to 
ethnic communities in the rest of the world, such as in North 
America, Great Britain, and the Netherlands (UNODC, World 
Drug Report, 2010). The airports of Amsterdam and London have 
become the main European distribution points (Beckerleg, 2008; 
Pennings, Opperhuizen, & van Amsterdam, 2008). In the 
Netherlands, the use of the unprocessed plant is legal and 
unrestricted, which makes this country a suitable platform to 
investigate the effects of the drug. 
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Surprisingly, only few studies have systematically looked 
into cognitive impairments in khat users so far. First, Colzato et al. 
(2011a) reported that khat users exhibit impairments in the 
inhibition of behavioral responses. Participants were asked to press 
a left or right button as soon as a green left-pointing or right-
pointing arrow appeared (go trials). However, if the color of the 
arrow suddenly changed to red, the participants were supposed to 
refrain from responding (stop trials). On go trials, khat users 
performed just as well as non-users in terms of both accuracy and 
response speed. However, khat users found it much more difficult 
than do non-users to inhibit responding on stop trials. 
Second, Colzato et al. (2011b) showed that khat users 
performed significantly worse than controls on tasks tapping into 
cognitive flexibility (the ability to adapt and restructure cognitive 
representations in response to changing situational demands; cf., 
(Monsell, 1996) as well as monitoring information in working 
memory. 
The current study focused on another key cognitive 
control function: the ability to deal with and resolve response 
conflict, that is, the ability to select a correct response in the face of 
other, competing response tendencies. The arguably purest 
assessment of response conflict is provided by the Simon task (cf., 
Hommel, 2011). In this task, participants respond to a non-spatial 
feature of commonly visual stimuli (e.g., color) by pressing left and 
right response buttons. Importantly, the location of the stimulus 
varies randomly so that it can spatially correspond or not 
correspond with the correct response. As one might expect, 
performance is better with stimulus–response correspondence than 
with noncorrespondence—the Simon effect (Simon & Small, 1969). 
The effect reflects the difficulty of selecting a response in the face 
of competing response tendencies and can thus be taken as a rather 
pure measure of (the efficiency of resolving) response conflict 
(Hommel, 2011; Kornblum, Hasbroucq, & Osman, 1990). 
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Interestingly, the ACC has been considered responsible for 
the detection of response conflict, and DA has been suggested to 
play a key role in coding such a conflict (Botvinick, 2007). Holroyd 
and Coles, (2002) argued that response errors or negative feedback 
induce a dip in DA cell firing, which is transmitted to the ACC, 
where the drop in DA levels disinhibits the apical dendrites of 
motor neurons. Indeed, the stimulation of the ACC can transiently 
inhibit DA release (Jackson, Frost, & Moghaddam, 2001). 
To sum up, in the present study, we used the Simon task 
(Simon & Small, 1969) to test whether khat use produces 
deficiencies in the resolution of response conflict. Given the 
aforementioned relation between DA and response conflict and 
ACC on the one hand, and between DA and khat on the other, we 
expected increased response conflict (as indicated by a larger Simon 
effect) in khat users than in khat-free controls. 
Material and Method 
Participants 
Thirty-two young healthy African adults (28 men and 4 
women) were compensated for their participation. They constituted 
the two groups of 16 khat users and 16 khat-free controls. The 
sample was drawn from 40 adults in the Leiden and The Hague 
metropolitan area, who volunteered to participate in studies of 
behavioral pharmacology and did not participate in previous studies 
of Leiden University. Participants were recruited via ads posted on 
community bulletin boards and by word of mouth. Participants 
were selected via an interview using the Mini International 
Neuropsychiatric Interview (Sheehan et al., 1998) (Sheehan et al., 
1998). The Mini International Neuropsychiatric Interview is a well-
established brief diagnostic tool in clinical, stress, and 
psychopharmacology research (Colzato, Huizinga, & Hommel, 
2009; Elzinga et al., 2008; Sheehan et al., 1998) that screens for 
several psychiatric disorders including post-traumatic stress 
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disorder, schizophrenia, depression, mania, attention 
deficit/hyperactivity disorder, and obsessive–compulsive disorder. 
On the basis of the interview, we excluded 8 of the 40 potential 
participants because of current medication use or hints to a 
possible psychiatric disorder (post-traumatic stress disorder) and/or 
current medication. 
Following Colzato et al. (2011b), we made sure that the 
users met the following criteria: (i) khat consumption by chewing 
route for a minimum of 1 year; (ii) no clinically significant medical 
disease; and (iii) no use of medication. All khat users met more than 
four of the seven criteria that according to the American Psychiatric 
Association Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition and the World Health Organization (International 
Classification of Diseases-10) define addiction: tolerance, 
withdrawal, difficulty controlling the use, negative consequences for 
job, family and health, significant time or emotional energy spent in 
searching/consuming the drug, put off or neglected activities 
because of the use, and desire to cut down the use. None of the 
khat-free controls reported any history of past or current khat use. 
Participants were asked to refrain from taking any 
psychoactive drugs for at least 24 h before the test, not to consume 
alcohol on the night before the experimental session, and to have a 
normal night rest. Participant's compliance with the instruction was 
encouraged by taking a (not further analyzed) saliva sample test at 
the beginning of the session (cf. Colzato et al., 2009; Colzato, 
Erasmus, & Hommel, 2004). 
The two groups were matched in terms of ethnicity (100% 
African), age, sex, IQ, (measured by Raven's Standard Progressive 
Matrices (SPM); Raven, Court, & Raven, 1988), socio-economic 
situation, and alcohol and cannabis consumption. In the 
Netherlands, the use of khat is confined to East-African 
immigrants and is predominantly used by male individuals 
(Pennings et al., 2008). All participants were rated middle 
socioeconomic status according to the Hollingshead Occupational 
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Status Scale (Hollingshead, 1975). Even though khat was the 
preferred drug for users, some of them drank alcohol (five) on a 
weekly base and used cannabis (two) on a monthly base. Khat users 
and non-users reported to have never used LSD, MDMA, cocaine, 
amphetamine, barbiturates, ketamine, GHB, or speed. 
Demographic and drug use information is provided in Table 1. 
Written informed consent was obtained from all participants after 
the nature of the study was explained to them. The protocol and 
the remuneration arrangement of €12 were approved by the 
institutional review board (Leiden University, Institute for 
Psychological Research). 
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Sample Khat users  Khat-free controls 
N (M:F) ns 16 (14:2)  16 (14:2) 
Age (years) ns 32.4 (7.2)  32.4 (7.2) 
Raven IQ ns 108 (3.0)  108 (3.0) 
Khat exposure (years) ** 9.6 (6.0)  9.6 (6.0) 
Khat times in a week ** 3.1 (1.8)  3.1 (1.8) 
Bundles used (khat shrubs) ** 2.9 (1.2)  2.9 (1.2) 
Bundles used in one session** 1.0 (1.9)  1.0 (1.9) 
Hours chewing khat ** 5.9 (1.9)  5.9 (1.9) 
Monthly exposure (joints) ns 0.4 (1.2)  0.4 (1.2) 
Monthly drinks (units) ns 1.5 (2.4)  1.5 (2.4) 
Lifetime cocaine (grams) ns 0  0 
Lifetime amphetamines (grams) ns 0  0 
Lifetime ketamine (grams) ns 0  0 
Lifetime Speed (grams) ns 0  0 
Table 1. Demographic characteristics and self-reported use of khat and other 
psychoactive drugs. Standard deviations are presented within parentheses. 
 
Notes. Raven IQ: IQ measured by means of the Raven’s Standard Progressive 
Matrices, 
Bundles used:  number of khat bundles consumed in a typical day/session 
Hours chewing khat: amount of time the users spend chewing khat in a typical 
day/session 
Monthly drinks: monthly number of standard alcoholic drinks 
ns Nonsignificant group difference 
* Significant group difference, p<0.05 
** Significant group difference, p<0.01 
Apparatus, stimuli, and task 
The Simon task has been previously used to systematically 
investigate the neurotoxic effects of methylphenidate (Rubia et al., 
2011). The experiment consisted of a 25-min session in which 
participants made speeded discriminative button-press responses to 
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the color of a circle. Participants responded left to a green circle 
and right to a blue circle. Circles were equiprobably presented to 
the right or to the left of a central fixation point until the response 
was given or 1500 ms has passed. Intervals between subsequent 
stimuli varied randomly but equiprobably, from 1750 to 2250 ms in 
steps of 100 ms. Participants were to ignore the location of the 
stimulus and to base their response exclusively on its color. 
Responses were to be given as fast as possible while keeping error 
rates below 15% on average; feedback was provided at the end of a 
trial block. The task consisted of six blocks of 60 trials (with all 
conditions being equiprobable), the first of which served as a 
practice block. 
Procedure and design 
All participants were tested individually. Individual IQs 
were determined by means of a 30-min reasoning-based intelligence 
test (SPM). The SPM assesses the individual's ability to create 
perceptual relations and to reason by analogy independent of 
language and formal schooling; it is a standard, widely used test to 
measure Spearman's g factor and of fluid intelligence in particular 
(Raven et al., 1988). Participants provided a saliva sample, 
completed the SPM, and subsequently performed the behavioral 
tasks measuring response conflict. Participants were allowed to take 
a short break (maximum of 5 min) between task blocks. The 
experiment was controlled by a PC attached to a 17-inch monitor 
with a refresh rate of 120 Hz. 
Statistical Analysis 
Independent t-tests were performed to test age, IQ, 
alcohol, and cannabis consumption differences between the groups. 
In the Simon task, mean reaction times (RTs) and (square-rooted) 
error percentages were analyzed by means of analyses of variance 
(ANOVAs) using spatial stimulus–response correspondence 
(versus noncorrespondence) as a within-participant factor and 
group as a between-participant factor. Moreover, Pearson 
correlation coefficients were computed between the degree of 
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exposure to khat and cognitive performance to test whether the 
magnitude of cognitive impairments is proportional to the amount 
of khat consumed. Effect magnitudes were assessed by calculating 
partial eta squared (η2p) for repeated-measures ANOVAs. A 
significance level of p < 0.05 was adopted for all tests. 
Results 
Participants 
No significant group differences were obtained for age, 
t(30) = 1.51, p = 0.13, intelligence, t(30) = 0.71, p = 0.48, alcohol 
consumption, t(30) = 0.15, p = 0.88, or cannabis consumption, 
t(30) = 0.56, p = 0.80. Table 1 shows drug-use profiles for the two 
groups. 
Simon Task  
The RT analysis showed evidence of a group effect, F(1, 
30) = 7.02, p < 0.05, mean squared error (MSE) = 8637.81, η2p  
= 0.19: khat users were in general slower than khat-free controls. 
The RT and error rates analyses showed a main effect of 
correspondence, F(1, 30) = 158.81, p < 0.0001, MSE = 159.58, 
η2p = 0.84 (RTs) and F(1, 30) = 51.90, p < 0.0001, MSE = 11.63, 
η2p = 0.63 (errors), which was modified by group in RTs but not in 
errors, F(1, 30) = 7.27, p < 0.05, MSE = 159.58, η2p = 0.19 (RTs) 
and F < 1 (errors). To verify whether the overall RT increase in 
khat users may have confounded this outcome, we ran another 
ANOVA with overall RT level as covariate; however, the crucial 3-
way interaction remained significant: F(1, 29) = 5.71, p < 0.05, 
MSE = 165.08, η2p = 0.16. 
Both groups showed a significant main effect of 
correspondence, F(1, 15) = 140.87, p < 0.0001, MSE = 55.57, 
η2p = 0.90 (RTs) and F(1, 15) = 24.71, p < 0.0001, MSE = 8.70, 
η2p = 0.62 (errors); F(1, 15) = 70.85, p < 0.0001, MSE = 263.60, 
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η2p = 0.82 (RTs) and F(1, 15) = 27.71, p < 0.0001, MSE = 14.57, 
η2p = 0.65 (errors), for khat-free controls and khat users, 
respectively. These main effects indicated that responses were faster 
and more accurate with stimulus–response correspondence (431 ms 
and 2.9%) than with non-correspondence (471 ms and 9.0%, 
respectively). As expected, however, the RT correspondence effect 
was reliably increased in khat users as compared with khat-free 
controls, and the error rates followed the same pattern (Table 2). 




Reaction Times (ms) 458 (16.5) 405 (16.5) 
Error Rates (%) 2.6 (0.8) 3.1 (0.8) 
Noncorrespondence   
Reaction Times (ms) 506 (16.6) 436 (16.6) 
Error Rates (%) 9.7 (1.6) 8.3 (1.6) 
Simon effect   
Reaction Times (ms)* 48 31 
Error Rates (%) 7.1 5.2 
Table 2. Performance on the Simon task as a function of correspondence 
(correspondent vs. noncorrespondent) and group (khat users vs. khat-free 
controls). Standard errors of reaction times and error rates are presented 
in parentheses. Significant group difference; * p< 0.05. 
Correlations 
To test whether the magnitude of cognitive impairments is 
proportional to the amount of khat consumed, we computed 
Pearson correlation coefficients between the individual lifetime 
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khat exposure, hours chewing, and number of bundles used in a 
khat session and Simon effects in RT and accuracy. Hours chewing 
positively correlated with Simon effect, r(16) = 0.62, p = 0.01, 
whereas khat exposure, peak and number of bundles used in a khat 
session did not, even though the direction of the associations was 
similar. Hence, longer chewing is associated with increased 
response conflict (Figure 1). 
Figure 1. Scatter diagram of individual hours chewing khat against Simon 
effect (in ms). 
Discussion 
This study tested, for the first time, whether long-term 
khat use is associated with a detectable selective impairment in 
cognitive control to resolve response conflict. As expected, khat 
users were slower than khat-free controls in selecting the correct 
response when an alternative response was simultaneously 
activated. Moreover, the size of this deficit corresponds to the 
hours spent in chewing khat. Hence, the longer the chewing, the 
more active compounds are released, the greater the magnitude of 
the loss in selecting the correct response. We suggest that this 
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impairment may be due to the long-term use of cathinone, the 
active ingredient of khat, which is associated with dysfunctions in 
PFC and a reduced DA level—the neurotransmitter that plays a key 
role in resolving response conflict (Botvinick, 2007; Cools, 2006). 
Taking into account the chemical resemblance between cathinone 
and amphetamine, our results are also in line with those of previous 
studies in humans showing impairments in response conflict as 
consequences of long-term amphetamine and methamphetamine 
use (Rubia et al., 2011; Salo, Ursu, Buonocore, Leamon, & Carter, 
2009; Salo, Nordahl, Buonocore, et al., 2009a; Salo, Nordahl, 
Galloway, et al., 2009b). Alongside all those studies, we found no 
group differences in accuracy, presumably reflecting the fact that 
error rates are not normally distributed and therefore less sensitive. 
As our participants were screened for several psychiatric 
disorders, we can rule out an alternative account in terms of pre-
existing psychiatric disorders (such as posttraumatic stress disorder 
and psychosis) that have been associated with khat-consuming 
populations such as Somali refugees (Kroll, Yusuf, & Fujiwara, 
2011). Particularly important was the matching of the age range: the 
ability to resolve response conflict is known to decline with 
increasing age (Mager et al., 2007). 
However, it is important to bear in mind that the causal 
relation between chronic use of khat and cognitive impairments is 
not necessarily clear-cut. We cannot rule out that pre-existing 
genetic or neurodevelopmental factors may play a modulating role. 
For instance, individuals with a genetic predisposition that hampers 
response conflict functions might be drawn to chewing khat more 
strongly so that what looks like an effect of drug use might actually 
represent a form of self-selection. 
It is also important to note that we cannot exclude that 
pesticides as DDT, which are still used in khat-growing countries, 
may have partially contributed to the adverse cognitive effects of 
chewing khat (Daba, Hymete, Bekhit, Mohamed, & Bekhit, 2011). 
Moreover, two other factors may be associated with our results of 
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increased response conflict: First, long-term khat users are known 
to undergo withdrawal symptoms during the first days of 
abstinence, such as mental fatigue, sleeplessness, and apathy. 
Second, since cathine lasts longer than one day in the system, it 
cannot be ruled out that our findings may be due to possible acute 
effects potentially masking or potentiating longer term effects (Al-
Habori, 2005). 
Even though positron emission tomography studies on 
DA receptors availability still need to be carried out, we may 
speculate that in khat users, the inputs from midbrain dopaminergic 
nuclei are drastically reduced. Such nuclei are fundamental in 
driving the ACC, which is assumed to bias response-selection 
mechanisms toward the correct response (Botvinick, 2007). 
The current findings raise the issue whether long-term khat 
use, as in the case of methamphetamine (Salo et al., 2009a), 
decreases the plasticity of the white matter (the structural 
connections between regions based on known axonal projections) 
underlying the cognitive control system in PFC and ACC. Of 
particular interest would be to investigate the acute effect of khat 
on cognitive functions. Given that the acute administration of 
amphetamine enhances inhibitory mechanisms involved in visual 
search (Fillmore, Rush, & Abroms, 2005) it is possible that the 
acute administration of khat improves rather than impairs the 
ability to inhibit irrelevant information and to select correct 
responses in the face of conflict. 
Moreover, given the chemical similarity of khat and 
synthetic cathinones in structure and pharmacological activity, the 
long-term use of these so called designer drugs, such as 
mephedrone, is likely to be associated with similar cognitive deficits 
such as in the case of the chronic use of khat. Given that the use of 
mephedrone has increased in recent years, because of the fall in the 
use of MDMA, it seems of societal relevance to devote more 
research on the functional significance of possible deficits 
associated with the use of designer drugs. 
Chapter 5 ─ 127 
 
Conclusion 
Together with previous demonstrations of khat-related 
impairments in working memory updating, flexibility, and inhibitory 
control (Colzato et al., 2011a, 2011b), the present finding that 
long-term khat use is associated with general slowing and a more 
specific decrement in the ability to resolve response conflict 
suggests an extensive and wide-ranging impact of khat use on 
human cognition. Therefore, using khat can be expected to have a 
negative effect on a broad range of everyday behavior. For instance, 
impairments in the selection of correct actions in the presence of 
less appropriate alternatives is fundamental in driving behavior, 
which is likely to account for the increasing number of traffic 
accidents in Eastern Africa and the south west of the Arabian 
Peninsula countries linked to khat-chewing habits (Toennes & 
Kauert, 2004). Moreover, even though general slowing by 62 ms 
and a specific conflict-induced delay of 17 ms seems negligible at 
first sight, these numbers correspond to a 12.8% and 35.4% 
slowing of general response speed and decision-making time, 
respectively. Moreover, the task we used to assess response conflict 
was incredibly simple in using minimalistic stimulus and response 
sets related by only two stimulus–response rules. Considering the 
much greater complexity of many everyday life decisions, together 
with the fact that decision-making time increases with the number 
of stimuli and responses involved (Hick, 1952), it is easy to imagine 
that even a small-looking impairment can have considerable 
consequences on real-life decision making. 
  




Al-Habori, M. (2005). The potential adverse effects of habitual use 
of Catha edulis (khat). Expert Opinion on Drug Safety, 4(6), 1145-
1154. doi:10.1517/14740338.4.6.1145 
Beckerleg, S. (2008). Khat special edition introduction. Substance Use 
& Misuse, 43(6), 749-761. doi:10.1080/10826080701739057 
Berman, S., O’Neill, J., Fears, S., Bartzokis, G., & London, E. D. 
(2008). Abuse of Amphetamines and Structural Abnormalities in 
the Brain. Annals of the New York Academy of Sciences, 1141(1), 
195-220. doi:10.1196/annals.1441.031 
Botvinick, M. M. (2007). Conflict monitoring and decision making: 
reconciling two perspectives on anterior cingulate function. 
Cognitive, Affective & Behavioral Neuroscience, 7(4), 356-366. 
Brenneisen, R., Fisch, H. U., Koelbing, U., Geisshusler, S., & Kalix, 
P. (1990). Amphetamine-like effects in humans of the khat 
alkaloid cathinone. British journal of clinical pharmacology, 30(6), 
825–828. 
Carrier, N. (2008). Is miraa a drug?: categorizing Kenyan khat. 
Substance Use & Misuse, 43(6), 803-818. 
doi:10.1080/10826080701739016 
Colzato, L., Huizinga, M., & Hommel, B. (2009). Recreational 
cocaine polydrug use impairs cognitive flexibility but not 
working memory. Psychopharmacology, 207(2), 225-234. 
doi:10.1007/s00213-009-1650-0 
Colzato, L. S., Erasmus, V., & Hommel, B. (2004). Moderate 
alcohol consumption in humans impairs feature binding in 
visual perception but not across perception and action. 
Neuroscience Letters, 360(1-2), 103-105. 
doi:10.1016/j.neulet.2004.01.054 
Colzato, L. S., Ruiz, M. J., van den Wildenberg, W. P. M., & 
Hommel, B. (2011). Khat use is associated with impaired 
working memory and cognitive flexibility. PloS one, 6(6), e20602. 
doi:10.1371/journal.pone.0020602 
Chapter 5 ─ 129 
 
Colzato, L. S., Ruiz, M. J., Wildenberg, W. P. M. van den, Bajo, M. 
T., & Hommel, B. (2011). Long-term effects of chronic khat 
use: impaired inhibitory control. Frontiers in Cognition, 1, 219. 
doi:10.3389/fpsyg.2010.00219 
Cools, R. (2006). Dopaminergic modulation of cognitive function-
implications for L-DOPA treatment in Parkinson’s disease. 
Neuroscience and Biobehavioral Reviews, 30(1), 1-23. 
doi:10.1016/j.neubiorev.2005.03.024 
Daba, D., Hymete, A., Bekhit, A. A., Mohamed, A. M. I., & Bekhit, 
A. E.-D. A. (2011). Multi residue analysis of pesticides in wheat 
and khat collected from different regions of Ethiopia. Bulletin of 
Environmental Contamination and Toxicology, 86(3), 336-341. 
doi:10.1007/s00128-011-0207-1 
Elzinga, B. M., Roelofs, K., Tollenaar, M. S., Bakvis, P., van Pelt, J., 
& Spinhoven, P. (2008). Diminished cortisol responses to 
psychosocial stress associated with lifetime adverse events a 
study among healthy young subjects. Psychoneuroendocrinology, 
33(2), 227-237. doi:10.1016/j.psyneuen.2007.11.004 
Fillmore, M. T., Rush, C. R., & Abroms, B. D. (2005). d-
Amphetamine-induced enhancement of inhibitory mechanisms 
involved in visual search. Experimental and Clinical 
Psychopharmacology, 13(3), 200-208. doi:10.1037/1064-
1297.13.3.200 
Hick, W. E. (1952). On the rate of gain of information. Quarterly 
Journal of Experimental Psychology, 4(1), 11-26. 
doi:10.1080/17470215208416600 
Hoffman, R., & al’ Absi, M. (2010). Khat use and neurobehavioral 
functions: Suggestions for future studies. Journal of 
Ethnopharmacology. doi:10.1016/j.jep.2010.05.033 
Hollingshead, A. (1975). Four Factor Index of Social Status. Yale 
University Department of Sociology: New Haven.  
Holroyd, C. B., & Coles, M. G. H. (2002). The neural basis of 
human error processing: reinforcement learning, dopamine, and 
the error-related negativity. Psychological Review, 109(4), 679-709. 
Chapter 5 ─ 130 
 
 
Hommel, B. (2011). The Simon effect as tool and heuristic. Acta 
Psychologica, 136(2), 189-202. doi:10.1016/j.actpsy.2010.04.011 
Jackson, M. E., Frost, A. S., & Moghaddam, B. (2001). Stimulation 
of prefrontal cortex at physiologically relevant frequencies 
inhibits dopamine release in the nucleus accumbens. Journal of 
Neurochemistry, 78(4), 920-923. doi:10.1046/j.1471-
4159.2001.00499.x 
Kalix, P. (1996). Catha edulis, a plant that has amphetamine effects. 
Pharmacy World & Science: PWS, 18(2), 69-73. 
Kornblum, S., Hasbroucq, T., & Osman, A. (1990). Dimensional 
overlap: cognitive basis for stimulus-response compatibility--a 
model and taxonomy. Psychological Review, 97(2), 253-270. 
Krikorian, A. D. (1984). Kat and its use: an historical perspective. 
Journal of Ethnopharmacology, 12(2), 115-178. 
Kroll, J., Yusuf, A. I., & Fujiwara, K. (2011). Psychoses, PTSD, and 
depression in Somali refugees in Minnesota. Social Psychiatry and 
Psychiatric Epidemiology, 46(6), 481-493. doi:10.1007/s00127-010-
0216-0 
Mager, R., Bullinger, A. H., Brand, S., Schmidlin, M., Schärli, H., 
Müller-Spahn, F., … Falkenstein, M. (2007). Age-related 
changes in cognitive conflict processing: an event-related 
potential study. Neurobiology of Aging, 28(12), 1925-1935. 
doi:10.1016/j.neurobiolaging.2006.08.001 
Miller, E. K. (2000). The prefrontal cortex and cognitive control. 
Nature Reviews. Neuroscience, 1(1), 59-65. doi:10.1038/35036228 
Monsell, S. (1996). Control of mental processes. En Unsolved 
Mysteries of the Mind (Bruce, V., pp. 93-148). Hove: Erlbaum. 
Patel, N. B. (2000). Mechanism of action of cathinone: the active 
ingredient of khat (Catha edulis). East African medical journal, 
77(6), 329-332. 
Pennings, E. J. M., Opperhuizen, A., & van Amsterdam, J. G. C. 
(2008). Risk assessment of khat use in the Netherlands: a review 
based on adverse health effects, prevalence, criminal 
Chapter 5 ─ 131 
 
involvement and public order. Regulatory Toxicology and 
Pharmacology: RTP, 52(3), 199-207. 
doi:10.1016/j.yrtph.2008.08.005 
Raven, J. C., Court, J. H., & Raven, J. (1988). Manual for Raven’s 
Progressive Matrices and Vocabulary Scales: Standard Progressive 
Matrices (r.e.). HK Lewis. 
Rubia, K., Halari, R., Cubillo, A., Smith, A. B., Mohammad, A.-M., 
Brammer, M., & Taylor, E. (2011). Methylphenidate normalizes 
fronto-striatal underactivation during interference inhibition in 
medication-naïve boys with attention-deficit hyperactivity 
disorder. Neuropsychopharmacology: Official Publication of the American 
College of Neuropsychopharmacology, 36(8), 1575-1586. 
doi:10.1038/npp.2011.30 
Salo, R., Nordahl, T. E., Buonocore, M. H., Natsuaki, Y., Waters, 
C., Moore, C. D., … Leamon, M. H. (2009a). Cognitive control 
and white matter callosal microstructure in methamphetamine-
dependent subjects: a diffusion tensor imaging study. Biological 
Psychiatry, 65(2), 122-128. doi:10.1016/j.biopsych.2008.08.004 
Salo, R., Nordahl, T. E., Galloway, G. P., Moore, C. D., Waters, C., 
& Leamon, M. H. (2009b). Drug abstinence and cognitive 
control in methamphetamine-dependent individuals. Journal of 
Substance Abuse Treatment, 37(3), 292-297. 
doi:10.1016/j.jsat.2009.03.004 
Salo, R., Ursu, S., Buonocore, M. H., Leamon, M. H., & Carter, C. 
(2009). Impaired prefrontal cortical function and disrupted 
adaptive cognitive control in methamphetamine abusers: a 
functional magnetic resonance imaging study. Biological Psychiatry, 
65(8), 706-709. doi:10.1016/j.biopsych.2008.11.026 
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, 
J., Weiller, E., … Dunbar, G. C. (1998). The Mini-International 
Neuropsychiatric Interview (M.I.N.I.): the development and 
validation of a structured diagnostic psychiatric interview for 
DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59 Suppl 
20, 22-33;quiz 34-57. 
Chapter 5 ─ 132 
 
 
Simon, J. R., & Small, A. M., Jr. (1969). Processing auditory 
information: interference from an irrelevant cue. The Journal of 
Applied Psychology, 53(5), 433-435. 
Toennes, S. W., & Kauert, G. F. (2004). Driving under the 
influence of khat--alkaloid concentrations and observations in 
forensic cases. Forensic Science International, 140(1), 85-90. 
doi:10.1016/j.forsciint.2003.11.028 
Wagner, G. C., Preston, K., Ricaurte, G. A., Schuster, C. R., & 
Seiden, L. S. (1982). Neurochemical similarities between d,l-
cathinone and d-amphetamine. Drug and Alcohol Dependence, 9(4), 
279-284. doi:10.1016/0376-8716(82)90067-9 
Wood, D. M., Greene, S. L., & Dargan, P. I. (2011). Clinical pattern 
of toxicity associated with the novel synthetic cathinone 
mephedrone. Emergency Medicine Journal: EMJ, 28(4), 280-282. 
doi:10.1136/emj.2010.09
Chapter 6 ─133 
 
Chapter 6 
Chronic and recreational use of 
cocaine is associated with a 
vulnerability to semantic interference 
Abstract 
Language production requires that speakers effectively 
recruit inhibitory control to successfully produce speech. The use 
of cocaine is associated with impairments in cognitive control 
processes in the nonverbal domain, but the impact of chronic and 
recreational use of cocaine on these processes during language 
production remains undetermined. This study aims to observe the 
possible impairment of inhibitory control in language production 
among recreational and chronic cocaine polydrug users. Two 
experiments were carried out on chronic (experiment 1) and 
recreational (experiment 2) cocaine polydrug users performing a 
blocked-cycled naming task, yielding an index of semantic 
interference. Participants were matched for sex, age, and 
intelligence (Raven’s progressive matrices) with cocaine free-
controls, and their performance was compared on the blocked-
cycled naming task. Chronic and recreational users showed 
significantly larger semantic interference effects than cocaine-free 
controls, thereby indicating a deficit in the ability to inhibit 
interfering information. Evidence indicates a relationship between 
the consumption of cocaine, even at recreational levels, and the 
inhibitory processes that suppress the overactive lexical 
representations in the semantic context. This deficit may be critical 
in adapting and responding to many real-life situations where an 
efficient self-monitoring system is necessary for the prevention of 
errors.  




Taking cocaine by the snorting route is Europe’s second 
preferred recreational drug habit after smoking cannabis (European 
Centre for Drugs and Drug Addiction, 2012). The popularity of 
cocaine has risen in recent years, and nowadays it is no longer 
considered to be an “elite drug” instead being one of the most 
commonly used drugs and, as with the USA, its use has now been 
identified as a public health issue in Europe as it is in the USA 
(EMCDDA, 2012; United Nations Office on Drugs & Crime, 
2013). 
Chronic and recreational cocaine users, as well as abstinent 
cocaine users, are characterized by showing significant decrements 
in neuropsychological performance when compared to cocaine-free 
controls (Bolla et al. 2004; Goldstein et al. 2004; Hulka et al. 2013a, 
2013b, 2013c; Jovanovski et al. 2005). Several studies have 
examined the long-term effects of chronic cocaine use on cognitive 
processes. Commonly observed impairments include deficiencies in 
cognitive flexibility (Verdejo-García et al. 2006; Verdejo-García and 
Pérez-García 2007), episodic memory (Manschreck et al. 1990; 
Mittenberg and Motta 1993; Reske et al. 2010; Vonmoos et al. 
2013), social and non-social decision-making (Hulka et al. 2013a), 
prosodic and cross-modal emotion processing (Hulka et al. 2013b) 
and inhibitory control processes (Ersche et al. 2012; Fillmore and 
Rush 2002; Goldstein and Volkow 2002; Rosselli et al. 2001; 
Volkow et al. 2010). Inhibitory control refers to the processes 
responsible for suppressing irrelevant and competing information 
to facilitate the selection of the correct representation according to 
the task goal (Anderson 2003; Brainerd and Dempster 1995; 
Miyake et al. 2000). The frontal regions are proposed as the neural 
substrate for inhibitory control (Bari and Robbins 2013; Miller and 
Cohen 2001) and dopamine, the neurotransmitter targeted by 
cocaine (Hershey et al. 2004), plays an important neuromodulatory 
role (Arnsten et al. 2012; Previc 1999; Robbins and Arnsten 2009). 
It is well known that in the long term, chronic (i.e. daily) use of 
cocaine is associated with a reduced functioning of dopamine D2 
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(DAD2) receptors in the orbitofrontal cortex, cingulate gyrus and 
striatum (Martinez et al. 2009; Tomasi et al. 2010; Volkow et al. 
1999) along with dysfunctions in the lateral prefrontal cortex, 
orbitofrontal cortex and anterior cingulate gyrus (Bolla et al. 2004; 
Bolla et al. 2003), as well the cerebellum (Hester and Garavan 
2004). 
Recent studies have showed that recreational cocaine 
polydrug users, who do not meet the criteria for abuse or 
dependence, but preferentially take cocaine on a monthly basis (1-4 
g monthly), as well as other substances of abuse (e.g. MDMA, 
alcohol, cannabis) also show cognitive impairments that resemble 
those of chronic cocaine users. Thus, Colzato et al. (2007) provided 
evidence that recreational cocaine polydrug users showed impaired 
response inhibition, measured through a stop signal task and 
inhibition of return, relative to non-cocaine users (Colzato and 
Hommel 2009). Furthermore, recreational use of cocaine is 
associated with impairments on tasks tapping into sustained 
attention, attentional shifting (Soar et al. 2012; Vonmoos et al. 
2013), and resolution of response conflict (Sellaro et al. 2013). 
Taken together, the available studies suggest that chronic and 
recreational use of small doses of cocaine may be involved in 
alterations in inhibitory control functions in the nonverbal domain. 
Nevertheless, no studies have directly investigated these executive 
control impairments in the language domain. Although there are 
some reports of worsened performance on the Stroop task (Rosselli 
et al. 2001; Verdejo-Garcia et al. 2004), deficits in naming ability 
(Ardila et al. 1991; Manschreck et al. 1990; Mittenberg and Motta 
1993; Rosselli et al. 2001) and in verbal memory and abstraction 
(Beatty et al. 1995; O'Malley and Gawin 1990; Rosselli and Ardila 
1996) observed in chronic and dependent cocaine users compared 
to non-users, the relationship between inhibitory control and 
language processing in cocaine users remains undetermined.  
The current study aims to explore whether cocaine use is 
associated with impairments in inhibitory control in language 
production. To do so, we used the semantic blocking task (Belke et 
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al. 2005; Damian et al. 2001; Kroll and Stewart 1994), where 
participants are asked to name images presented in a context where 
all items belong to the same semantic category (homogeneous 
condition: e.g., TRAIN, CAR, BIKE) or in a context in which 
elements belong to different semantic categories (heterogeneous 
condition: e.g., TRAIN, BED, DOG). The typical result is slower 
naming latencies to elements presented in a homogeneous context 
than in a heterogeneous context. This interference effect is 
accounted for in terms of competition among the co-activated 
lexical entries, by virtue of their semantic relatedness. During lexical 
selection, semantically-related concepts receive extra activation and 
they become potent competitor-distractors, relative to those 
concepts that are presented in a semantically-unrelated context 
(Roelofs 1992; Roelofs 2003; Schriefers et al. 1990). In interference 
paradigms, speakers have to prevent responses corresponding to 
highly salient competitors and selective inhibition may be involved 
(Roelofs and Piai 2011; Shao et al. 2013). Further evidence 
supporting the idea that the semantic blocking task can reflect the 
ability to inhibit specific unwanted responses comes from 
neuropsychological studies. For instance, Biegler and Martin (2008) 
observed exaggerated semantic blocking effects in patients with 
damage to the left inferior frontal gyrus (Biegler et al. 2008), which 
is thought to be involved in the selection among semantic 
competing representations (Thompson-Schill 2003; Thompson-
Schill et al. 1997; Thompson-Schill et al. 2002). 
In the present study, we investigated whether the abuse of 
cocaine predisposes an individual to showing a possible deficit in 
verbal inhibitory control in chronic (Experiment 1) and recreational 
cocaine polydrug users1 (Experiment 2). The focus of Experiment 
                                                 
 
1 Chronic cocaine users were screened for other drug use. We found that they only 
used cocaine except for one participant that had also used MDMA. Recreational 
cocaine users, on the other hand, sporadically used other drugs such as MDMA or 
cannabis, but they mainly and preferably used cocaine. As the recreational users 
were not “pure” cocaine users, this group of users was called “recreational cocaine 
polydrug users”. 
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1 was to examine if chronic cocaine users, who have not been using 
drugs other than cocaine (except alcohol and tobacco), show higher 
vulnerability to semantic interference - if so, we would expect larger 
semantic blocking effects in users than in cocaine-free controls. In 
Experiment 2, we hypothesized that the abuse of small amounts of 
cocaine predispose to a greater semantic blocking effect with 
respect to cocaine-free controls, and therefore we expected to find 
larger semantic blocking effects in the recreational cocaine polydrug 
users due to inefficient inhibitory mechanisms at lexical selection. 
General method 
Apparatus, stimuli and procedure 
All participants were tested individually in a session that 
lasted approximately 60 minutes. They first completed a drug use 
questionnaire, before performing the screening tasks, followed by a 
Spanish version of the semantic blocking task. This task consisted 
of twenty images belonging to different semantic categories (faces, 
vehicles, vegetables, instruments and clothes) shown on a computer 
screen. The exemplars were selected to minimize within-category 
visual similarity, associative relations between exemplars, and 
overlap of initial phonemes of the names of the stimuli. The 
frequency and number of letters were controlled. The stimuli were 
arranged in a 5x5 item matrix. Columns corresponded to categories 
and formed homogeneous groups of five items, while rows formed 
groups of five items from different categories. Thus, there were five 
blocks with five items each from the same category, and five blocks 
with the same number of items from different categories. Each 
block contained four repetitions (four presentation cycles), a total 
of 20 trials per block. Each presentation cycle contained five 
different items and each item occurred once in each position within 
a cycle. The last item of a cycle was never the same as the first of 
the next cycle to avoid repetition of items on successive trials 
(Belke et al. 2005). 
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For counterbalancing purposes, we created five different 
homogeneous lists and five different heterogeneous lists from the 
combination of the 10 blocks in a Latin Square design. 
Homogeneous and heterogeneous lists were presented in 
alternating orders, with a pause after each list.  
The participants were instructed to name each item as 
quickly and accurately as possible. We presented images on a screen 
using a computer, and an electronic device recorded verbal 
responses. The experimenter recorded errors and equipment 
failures. Before the naming task, participants were familiarized with 
the complete set of stimuli with the corresponding name printed 
below. A trial consisted of the following: a fixation cross at the 
center of the screen for 500 ms; the stimulus remained on the 
screen until the response or for a maximum of 3000 ms; a blank 
interval for 500 ms. Response latencies were measured from the 
presentation of the stimulus to the onset of the response.  
In both experiments, participants were matched for race, 
age and IQ [measured by Raven’s Standard Progressive Matrices 
(Raven et al. 1988)]. Furthermore, to ensure intact verbal and 
memory functions, the participants preformed a Boston Naming 
Test (Kaplan et al. 1983), a modified version of the Verbal Fluency 
Test (VFT) for native Spanish speakers from SCIP [Screen for 
Cognitive impairment in Psychiatric patients] (Pino et al. 2006) and 
the Memory Span Test (Daneman and Carpenter 1980). 
Participants filled in a self-report questionnaire on recent use, 
amounts, and patterns of alcohol and drug consumption during the 
last six months (cf. Colzato et al., 2007, 2009). To encourage 
participants’ compliance with the instructions, saliva samples were 
obtained (not further analyzed) at the beginning of the experiment 
(cf. Colzato, Erasmus and Hommel, 2004). We obtained written 
informed consent from all participants after providing them with 
explanations about the nature of the experiment. The local ethics 
committee approved the protocol and the compensation of 20 euro 
for participation in the study. 




Thirty-two adults (30 men and 2 women) participated in 
the experiments. They formed the two experimental groups of 16 
chronic cocaine users and 16 cocaine-free controls. Chronic 
cocaine users were recruited from Proyecto Hombre Granada 
rehabilitation center. The inclusion criteria were: 1) meeting the 
DSM-IV criteria for cocaine dependence as assessed by the 
Structured Clinical Interview for DSM-IV disorders (SCID) 
(American Psychological Association 2000) – Clinician version 
(First et al. 1996) 2) a minimum abstinence interval of two days for 
all abuse substances except nicotine, observed by periodic urine 
toxicology tests, therapist reports or self-reports. The exclusion 
criteria were 1) the presence of any Axis I or Axis II disorders 
except substance abuse, determined by the Mini International 
Neuropsychiatric Interview (MINI) (Lecrubier et al. 1997), a brief 
diagnostic tool that screens for several psychiatric disorders; and 2) 
the presence of history of brain injury or central nervous system 
diseases; and 3) an excessive intake of alcohol (>280 g/week for 
men and >168g/week for women) (Foster and Marriott 2006). 
Four of the chronic cocaine users were using prescribed 
benzodiazepines, but they were asked not to use the medication 
two days before the assessment. Sixteen healthy adults formed the 
control group. We recruited the control participants via notes 
posted on community bulletin boards and by word of mouth. The 
control group did not meet any criteria for Axis I or Axis II 
psychiatric disorders, including substance abuse, and had no 
clinically significant medical disease (e.g. multiple sclerosis or brain 
injury). In the last six months, prior to participation, three chronic 
cocaine and three cocaine-free users also smoked marijuana, whilst 
one chronic cocaine user reported having used MDMA (ecstasy). 
Although participants in the chronic group were engaged in the 
detoxification program, they were periodically (every 30 days) 
screened for drug use through urine analysis, and we asked them to 
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refrain from taking all types of psychoactive drugs for at least two 
days before the experiment. In addition, all participants were asked 
not to consume alcohol the night before the experimental session 
and to have a normal night of rest. Researchers were also instructed 
to observe if participants had used alcohol prior to the 
experimental session. 
Table 1. Demographic characteristics and self-reported use of cocaine and 
other psychoactive drugs in Experiment 1. 
Notes. Raven IQ: IQ measured by means of the Raven’s Standard 
Progressive Matrices 
1Unit equals to a 10 ml or 8 grams of pure ethanol (International Center 
for Alcohol Policies, 2005; Spanish Ministry of Health, 2007). Chronic 
cocaine users are alcohol abstinent once engaged in the detoxification 
program. 
nsNon-significant difference 
* Significant group difference; p<0.05; ** Significant group difference; 
p<0.01. 




N (M:F) ns 16 (15:1) 16 (15:1) 
Age (years) ns 33.75 (4.46) 31.25 (4.97) 
Raven IQ ns 98 (5.43) 101 (8.60) 
Cigarettes (unit/day) ** 12.13 (7.44) 1.69 (3.38) 
alcohol (units/weeks)1 ** 24.4 (18.3) 1.8 (3.7) 
Monthly Cannabis (joints) * 2.75 (6.64) 0.75 (1.61) 
Years using cocaine 10.31 (4.88) 0 
Monthly exposure (grams) 15.37 (16.96) 0 
Maximum amount in a 12-
h period (grams) 
2.81 (1.52) 0 
Mean weeks in abstinence  24.71 (17.68) 0 
Monthly spent money 
(EUR) 
922.5 (1017.96) 0 
MDMA (grams/ last 6 
months) 
0.40 (1.62) 0 
Chapter 6 ─ 141 
 
Results 
Demographic and drug use statistics are provided in Table 
1. As mentioned, we assessed the alcohol habits of the participants 
through a self-reported questionnaire enquiring about their weekly 
intake of alcoholic drinks. Since the strengths of different types of 
alcoholic beverages vary significantly, we adopted the definitions of 
standard "drinks" or "units," equal to a 10 ml or 8 grams of pure 
ethanol (International Center for Alcohol Policies, 2005; Spanish 
Ministry of Health, 2007). As can be observed in Table 1, users 
differed from controls in the amount of tobacco, alcohol and 
cannabis consumed before they entered into the rehabilitation 
program, although none of them were consuming alcohol or 
cannabis once they entered into the program. 
Test Chronic cocaine users Cocaine-free controls 
BNT ns 50.94 (4.64) 49 (5.5) 
VFT ns 40.25 (7.2) 43.25 (8.9) 
MST ns 2.68 (0.92) 3.12 (0.64) 
Table 2. Mean scores obtained in neuropsychological test performance in 
Experiment 1.  
Notes. BNT: Boston Naming Test; VF: Verbal Fluency Test; MST: 
Memory span Test. 
nsNon-significant difference 
No significant group differences were obtained for IQ 
t(30) = 1.10, p = .27; Verbal functions Boston Naming Test, t(30) = 
-0.1, p = .29, Verbal Fluency Test, t(30) = 1.04, p = .30 and 
Memory Span Test, t(30) = 1.54, p = .13. Table 2 shows 
performance on the neuropsychological tests. 
Separate analyses were performed using IBM SPSS 
statistics® 20 for participants and items, yielding F1 and F2 statistics 
respectively. Given the traditional logic in the psycholinguistics 
field, we report both analyses to check whether the findings could 
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be generalized not only across participants, but also across similar 
stimulus materials. 
 We carried out a repeated measures ANOVA to compare 
the response latencies (RL) and errors with context (homogeneous 
vs. heterogeneous) as a within-subjects factor and group (chronic 
cocaine users vs. cocaine free controls) as a between groups factor. 
Three types of responses were excluded from the analysis 
(5.14%): 1) naming errors, hesitations and microphone failures; 2) 
responses longer than 1500 ms or shorter than 250 ms; 3) trial 
pictures that accounted for more than 15% of errors on overall task 
performance. In addition, as context effects are being targeted, 
following the procedure of analysis adopted by Damian et al. 
(2001), the first occurrence of each stimulus on each block was first 
excluded (first cycle), and the data from the other three cycles were 
collapsed. Figure 1 reports the mean RLs for correct responses and 
error means are reported in Table 3. 
Response latencies 
The RL analysis showed a significant effect of context [F1 
(1, 30) = 66.19, p < .001, η2p = .68; F2 (1, 48) = 44.19, p <.001, η2p = 
.47] indicating that the homogeneous condition led to longer 
naming latencies (M=664, SD=80) than the heterogeneous 
condition (M=612, SD=65). The main effect of group was 
significant in the item analysis [F1 = (1, 30) = 3.14, p = .86, η2p = 
.09; F2 (1, 48) = 26.3, p <.001, η2p = .35] showing that chronic 
cocaine users need more time to name the stimuli (M=660, SD=89) 
than the cocaine-free control group (M=617, SD=57).  Most 
importantly, the context x group interaction was significant [F1 (1, 
30) = 11.19, p = .002, η2p = .27; F2 (1, 48) = 7.07, p = .011, η2p = 
.12], showing that chronic users had larger semantic interference 
effects than the cocaine-free controls. Posthoc Newman-Keuls 
analyses showed a reliable difference between the homogeneous 
and heterogeneous condition (both ps < .05) for the group of 
chronic users (73 ms) and cocaine-free group (30 ms).  
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Figure 1. Mean response latencies (in milliseconds) by conditions in 
Experiment 1. Standard deviation in parentheses.  
 
Errors 
The main effect of context was significant in the analysis 
by items [F1 (1, 30) = 3.28, p = .07, η2p = .09]; F2 (1, 48) = 4.26, p = 
.04, η2p = .08] indicating that the homogeneous condition produced 
more errors than the heterogeneous condition. Neither the main 
effect of group nor the context x group interaction was significant 
[F< 1]. 
 
Table 3. Mean error execution (in percentage) by conditions.  




Chronic cocaine users 
Homogeneous 3.37 
Heterogeneous 1.76 




To test whether the magnitude of semantic interference 
was proportional to the amount of cocaine consumed, we 
computed partial correlation coefficients between relevant cocaine 
use variables (e.g., lifetime amount, times per week of cocaine use, 
maximum peak in 12 hours, and monthly consumed cocaine in 
grams) and both semantic blocking (the result of the subtraction 
between homogeneous and heterogeneous response latencies) and 
error, when controlling for other drug use (tobacco, MDMA and 
alcohol). The variable error commission correlated positively with 
times per week of cocaine use r = .681 (p = .01) (figure 2) and 
maximum peak of cocaine used in 12 hours r = .718 (p = .006) 
(figure 3). Although the variable semantic effect followed the same 
trend, no correlations reached significance (rs ≤ .41, ps ≥ .15). Thus, 
it seems that the heavy cocaine usage (more times per week and 
high picks in 12 hours) may impair performance on the semantic 
blocking task. No other significant correlations were found (ps > 
.05). 
 
Figure 2. Scatter diagram of the partial correlation between the error 
commission and weekly comsuption of cocaine (residuals) in experiment 
1, controlling for the use of other drugs. 
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Figure 3. Scatter diagram of the partial correlation between the error 
commission and maximum comsuption of cocaine in 12 h (residuals) in 
experiment 1, controlling for the use of other drugs. 
Discussion 
Experiment 1 tested the hypothesis that chronic cocaine 
users have an impairment in inhibitory processes in the verbal 
domain. If so, chronic cocaine users would show a more 
pronounced semantic blocking effect due to an inefficient selection 
mechanism when items became stronger competitors during lexical 
selection. This is exactly what we observed: both groups showed 
similar performance on naming items in a semantically-unrelated 
condition, but chronic cocaine users showed larger naming 
latencies for the items to be named in a semantically-related 
condition in comparison to the cocaine-free controls. In addition, 
partial correlations showed that heavy cocaine (more times per 
week and high picks in 12 hours) seems to contribute to the greater 
semantic effect. Based on the assumption of there being impaired 
inhibitory processes in long-term cocaine users (Ersche et al. 2012; 
Fillmore and Rush 2002; Goldstein and Volkow 2002; Rosselli et al. 
2001; Volkow et al. 2010), we consider that the greater semantic 
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interference that chronic cocaine users show reflects a deficit in the 
inhibitory mechanism involved during lexical selection. 
Experiment 2 
Participants 
Forty healthy adults (20 men and 20 women) served as 
participants for partial fulfillment of course credits or financial 
compensation. They formed the two experimental groups of 20 
recreational cocaine polydrug users and 20 cocaine free controls. 
We recruited the participants via notes posted on community 
bulletin boards and by word of mouth. Recreational cocaine 
polydrug users met the following criteria: 1) a monthly 
consumption (1 to 4 grams) by the snorting route for a minimum 
of two years; 2) no Axis I or Axis II psychiatric disorders 
[Diagnostic and Statistical Manual of Mental Disorders IV DSM-
IV; (American Psychological Association 2000)], including 
substance abuse; 3) no clinically significant medical disease; 4) no 
use of prescription medication and 5) non-excessive below-risk 
intake of alcohol (>280 g/week for men and >168 g/week for 
women) (Foster and Marriott 2006). Cocaine free-controls met the 
same criteria but they reported no history of past or current cocaine 
use.  
In the six months prior to participation, fourteen 
recreational cocaine polydrug users and two cocaine-free users also 
smoked marijuana, while fourteen recreational users reported 
having used MDMA (ecstasy) and six reported using ketamine. 
Participants were asked to refrain from taking all psychoactive 
drugs for at least two days, not to consume alcohol the night before 
the experimental session, and to have a normal night of rest. 
Researchers were instructed to observe if participants had used 
alcohol prior to the experimental session. Participants were selected 
by means of a telephone interview using the Mini International 
Neuropsychiatric Interview (MINI) (Lecrubier et al. 1997). The 
sample was obtained from a pool of 50 potential volunteers who 
responded to the advertisements for studies conducted in our lab 
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over a period of six months. Within this pool of potential 
participants, the most common reason for excluding an individual 
from the study was meeting criteria for psychiatric disorders, 







N (M:F) ns 20 (10:10)  20 (10:10) 
Age (years) ns 24.7 (4.26)  23.35 (3.24) 
Raven IQ ns 103 (9.2)  101 (9.5) 
Cigarettes (unit/day) * 7.6 (8)  1.95 (3.30) 
alcohol (units/weeks) **1 15 (9.89)   4.75 (5.31) 
Monthly Cannabis (joints) ** 25.6 (26.57)  1.2 (4.51) 
Years using cocaine 4 (2.43)  0 
Monthly exposure (grams) 2.56 (1.74)  0 
Maximum amount in a  12-h 
period (grams) 
1.61 (0.76)  0 
Mean days in abstinence  13.25 (10)  0 
Monthly spent money (EUR) 98 (46.29)  0 
MDMA (grams/ last 6 
months) 
1.95 (1.92)  0 
Table 4. Demographic characteristics and self-reported use of cocaine and other 
psychoactive drugs in Experiment 2 
 
Notes. Raven IQ: IQ measured by means of the Raven’s Standard Progressive 
Matrices. 
1Unit equals to a 10 ml or 8 g of pure ethanol (International Center for Alcohol 
Policies, 2005; Spanish Ministry of Health, 2007. 
ns Non-significant difference 
* Significant group difference; p<0.05: ** Significant group difference; p<0.01
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Results 
Demographic and drug use statistics are provided in Table 
4. Recreational cocaine polydrug users significantly used more 
tobacco, alcohol and cannabis than the control group in the last six 
months prior to the test. No significant group differences were 
obtained for intelligence, t(38) = .66, p = .51; Boston Naming Test, 
t(38) = 1.18, p = .24, Memory span, t(38) = .99, p = .32 or verbal 
fluency test, t(38) = 1.12, p = .26. Table 5 shows performance on 
the neuropsychological tests.   
Test Recreational cocaine  Cocaine-free controls 
BNT ns 50.25 (3.1) 51.75 (4.74) 
VFT ns 43.20 (10.43) 46.7 (9.22) 
MST ns 3.23 (0.90) 3.50 (0.76) 
Table 5. Mean scores obtained in neuropsychological test performance in 
Experiment 2. 
Notes. BNT: Boston Naming Test; VF: Verbal Fluency Test. MST: 
Memory span Test.; ns: Non-significant difference. 
As for Experiment 1, three types of responses were 
excluded from the analysis (3.56%): 1) naming errors, hesitations 
and microphone failures; 2) responses longer than 1500 ms or 
shorter than 250 ms; 3) trial pictures that accounted for more than 
15% of errors on overall task performance. 
Response latencies  
The RL analysis showed a significant effect of context [F1 
(1, 38) = 40.15, p < .001, η2p = .51; F2 (1, 48) = 22.26, p <.001, η2p = 
.31] indicating that the homogeneous condition led to longer 
naming latencies (M=604, SD=80) than the heterogeneous 
condition (M=572, SD=78.5). The main effect of group was 
marginally significant in the item analysis [F1 (1, 38) = .37, p = .54, 
η2p = .009; F2 (1, 48) = 3.62, p = .063, η2p = .07] showing that 
recreational polydrug cocaine users needed more time to name the 
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stimuli (M=595, SD=87.6) than cocaine-free control group 
(M=580, SD=73.6). Most importantly, the context x group 
interaction reached significance [F1 (1, 38) = 6.95, p = .012, η2p = 
.15; F2 (1, 48) = 4.02, p = .05, η2p = .07], showing that recreational 
polydrug cocaine users had stronger semantic interference than the 
cocaine-free controls. Posthoc Newman-Keuls analyses showed a 
reliable difference between the homogeneous and heterogeneous 
condition (both ps< .05) for the group of recreational cocaine 
polydrug users (46 ms) and cocaine-free group (19 ms). Figure 4 
reports the mean RLs for correct responses. 
Figure 4. Mean response latencies (in milliseconds) by conditions in 
Experiment 2. Standard deviation in parentheses. 
 
Errors 
The main effect of context was not significant in either the 
subject and items analysis. The main effect of group was significant 
in the item analysis [F1 (1, 38) = 8.43, p = .006, η2p = .18; F2 (1, 48) 
= 12.35, p < .001, η2p = .20] showing a higher rate of error 
commission in the recreational cocaine polydrug group compared 
to the cocaine free control group. Interestingly, the context x group 
interaction reached significance in the item analysis [F1 (1, 38) = 
3.76, p = .06, η2p = .08; F2 (1, 48) = 5.6, p = .022, η2p = .10]. Posthoc 
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Newman-Keuls analyses showed that the recreational cocaine 
polydrug users committed a higher rate for semantically-related 
items than the control group. Error means are reported in Table 6. 
Table 6. Mean error execution (in percentage) by conditions in 
Experiment 2. 
Correlations 
To test whether the magnitude of semantic interference is 
proportional to the amount of cocaine consumed, we computed 
partial correlation coefficients between relevant cocaine use 
variables (such as lifetime amount consumed, maximum peak in 12 
hours, and cocaine grams consumed per month) and both the 
semantic blocking effect and error commission, when controlling 
for other drug use (tobacco, MDMA and alcohol). However, no 
correlation reached significance (rs ≤ .41, ps ≥ .10). 
Discussion 
As expected in Experiment 1, recreational cocaine 
polydrug users showed larger semantic blocking effects in 
comparison with a cocaine-free group, reflecting vulnerability to 
semantic interference in a language production task. The results are 
in line with those studies in which recreational cocaine polydrug 
users show decreased performance in tasks tapping inhibition 
(Colzato and Hommel 2009; Colzato et al. 2007; Sellaro et al. 2013). 
Taken together, these results suggest that even small amounts of 
cocaine may predispose to inefficient selection mechanisms for 
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lexical selection during language production. However, the possible 
causal role of drug consumption in language selection has to be 
taken with caution since recreational cocaine polydrug users 
significantly used more tobacco, alcohol, and cannabis than the 
control group and, partial correlations between cocaine use and 
semantic blocking did not reach significance. It is also important to 
note the possibility that preexistent endophenotypes that are known 
to contribute to behavioral performance in cocaine users may have 
a role to play in the impairment of language competition in 
recreational users (Ersche et al. 2012; Verdejo-Garcia et al. 2008). 
General discussion 
This study investigated for the first time whether the 
chronic and recreational use of cocaine leads to a detectable 
increase in semantic interference. The magnitude of the semantic 
effect was substantially larger in the chronic and recreational 
cocaine groups relative to cocaine-free controls during the naming 
of semantically-related objects. This semantic interference can be 
accounted for by the competition between co-activated lexical 
entries in a homogeneous context that affects selection latencies 
(Roelofs 1992; Schriefers et al. 1990). To ensure the success of the 
lexical selection, the inhibitory system must act to selectively 
suppress semantically-related lexical entries that are strong 
competitors for the correct answer (Roelofs and Piai 2011; Shao et 
al. 2013). Following the study of Biegler and Martin (2008), patients 
with left inferior frontal gyrus damage showed an exaggerated 
semantic blocking effect, suggesting that the brain adjusts the 
weight derived from the co-activation of semantic-related items 
(Biegler et al. 2008). Thus, we propose that the chronic and 
recreational cocaine users may suffer from the same deficit, albeit in 
a milder form. Our results are in line with the available studies on 
recreational and chronic users of cocaine, which report 
impairments on tasks measuring inhibition in non-verbal domains 
(Colzato et al. 2007; Fillmore and Rush 2002; Sellaro et al. 2013; 
Verdejo-García et al. 2007). However, this is the first study in 
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which a semantic blocking task is used as an indicator of 
interference resolution in the verbal domain in cocaine users. Both 
chronic and recreational cocaine-users showed larger semantic 
blocking, probably due to inefficient use of verbal inhibitory 
processes.  
The design of our study allows us to reject alternative 
accounts of our observations in terms of age, IQ, and sex, since the 
two user groups were matched with the controls on these variables. 
Similarly, the present results cannot be explained by factors related 
to pre-existing psychiatric disorders which are known to affect 
response inhibition (Rosenberg et al. 1997; Schachar and Logan 
1990; Thoma et al. 2007) since we conducted extensive screening 
using the MINI to exclude any preexisting psychiatric disorders 
(e.g. ADHD). 
Nevertheless, the results of the study for the recreational 
polydrug group do not allow us to completely rule out an account 
of their deficit in terms of preexistent underlying neurocognitive 
endophenotype for stimulant drug addiction that may contribute to 
task performance (Ersche et al. 2012; Verdejo-Garcia et al. 2008). 
However, the fact that the impairment was found for both chronic 
and recreational users with very different social and personal 
profiles may suggest that recreational cocaine use is also related to 
the larger blocking effects found in the recreational polydrug users 
relative to the controls.    
Another possible shortcoming of our study is that, given 
the abuse rate of other drugs when consuming cocaine among 
recreational users (Grov et al. 2009; Kelly and Parsons 2008), it is 
difficult to separate the cognitive deficit produced by cocaine use 
from the effect of the use of other drugs. It should be noted that 
the difference in significance in the use of tobacco, alcohol and 
cannabis between the groups may also be influencing difference in 
the semantic effect. We tried to minimize this fact by selecting a 
sample of users who predominantly used cocaine and, avoiding as 
far as possible the selection of people that also abuse other 
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stimulant drugs. We based our selection on self-report measures, 
since previous studies have shown that self-reports of drug abuse 
are quite reliable, and are strongly correlated with objective 
measures of drug abuse (Glintborg et al. 2008; Zaldívar Basurto et 
al. 2009). Since our participants reported very low consumption of 
cannabis and MDMA, we doubt that our results may be attributed 
to the use of the effects of any of these two drugs. Moreover, 
studies that have examined the effect of MDMA and cannabis on 
executive functions have provided conflicting results. Whereas 
deficits in working memory appear to be likely consequences of 
chronic MDMA and impairments in cognitive flexibility due to 
cannabis use (Verdejo-García et al. 2005), less consistent results 
were found in studies investigating inhibitory control in the abuse 
of both substances (Crean et al. 2011; Kalechstein et al. 2007).   
A more important limiting factor of our study is the fact 
that cocaine and alcohol are more often than not, consumed 
together and our sample of cocaine users was not an exception (see 
Table 1). Given the fact that acute alcohol use impairs inhibitory 
control (Fillmore and Vogel-Sprott 2000; Fillmore 2007; Noël et al. 
2010), it is difficult to determine whether the obtained effects are 
the result of cocaine, or the effects of alcohol and cocaine together 
(Jatlow et al. 1996). In this regard, the screening of alcohol 
consumption in both groups was particularly important, so that 
participants selected for the study reported an average long-term 
consumption below the criteria for high alcohol use (280 g/week 
for men and 168g/week for women). In addition, the group of 
chronic users were undergoing regular urine toxicology screens as 
part of their treatment. However, whilst we used self-report 
measures and provided specific instructions not to consume 
alcohol or other drugs before the experimental session, we cannot 
be sure that participants in Experiment 2 may have actively used 
either alcohol or cocaine shortly before the session, with 24 to 48 
hours prior to the experimental session potentially affecting 
performance on the semantically-blocked naming task. Although 
this suggestion should be treated with caution, the fact that the 
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impairment appeared in both recreational and chronic users (urine 
tested) suggests that this might not have been the case.  
The outcomes from both experiments show that the use of 
high and low amounts of cocaine may be influencing vulnerability 
to interference in verbal cognitive processes in which inhibitory 
control is required. Although the role of some preexisting factor 
such as impulsiveness, risky behavior, driving or illegal activity 
(Verdejo-Garcia et al. 2008) cannot be ruled out, the present results 
support the broader notion that cocaine use may impair  inhibitory 
processes including those that subserve speech production.   
  
Chapter 6 ─155 
 
References 
European Monitoring Centre for drugs and drug addiction 
EMCDDA (2012). 2012 Annual report on the state of the drugs 
problem in Europe. Publications Office of the European Union. 
American Psychological Association, A. P. A (2000). Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV-
TR®: American Psychiatric Pub. 
Anderson, M. C. (2003). Rethinking interference theory: Executive 
control and the mechanisms of forgetting. Journal of Memory and 
Language, 49(4), 415-445. doi: 10.1016/j.jml.2003.08.006 
Ardila, A., Rosselli, M., & Strumwasser, S. (1991). 
Neuropsychological deficits in chronic cocaine abusers. The 
International journal of neuroscience, 57(1-2), 73-79.  
Arnsten, A. F. T., Wang, M. J., & Paspalas, C. D. (2012). 
Neuromodulation of Thought: Flexibilities and Vulnerabilities 
in Prefrontal Cortical Network Synapses. Neuron, 76(1), 223-239. 
doi: 10.1016/j.neuron.2012.08.038 
Bari, A., & Robbins, T. W. (2013). Inhibition and impulsivity: 
Behavioral and neural basis of response control. Progress in 
Neurobiology, 108, 44-79. doi: 10.1016/j.pneurobio.2013.06.005 
Beatty, W. W., Katzung, V. M., Moreland, V. J., & Nixon, S. J. 
(1995). Neuropsychological performance of recently abstinent 
alcoholics and cocaine abusers. Drug and Alcohol Dependence, 
37(3), 247-253. doi: 10.1016/0376-8716(94)01072-S 
Belke, E., Meyer, A. S., & Damian, M. F. (2005). Refractory effects 
in picture naming as assessed in a semantic blocking paradigm. 
The Quarterly Journal of Experimental Psychology. A, Human 
Experimental Psychology, 58(4), 667-692.  
Biegler, K. A., Crowther, J. E., & Martin, R. C. (2008). 
Consequences of an inhibition deficit for word production and 
comprehension: evidence from the semantic blocking paradigm. 
Chapter 6 ─156 
 
 
Cognitive Neuropsychology, 25(4), 493-527. doi: 
10.1080/02643290701862316 
Bolla, K. I., Rothman, R., & Cadet, J. L. (1999). Dose-Related 
Neurobehavioral Effects of Chronic Cocaine Use. The Journal of 
Neuropsychiatry and Clinical Neurosciences, 11(3), 361-369.  
Brainerd, C. J., & Dempster, F. N. (1995). Interference and Inhibition in 
Cognition: Academic Press. 
Colzato, L. S., Erasmus, V., & Hommel, B. (2004). Moderate 
alcohol consumption in humans impairs feature binding in 
visual perception but not across perception and action. 
Neuroscience Letters, 360(1-2), 103-105. doi: 
10.1016/j.neulet.2004.01.054 
Colzato, L. S., & Hommel, B. (2009). Recreational use of cocaine 
eliminates inhibition of return. Neuropsychology, 23(1), 125-129. 
doi: 10.1037/a0013821 
Colzato, L. S., van den Wildenberg, W. P. M., & Hommel, B. 
(2007). Impaired Inhibitory Control in Recreational Cocaine 
Users. PLoS ONE, 2(11). doi: 10.1371/journal.pone.0001143 
Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An Evidence 
Based Review of Acute and Long-Term Effects of Cannabis 
Use on Executive Cognitive Functions. Journal of addiction 
medicine, 5(1), 1-8. doi: 10.1097/ADM.0b013e31820c23fa 
Damian, M. F., Vigliocco, G., & Levelt, W. J. M. (2001). Effects of 
semantic context in the naming of pictures and words. Cognition, 
81(3), B77-B86. doi: 10.1016/S0010-0277(01)00135-4 
Daneman, M., & Carpenter, P. A. (1980). Individual differences in 
working memory and reading. Journal of Verbal Learning and 
Verbal Behavior, 19(4), 450-466. doi: 10.1016/S0022-
5371(80)90312-6 
Ersche, K. D., Jones, P. S., Williams, G. B., Turton, A. J., Robbins, 
T. W., & Bullmore, E. T. (2012). Abnormal Brain Structure 
Implicated in Stimulant Drug Addiction. Science, 335(6068), 601-
604. doi: 10.1126/science.1214463 
Chapter 6 ─ 157 
 
Fillmore, M. T., & Rush, C. R. (2002). Impaired inhibitory control 
of behavior in chronic cocaine users. Drug and Alcohol Dependence, 
66(3), 265-273. doi: 10.1016/S0376-8716(01)00206-X 
Fillmore, M. T., & Vogel-Sprott, M. (2000). Response inhibition 
under alcohol: effects of cognitive and motivational conflict. 
Journal of studies on alcohol, 61(2), 239-246.  
Fillmore, M. Τ. (2007). Acute alcohol-induced impairment of 
cognitive functions: Past and present findings. International 
Journal on Disability and Human Development, 6(2), 115-126. doi: 
10.1515/IJDHD.2007.6.2.115 
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). 
Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician 
Version (SCID-CV). Washington, D.C.: American Psychiatric 
Press, Inc. 
Glintborg, B., Olsen, L., Poulsen, H., Linnet, K., & Dalhoff, K. 
(2008). Reliability of self-reported use of amphetamine, 
barbiturates, benzodiazepines, cannabinoids, cocaine, 
methadone, and opiates among acutely hospitalized elderly 
medical patients. Clinical toxicology (Philadelphia, Pa.), 46(3), 239-
242. doi: 10.1080/15563650701586397 
Goldstein, R. Z., Leskovjan, A. C., Hoff, A. L., Hitzemann, R., 
Bashan, F., Khalsa, S. S., . . . Volkow, N. D. (2004). Severity of 
neuropsychological impairment in cocaine and alcohol 
addiction: association with metabolism in the prefrontal cortex. 
Neuropsychologia, 42(11), 1447-1458. doi: 
10.1016/j.neuropsychologia.2004.04.002 
Goldstein, R. Z., & Volkow, N. D. (2002). Drug Addiction and Its 
Underlying Neurobiological Basis: Neuroimaging Evidence for 
the Involvement of the Frontal Cortex. The American journal of 
psychiatry, 159(10), 1642-1652.  
Grov, C., Kelly, B. C., & Parsons, J. T. (2009). Polydrug Use 
Among Club-Going Young Adults Recruited Through Time-
Space Sampling. Substance Use & Misuse, 44(6), 848-864. doi: 
10.1080/10826080802484702 
Chapter 6 ─158 
 
 
Hershey, T., Black, K. J., Hartlein, J., Braver, T. S., Barch, D. M., 
Carl, J. L., & Perlmutter, J. S. (2004). Dopaminergic modulation 
of response inhibition: an fMRI study. Brain research. Cognitive 
brain research, 20(3), 438-448. doi: 
10.1016/j.cogbrainres.2004.03.018 
Hester, R., & Garavan, H. (2004). Executive dysfunction in cocaine 
addiction: evidence for discordant frontal, cingulate, and 
cerebellar activity. The Journal of neuroscience: the official journal of the 
Society for Neuroscience, 24(49), 11017-11022. doi: 
10.1523/JNEUROSCI.3321-04.2004 
Hulka, L. M., Eisenegger, C., Preller, K. H., Vonmoos, M., Jenni, 
D., Bendrick, K., . . . Quednow, B. B. (2013). Altered social and 
non-social decision-making in recreational and dependent 
cocaine users. Psychological Medicine, 1-14. doi: 
10.1017/S0033291713001839 
Hulka, L. M., Preller, K. H., Vonmoos, M., Broicher, S. D., & 
Quednow, B. B. (2013). Cocaine users manifest impaired 
prosodic and cross-modal emotion processing. Frontiers in 
Psychiatry, 4, 98. doi: 10.3389/fpsyt.2013.00098 
Hulka, L. M., Wagner, M., Preller, K. H., Jenni, D., & Quednow, B. 
B. (2013). Blue-yellow colour vision impairment and cognitive 
deficits in occasional and dependent stimulant users. International 
Journal of Neuropsychopharmacology, 16(3), 535-547. doi: 
10.1017/S1461145712000624 
International Center for Alcohol Policies (2005) ICAP Blue Book : 
Practical Guides for Alcohol Policy and Targeted Interventions. 
ICAP: Washintong DC  
Jatlow, P., McCance, E. F., Bradberry, C. W., Elsworth, J. D., 
Taylor, J. R., & Roth, R. H. (1996). Alcohol plus cocaine: the 
whole is more than the sum of its parts. Therapeutic Drug 
Monitoring, 18(4), 460-464.  
Jovanovski, D., Erb, S., & Zakzanis, K. K. (2005). Neurocognitive 
deficits in cocaine users: a quantitative review of the evidence. 
Journal of Clinical and Experimental Neuropsychology, 27(2), 189-204.  
Chapter 6 ─ 159 
 
Kalechstein, A. D., De la Garza II, R.,. Mahoney III, J. J., 
Fantegrossi, W. E., & Newton, T. F. (2007). MDMA use and 
neurocognition: a meta-analytic review. Psychopharmacology, 
189(4), 531-537. doi: 10.1007/s00213-006-0601-2 
Kaplan, E., Goodglass, H., & Weintraub, S. (1983). Boston naming 
test. Philadelphia: Lea & Febiger. 
Kelly, B. C., & Parsons, J. T. (2008). Predictors and Comparisons 
of Polydrug and Non-Polydrug Cocaine Use in Club 
Subcultures. The American Journal of Drug and Alcohol Abuse, 34(6), 
774-781. doi: 10.1080/00952990802455451 
Kroll, J. F., & Stewart, E. (1994). Category Interference in 
Translation and Picture Naming: Evidence for Asymmetric 
Connections Between Bilingual Memory Representations. 
Journal of Memory and Language, 33(2), 149-174. doi: 
10.1006/jmla.1994.1008 
Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonora, I., 
Harnett Sheehan, K., . . . Dunbar, G. C. (1997). The Mini 
International Neuropsychiatric Interview (MINI). A short 
diagnostic structured interview: reliability and validity according 
to the CIDI. European Psychiatry, 12(5), 224-231. doi: 
10.1016/S0924-9338(97)83296-8 
Manschreck, T. C., Schneyer, M. L., Weisstein, C. C., Laughery, J., 
Rosenthal, J., Celada, T., & Berner, J. (1990). Freebase cocaine 
and memory. Comprehensive psychiatry, 31(4), 369-375.  
Miller, E. K., & Cohen, J. D. (2001). An integrative theory of 
prefrontal cortex function. Annual review of neuroscience, 24(1), 
167-202.  
Mittenberg, W., & Motta, S. (1993). Effects of chronic cocaine 
abuse on memory and learning. Archives of clinical neuropsychology: 
the official journal of the National Academy of Neuropsychologists, 8(6), 
477-483.  
Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., 
Howerter, A., & Wager, T. D. (2000). The unity and diversity of 
executive functions and their contributions to complex "Frontal 
Chapter 6 ─160 
 
 
Lobe" tasks: a latent variable analysis. Cognitive Psychology, 41(1), 
49-100. doi: 10.1006/cogp.1999.0734 
Noël, X., Tomberg, C., Verbanck, P., & Campanella, S. (2010). The 
influence of alcohol ingestion on cognitive response inhibition 
and error processing. Journal of Psychophysiology, 24(4), 253-258. 
doi: 10.1027/0269-8803/a000039 
O'Malley, S. S., & Gawin, F. H. (1990). Abstinence 
symptomatology and neuropsychological impairment in chronic 
cocaine abusers. NIDA research monograph, 101, 179-190.  
Pino, Ó., Guilera, G., Gómez, J., Emilio Rojo, J., Vallejo, J., & 
Purdon, S. E. (2006). A brief scale to assess cognitive 
impairment in psychiatric patients. Psicothema, 18(3), 447-452.  
Previc, F. H. (1999). Dopamine and the Origins of Human 
Intelligence. Brain and Cognition, 41(3), 299-350. doi: 
10.1006/brcg.1999.1129 
Raven, J. C., Court, J. H., & Raven, J. (1988). Manual for Raven's 
Progressive Matrices and Vocabulary Scales: Standard Progressive 
Matrices (r.e. ed.): HK Lewis. 
Reske, M., Eidt, C. A., Delis, D. C., & Paulus, M. P. (2010). 
Nondependent Stimulant Users of Cocaine and Prescription 
Amphetamines Show Verbal Learning and Memory Deficits. 
Biological Psychiatry, 68(8), 762-769. doi: 
10.1016/j.biopsych.2010.04.021 
Robbins, T. W., & Arnsten, A. F. T. (2009). The 
neuropsychopharmacology of fronto-executive function: 
monoaminergic modulation. Annual review of neuroscience, 32, 267-
287. doi: 10.1146/annurev.neuro.051508.135535 
Roelofs, A. (1992). A spreading-activation theory of lemma retrieval 
in speaking. Cognition, 42(1-3), 107-142.  
Roelofs, A. (2003). Goal-referenced selection of verbal action: 
Modeling attentional control in the Stroop task. Psychological 
Review, 110(1), 88-125. doi: 10.1037/0033-295X.110.1.88 
Chapter 6 ─ 161 
 
Roelofs, A., & Piai, V. (2011). Attentional inhibition in bilingual 
naming performance: evidence from delta-plot analyses. Frontiers 
in Cognition, 2. doi: 10.3389/fpsyg.2011.00184 
Rosenberg, D. R., Dick, E. L., O'Hearn, K. M., & Sweeney, J. A. 
(1997). Response-inhibition deficits in obsessive-compulsive 
disorder: an indicator of dysfunction in frontostriatal circuits. 
Journal of Psychiatry and Neuroscience, 22(1).  
Rosselli, M., & Ardila, A. (1996). Cognitive effects of cocaine and 
polydrug abuse. Journal of Clinical and Experimental Neuropsychology, 
18(1), 122-135. doi: 10.1080/01688639608408268 
Rosselli, M., Ardila, A., Lubomski, M., Murray, S., & King, K. 
(2001). Personality profile and neuropsychological test 
performance in chronic cocaine-abusers. The International journal 
of neuroscience, 110(1-2), 55-72.  
Schachar, R., & Logan, G. D. (1990). Impulsivity and inhibitory 
control in normal development and childhood psychopathology. 
Developmental psychology, 26(5), 710-720. doi: 10.1037/0012-
1649.26.5.710 
Schriefers, H., Meyer, A. S., & Levelt, W. J. M. (1990). Exploring 
the time course of lexical access in language production: Picture-
word interference studies. Journal of Memory and Language, 29(1), 
86-102. doi: 10.1016/0749-596X(90)90011-N 
Sellaro, R., Hommel, B., & Colzato, L. S. (2013). Increased 
response conflict in recreational cocaine polydrug users. 
Experimental Brain Research. doi: 10.1007/s00221-013-3724-9 
Shao, Z., Meyer, A. S., & Roelofs, A. (2013). Selective and 
nonselective inhibition of competitors in picture naming. 
Memory & Cognition. doi: 10.3758/s13421-013-0332-7 
Soar, K., Mason, C., Potton, A., & Dawkins, L. (2012). 
Neuropsychological effects associated with recreational cocaine 
use. Psychopharmacology, 222(4), 633-643. doi: 10.1007/s00213-
012-2666-4 
Spanish Ministry of Health/Ministerio de Sanidad y Consumo 
(2007) Prevención de los problemas derivados del alcohol. 1ª 
Chapter 6 ─162 
 
 
Conferencia de prevención y promoción de la salud en la 
práctica en España. Ministerio de Sanidad y Consumo 
Thoma, P., Wiebel, B., & Daum, I. (2007). Response inhibition and 
cognitive flexibility in schizophrenia with and without comorbid 
substance use disorder. Schizophrenia research, 92(1), 168-180.  
Thompson-Schill, S. L. (2003). Neuroimaging studies of semantic 
memory: inferring “how” from “where”. Neuropsychologia, 41(3), 
280-292.  
Thompson-Schill, S. L., D’Esposito, M., Aguirre, G. K., & Farah, 
M. J. (1997). Role of left inferior prefrontal cortex in retrieval of 
semantic knowledge: A reevaluation. Proceedings of the National 
Academy of Sciences, 94(26), 14792-14797.  
Thompson-Schill, S. L., Jonides, J., Marshuetz, C., Smith, E. E., 
D’Esposito, M., Kan, I. P., . . . Swick, D. (2002). Effects of 
frontal lobe damage on interference effects in working memory. 
Cognitive, Affective, & Behavioral Neuroscience, 2(2), 109-120.  
Tomasi, D., Volkow, N. D., Wang, R., Carrillo, J. H., Maloney, T., 
Alia-Klein, N., . . . Goldstein, R. Z. (2010). Disrupted 
Functional Connectivity with Dopaminergic Midbrain in 
Cocaine Abusers. PLoS ONE, 5(5). doi: 
10.1371/journal.pone.0010815 
United Nations Office on Drugs & Crime UNODC (2013). World 
drug report, 2013. New York: United Nations. 
Verdejo-García, A., Bechara, A., Recknor, E. C., & Pérez-García, 
M. (2006). Executive dysfunction in substance dependent 
individuals during drug use and abstinence: an examination of 
the behavioral, cognitive and emotional correlates of addiction. 
Journal of the International Neuropsychological Society: JINS, 12(3), 
405-415.  
Verdejo-Garcia, A., Lopez-Torrecillas, F., Gimenez, C. O., & 
Perez-Garcia, M. (2004). Clinical implications and 
methodological challenges in the study of the 
neuropsychological correlates of cannabis, stimulant, and opioid 
abuse. Neuropsychol Rev, 14(1), 1-41.  
Verdejo-García, A., & Pérez-García, M. (2007). Profile of executive 
deficits in cocaine and heroin polysubstance users: common and 
Chapter 6 ─ 163 
 
differential effects on separate executive components. 
Psychopharmacology, 190(4), 517-530. doi: 10.1007/s00213-006-
0632-8 
Verdejo-García, A. J., López-Torrecillas, F., Aguilar de Arcos, F., & 
Pérez-García, M. (2005). Differential effects of MDMA, 
cocaine, and cannabis use severity on distinctive components of 
the executive functions in polysubstance users: a multiple 
regression analysis. Addictive Behaviors, 30(1), 89-101. doi: 
10.1016/j.addbeh.2004.04.015 
Verdejo-García, A. J., Perales, J. C., & Pérez-García, M. (2007). 
Cognitive impulsivity in cocaine and heroin polysubstance 
abusers. Addictive Behaviors, 32(5), 950-966. doi: 
10.1016/j.addbeh.2006.06.032 
Volkow, N. D., Fowler, J. S., Wang, G.-J., Telang, F., Logan, J., 
Jayne, M., . . . Swanson, J. M. (2010). Cognitive Control of Drug 
Craving Inhibits Brain Reward Regions in Cocaine Abusers. 
NeuroImage, 49(3). doi: 10.1016/j.neuroimage.2009.10.088 
Vonmoos, M., Hulka, L. M., Preller, K. H., Jenni, D., Baumgartner, 
M. R., Stohler, R., . . . Quednow, B. B. (2013). Cognitive 
dysfunctions in recreational and dependent cocaine users: role 
of attention-deficit hyperactivity disorder, craving and early age 
at onset. The British Journal of Psychiatry, 203(1), 35-43. doi: 
10.1192/bjp.bp.112.118091 
Zaldívar Basurto, F., García Montes, J. M., Flores Cubos, P., 
Sánchez Santed, F., López Ríos, F., & Molina Moreno, A. 
(2009). Validity of the self-report on drug use by university 
students: correspondence between self-reported use and use 
detected in urine. Psicothema, 21(2), 213-219. 
Chapter 7 ─ 165 
 
Chapter 7 
Directed Forgetting of memories and 
cocaine use 
Abstract 
Memory retrieval requires an effective recruitment of 
inhibitory control to successfully reject unnecessary memories. The 
use of cocaine is associated with poor cognitive control processes, 
but little is known about the impact of chronic and recreational use 
of cocaine on inhibitory control during intentional forgetting. We 
studied whether chronic and recreational users of cocaine show 
impairments on the mechanism responsible for intentional 
forgetting of memories. Two experiments were carried out on 
chronic cocaine users in rehabilitation (experiment 1) and 
recreational cocaine polydrug users (experiment 2) performing a 
directed forgetting (DF) task, an index of memory suppression. 
Participants were matched for sex, age, and intelligence (Raven’s 
standard progressive matrices) with cocaine-free controls and 
compared on their performance on a DF procedure. Chronic 
cocaine users in rehabilitation and recreational cocaine polydrug 
users compared to controls were not able to intentionally suppress 
the required information, and they did not show a reliable DF 
effect. The consumption of cocaine appears to alter the control 
processes related to intentional suppression of non-relevant 
memories in episodic memory. The use of cocaine, even for 
recreational purposes, seems to be associated with poor 
performance in effectively triggering this control mechanism. The 
inability to suppress interference in declarative memory may have 
repercussion for daily activities. 
  




The use of cocaine is, after heroin, the second most 
problematic illicit drug world-wide in terms of negative health 
consequences (United Nations Office on Drugs & Crime, 2013). 
The popularity of cocaine has risen in the last years, and it is 
estimated that about 2.2 million young adults aged 15 to 34 used 
cocaine in 2013 (EMCDDA, 2014). Despite the negative 
consequences associated with repeated drug abuse, cocaine users 
continue to use the drug. In the last years the focus on cocaine-
related cognitive deficits has risen and a number of studies have 
examined the long-term effects of cocaine on cognitive processes 
when comparing users to cocaine-free individuals (Bolla, Rothman, 
& Cadet, 1999; Goldstein et al., 2004; Jovanovski, Erb, & Zakzanis, 
2005; Hulka et al. 2013 a, b, c). Typically observed impairments 
include deficits in cognitive flexibility (Verdejo-García, Bechara, 
Recknor, & Pérez-García, 2006; Verdejo-García & Pérez-García, 
2007), episodic memory (Manschreck et al., 1990; Mittenberg & 
Motta, 1993; Reske, Eidt, Delis, & Paulus, 2010; Vonmoos et al., 
2013b), inhibitory control processes (Ersche et al., 2012; Fillmore 
& Rush, 2002; Goldstein & Volkow, 2002; Rosselli, Ardila, 
Lubomski, Murray, & King, 2001; Volkow et al., 2010), social and 
non-social decision-making (Hulka et al., 2014), prosodic and cross-
modal emotion processing (Hulka, Preller, Vonmoos, Broicher, & 
Quednow, 2013) and recently, the control of semantic interference 
in language production (Ruiz et al. 2014). Thus, many processes 
that regulate thought and action seem to be especially impaired 
after long-term consumption (Block, Erwin, & Ghoneim, 2002; 
Jovanovski, et al., 2005; Volkow et al., 1992). Chronic users, 
compared to non-users, show impaired performance on a variety of 
tasks that measure executive control related-functions: a poorer 
ability to inhibit overt responses (Fillmore & Rush, 2002), 
compromised performance on tasks measuring flexibility (Verdejo-
García, et al., 2006), dysfunctions in attention switching (Kübler, 
Murphy, & Garavan, 2005) and a poor performance on decision-
making tasks (Monterosso, Ehrman, Napier, O'Brien, & Childress, 
2001). Namely inhibition, the ability to stop predominant responses 
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or suppress irrelevant information, has been highlighted as a 
relevant impairment in stimulant abusers (Fillmore & Rush, 2002; 
Hester and Garavan, 2004; Morie et al. 2014; Morein-Zamir et al. 
2013). The fronto-striatal circuitry is proposed as the neural 
substrate for inhibitory control (Bari & Robbins, 2013; Miller & 
Cohen, 2001) and dopamine, the neurotransmitter targeted by 
cocaine (Hershey et al., 2004) plays an important neuromodulatory 
role (Arnsten, Wang, & Paspalas, 2012; Previc, 1999; Robbins & 
Arnsten, 2009). In this regard, response-inhibition has proven a 
useful cognitive function to gauge the integrity of fronto-striatal 
systems in stimulants drugs users (Morein-Zamir and Robbins, 
2014). 
Recent studies show that an increasing population of 
recreational cocaine polydrug users, who do not meet the criteria 
for abuse or dependence but take cocaine on a monthly frequency 
(1-4 g per month), show similar cognitive impairments to chronic 
cocaine users. For example, in the study of Colzato, van den 
Wildenberg and Hommel (2007), it was shown that recreational 
cocaine polydrug users evidenced impairments in response 
inhibition, but not response execution, measured through a stop 
signal task. They also do not show the phenomenon of inhibition 
of return as compared to non-cocaine users (Colzato & Hommel, 
2009). Furthermore, recent studies show that recreational use of 
cocaine is also associated with impairments on tasks tapping 
sustained attention and attentional shifting (Soar, Mason, Potton, & 
Dawkins, 2012; Vonmoos et al., 2013) and the emergence and 
resolution of response conflict (Sellaro, Hommel, & Colzato, 2013). 
Many studies have consistently demonstrated difficulties in 
the ability to inhibit responses in cocaine users (Bolla, Cadet, & 
London, 1998; Colzato & Hommel, 2009; Colzato, et al., 2007; 
Morie at al. 2014; Fillmore et al. 2002; Hester and Garavan, 2002; 
Garavan and Hester, 2004). Inhibition represents a family of 
processes, rather than a single-unitary process, that acts at different 
stages of information processing. For this reason, Miyake and 
colleagues (2004) proposed two processes that distinguish between 
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the stopping of dominant responses (behavioral inhibition) and the 
capacity to suppress interference, i.e. the exclusion of non-relevant 
information in accordance with the demands of the current 
situation (cognitive inhibition). This cognitive inhibition permits the 
selection of relevant information and avoids the irrelevant 
information that can interfere during processing stages 
(Harnishfeger, 1995; Nigg, 2000). Similarly, memory retrieval 
requires us to suppress no-longer relevant information from our 
memory and replace it with new information, possibly by erasing 
the memory traces and associated information through an 
inhibitory-like mechanism (Anderson, 2003; Bjork, Bjork, & 
Anderson, 1998; Bjork, 1989).  
To date, much research has sought to clarify the 
relationship between drug abuse and inhibitory control using 
selective attention and action control tasks (see Bardo, Fishbein & 
Milich, 2011), however few studies have studied specifically the 
plausible impairment of intentional memory suppression in drug 
abuse (Noël et al., 2009; Zou, Zhang, Huang, & Weng, 2011). 
The aim of this paper is to observe whether cocaine abuse 
may contribute to impairments in intentional suppression in 
episodic memory. In order to examine this possibility, we used a 
directed forgetting (DF) task using the list method (Bjork, 1970, 
1989; MacLeod, 1999), in which participants are overtly instructed 
to forget recently encoded items, inducing memory impairment for 
those items. In the list version of DF, participants are presented 
with a list of items to be studied for later recall. After presentation 
of the first list, participants in the forget condition are instructed to 
forget the items they have just learned. Following these 
instructions, a second list is presented, and participants are required 
to learn these new items. For the recall test, they are asked to 
remember the items from both lists. As a control, there is a 
remember condition where participants are presented two lists of 
items, and they are instructed to remember both. That is, 
participants in the remember condition also learn two lists, but they 
are not instructed to forget the first one before presentation of the 
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second list. Although the procedure usually involves comparison of 
two groups, remember and forget, directed forgetting effects are 
also observed in within-participant designs, where all participants 
performed the remember task in the first session and the forget 
task in the second session (e.g., Soriano et al. 2009). Two findings 
are observed consistently: First, cost effects triggered by the 
instruction to forget, where people’s recall is impaired for List 1 
items in the forget condition as compared to List 1 recall in the 
remember condition and as compared to List 2 recall in the forget 
condition. Second, when participants believe that they can forget 
the first list, they often recall more List 2 items on the final test 
when compared to the remember condition, providing a clear 
benefit effect from the instruction to forget. The so-called directed 
forgetting effects (lower recall of List 1 items as compared to List 2 
items in the forget instructions and List 1 items in the recall 
condition) are taken as measures of memory suppression (Bjork, et 
al., 1998; Johnson, 1994; MacLeod, 1999). 
Although there are alternative accounts of the DF effects 
and there might be more than one possible factor underlying them, 
current theories favor an account in terms of inhibition (Anderson 
& Hanslmayr, 2014; Bjork, et al., 1998; Bjork, 1989; see Sahakyan & 
Kelley, 2002 for a contextual-based account). This account assumes 
that instructions to forget convert List 1 items to potential 
competitors that may suffer a transitory state of inhibition, which is 
regulated by a control mechanism that reduces the accessibility of 
List1 items (Anderson, 2001; Anderson & Green, 2001; Bjork, et 
al., 1998; Bjork, 1989). Several studies found reduced DF effects in 
populations thought to suffer executive control deficit, such as the 
elderly (Aguirre, Gomez-Ariza, Bajo, Andres, & Mazzoni, 2014; 
Zacks & Hasher, 1994), young children (Harnishfeger & Pope, 
1996), frontal-lobe damaged patients (Conway & Fthenaki, 2003), 
and patients with schizophrenia (Soriano, Jimenez, Roman, & Bajo, 
2009). More relevant for our work is that DF seems to be impaired 
in abstinent heroin addicts (Zou, et al., 2011) and abstinent 
individuals with alcoholism (Noël, et al., 2009), who show greater 
susceptibility to proactive interference. 
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In this paper, we investigated whether cocaine use may 
impair the mechanism responsible for intentional forgetting of 
memories in chronic cocaine users in rehabilitation (experiment 1) 
and recreational cocaine polydrug users (experiment 2),  by using a 
DF procedure (Bjork, Laberge, & Legrand, 1968) in which 
participants were overtly instructed to self-initiate the forgetting of 
recent acquired information. Based on recent research showing 
deficits in inhibitory control in cocaine users, we expected reduced 
DF effects for both chronic users (experiment 1) and recreational 
users (experiment 2) 1  relative to matched cocaine-free control 
participants. 
General methods 
Apparatus, stimuli and procedure 
All participants were tested individually. They first 
completed a drug use questionnaire, then they performed the 
screening and the intelligence task, and finally the DF task using the 
list method. In this task participants were told that they would be 
presented with two lists of words to learn that they would have to 
recall later. The DF procedure’s stimuli consisted of two lists of ten 
words each that were matched on frequency and word length 
(stimuli were drawn from Soriano & Bajo, 2007). For the remember 
condition and the forget condition, two lists of ten words each 
were randomly taken from a pool of twenty words: ten words 
served as stimuli for List 1 and the remaining words constituted the 
List 2 stimuli. The two lists were randomly assigned to the 
condition of forget or remember instructions. The assignment of 
items to each list was constant for all participants. Item order 
                                                 
 
1 Chronic cocaine users in rehabilitation were screened for other drug use. We 
found that they only used cocaine except for one participant, who had also used 
MDMA. Recreational cocaine users, on the other hand, sporadically used other 
drugs such as MDMA or cannabis, but they mainly and preferably used cocaine. 
As the recreational users were not “pure” cocaine users, this group of users was 
called “recreational cocaine polydrug users”. 
Chapter 7 ─ 171 
 
within the lists was randomized for each participant and each list 
was equally often used in the condition of remember and forget, 
and equally often served as the first or second presented list. The 
experiment had a 2 x 2 x 2 mixed design, with instructions 
(remember or forget) and list output (List 1 and List 2) as within 
participants factors and group (chronic cocaine users in abstinence 
or recreational cocaine polydrug users and controls) as the 
between-groups factor.  
In the remember condition, participants were instructed to 
study two list of items. First, a List 1 was presented in the center of 
a computer screen in intervals of two seconds. Second, after a 
pause, List 2 items were also presented for studying. Once List 1 
and List 2 were presented, participants were required to count 
backwards from a three-digit number in steps of three for 30 
seconds as a distractor task to control for recency effects. After 
this, participants were given a sheet of paper and were asked to 
freely recall as many of the words as they could from both lists.  
The forget condition was similar to the remember 
condition with the exception of the forget instructions provided 
after studying List 1. Participants were told that List 1 was just a 
practice list to familiarize them with the procedure; and they were 
asked to forget the just presented items and to remember only the 
next list, which was the real experimental list that they would have 
to recall later. At recall, they were asked to recall all of the words 
they were presented, even the words they had been told to forget 
(see figure 1). The experiment was conducted in two sessions. The 
order of the conditions remained fixed for all participants, since 
results by Zellner and Bauml (2006) and Soriano and Bajo (2007) 
have shown that the order of conditions does not affect the DF 
effect. Also, presenting the remember condition first avoided 
confronting the participants with the surprise test after the first 
session, and having to give them further instructions to ensure that 
they would not be deceived again (see Soriano et al., 2009 for a 
similar procedure). To avoid that participants noticed that both 
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tasks were related, care was taken that a period between 1 and 3 
months elapsed between the two sessions. 
Figure 1. Sketch of the directed forgetting procedure used in experiment 
1 and experiment 2. 
 
In both experiments, participants were matched for race, 
age and IQ [measured by Raven’s standard progressive matrices 
(Raven et al. 1988)]. Furthermore, to ensure intact verbal and 
memory functions, the participants preformed a Boston naming 
test (Kaplan et al. 1983), a modified version of the verbal fluency 
test (VFT) for native Spanish speakers from SCIP [Screen for 
cognitive impairment in psychiatric patients] (Pino et al. 2006) and 
the memory span test (Daneman and Carpenter 1980). Participants 
filled in a self-report questionnaire on recent use, amounts, and 
patterns of alcohol and drug consumption during the last six 
months (cf. Colzato and Hommel, 2009, Colzato et al., 2007). To 
encourage participants’ compliance with the instructions, saliva 
samples were obtained (not further analyzed) at the beginning of 
the experiment (cf. Colzato, Erasmus and Hommel, 2004). We 
obtained written informed consent from all participants after 
providing them with an explanation of the nature of the 
experiment. The local ethics committee approved the protocol and 
the compensation of 20 euro for participation in the study. 
Statistical analysis 
Analyses were performed using IBM SPSS statistics® 20. 
In both experiments we adopted a significance level of p < 0.05. 
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Independent samples t-tests were used to analyze binary 
comparisons and analyses of variance (ANOVAs) otherwise. We 
performed t-test for analysis of age, IQ, and alcohol consumption 
and neuropsychological screening task differences between the 
chronic cocaine users in rehabilitation group or the recreational 
cocaine users groups, and cocaine-free controls. Differences 
between groups in the DF effects were analyzed using repeated 
measures ANOVA, with group (chronic cocaine users in abstinence 
or recreational cocaine polydrug users vs cocaine-free controls) as 
between-subject factor. We also performed interquartile analyses 
for outliers detection. The results of these analyses indicated that 
two participants from Experiment 1 (one in the control group and 
one chronic cocaine user) were classified as outliers and they were 
excluded from the analyses. Newman-Keuls post hoc analyses were 
carried out on the critical comparisons to asses DF effects. Partial 
correlation coefficients were computed between relevant cocaine 
use variables (e.g., lifetime amount, times per week of cocaine use, 
maximum peak in 12 hours, and monthly consumed cocaine in 
grams) and cognitive performance on the DF task in order to test 
whether the magnitude of cognitive impairments is proportional to 
the amount of cocaine consumed and to control for the 
consumption of those drugs (alcohol, tobacco, and cannabis) that 
varied significantly between the cocaine groups and controls. Effect 
magnitudes were assessed by calculating partial Eta squared (η2p). 
Experiment 1 
Participants 
Thirty-eight adults (33 men and 5 women) participated in 
the experiments. They formed the two experimental groups of 19 
chronic users in rehabilitation and 19 cocaine-free control. Chronic 
cocaine users in rehabilitation were recruited from Proyecto Hombre 
Granada rehabilitation center. Before their participation in the 
rehabilitation program, chronic users were taking cocaine on a daily 
basis for several years (M=8.92, SD=4.67), administrated by 
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snorting route. Cocaine abstinence is a requirement to attend the 
rehabilitation program, and at the moment of experimental testing, 
they were cocaine abstinent for several months (M=4.71, 
SD=4.03). The inclusion criteria were 1) meeting the Diagnostic 
and Statistical Manual of Mental Disorders (DSM)-IV criteria for 
cocaine dependence as assessed by the Structured Clinical Interview 
for DSM-IV disorders (American Psychological Association, 2000) 
– Clinician version (SCID, First et al. 1997); 2) a minimum 
abstinence interval of 30 days for all abuse substances except 
tobacco, checked by periodic urine toxicology tests, therapists or 
self-reports. The exclusion criteria were 1) the presence of any Axis 
I or Axis II disorders except substance abuse, determined by the 
Mini International Neuropsychiatric Interview (MINI) (Lecrubier et 
al., 1997), a brief diagnostic tool that screens for several psychiatric 
disorders; 2) a history of brain injury or central nervous system 
diseases; 3) an excessive intake of alcohol (>280 g/week for men 
and >168g/week for women) (Foster and Marriott 2006). At the 
time of the assessment, individuals in the rehabilitation program 
were free of psychiatric prescription medication. Nineteen adults 
comprised the control group. We recruited the control participants 
via notes posted on community bulletin boards and by word of 
mouth. Control group individuals did not meet any Axis I or Axis 
II psychiatric disorders, including substance abuse (except for 
tobacco) and no clinically significant medical disease (e.g. multiple 
sclerosis). Participants in the two groups were matched on race, age 
and IQ [measured by Raven’s standard progressive matrices 
(Raven, Court, & Raven, 1988)]. 
In the last six months, prior to participation, five chronic 
cocaine users in rehabilitation and three cocaine-free user also 
smoked marijuana, while one chronic cocaine user in rehabilitation 
reported having used MDMA (ecstasy). All participants reported 
never using ketamine, LSD, steroids, GHB, barbiturates or opioids. 
Although chronic cocaine users in rehabilitation group were 
engaged in the detoxification program, they were periodically (every 
30 days) screened for drug use through urine analysis, and we asked 
them to refrain from taking all types of psychoactive drugs for at 
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least two days before the experiment. In addition, all participants 
were asked not to consume alcohol the night before the 







N (M:F) ns 19 (16:3)  19 (17:2) 
Age (years) ns 31.9 (4.7)  29.6 (5.9) 
Raven IQ ns 104.7 (7.7)  101.6 (5) 
Cigarettes (unit/day) * 12.6 (7.1)  1.9 (3.7) 
Alcohol (units/weeks) ** 26.9 (22.81)  4.2 (4.9) 
Monthly cannabis (joints) ns 3.6 (7.3)  0.6 (1.5) 
Years using cocaine 8.9 (4.68)  0 
Monthly exposure (grams) 14.9 (15.9)  0 
Maximum amount in a 12-h 
period (grams) 
2.7 (1.6)  0 
Mean months in abstinence  4.01 (4.73)  0 
Monthly spent money (EUR) 896 (956.9)  0 
MDMA (grams/ last 6 
months) 
0.3 (1.5)  0 
Table 1. Demographic characteristics and self-reported use of cocaine and 
other psychoactive drugs in experiment 1. 
 
Notes. Raven IQ: IQ measured by means of the Raven’s standard 
progressive matrices,   
MST: Memory span test 
nsNon-significant difference 
*Significant group difference; p< 0.05; ** p < 0.01 
  




Demographics and drug use statistics are provided in Table 
1. As mentioned, we assessed the alcohol habits of the participants 
through a self-reported questionnaire enquiring about their weekly 
intake of alcoholic drinks. Since the strengths of different types of 
alcoholic beverages vary significantly, we adopted the definitions of 
standard "drinks" or "units," equal to a 10 ml or 8 grams of pure 
ethanol (International Center for Alcohol Policies, 2005; Spanish 
Ministry of Health, 2007). As can be observed in Table 1, chronic 
cocaine users differed from controls in the amount of tobacco, 
alcohol and cannabis consumed before they entered into the 
rehabilitation program, although all of them were not consuming 
alcohol or cannabis once they entered into the program. 
Test Chronic cocaine users 
in rehabilitation 
Cocaine-free controls 
BNT ns 51.8 (4.9) 49.6 (5.4) 
VFT ns 44.4 (8.3) 47 (10.8) 
MST ns 3.2 (0.7) 2.78 (1.03) 
Table 2. Mean scores of neuropsychological test performance in 
Experiment 1. 
 




Figure 2. Mean number of recalled words as a function of group, 
instruction, and list in experiment 1. Error bars represent standard error of 
mean. 
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To ensure intact verbal and memory functions, the 
participants performed several screening tasks: a Boston naming 
test (Kaplan, Goodglass, & Weintraub, 1983), a modified version of 
test of verbal fluency (VFT) for native Spanish speakers from SCIP 
[Screen for cognitive impairment in psychiatric patients] (Pino et al., 
2006) and the memory span test (Daneman & Carpenter, 1980). No 
significant group differences were obtained for intelligence, t(36) = 
-1.49, p = 0.14; memory span test, t(36) = -1.63, p = 0.11; Boston 
naming task, t(36) = -1.31, p = 0.19 or verbal fluency, t(36) = 0.82, 
p = 0.41. Table 2 shows performance on intelligence and 
neuropsychological test.  
Figure 2 shows the mean number of words recalled for 
each condition of the DF experiment. The results of the ANOVA 
on correct recall with group (chronic cocaine users and cocaine-free 
controls) as a between subject factor, and instructions (forget and 
remember) and List (List 1 and List 2) as a within-subject factor 
showed a significant main effect of group [F (1, 36) = 32.63, p < 
0.001, η2p = 0.37]. This indicated that the cocaine-free control 
group remembered more items (M=4.66, SD=1.93) relative to the 
chronic cocaine users in rehabilitation group (M=2.75, SD=1.34). 
Moreover, the main effect of List was significant [F (1, 36) = 21.35, 
p < 0.001, η2p = 0.27] showing that more items were recalled for 
List 2 (M=4.16, SD=2.03) than for List 1 (M=3.25, SD=1.67). The 
interaction List x group was significant [F (1, 36) = 11.64, p < 0.01, 
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η2p = 0.24]. Post hoc Newman-Keuls analyses showed that the 
control group remembered fewer List 1 items (M=3.87, SD=1.76) 
relative to List 2 items (M=5.45, SD=1.78) [p < 0.001], whereas this 
difference between List 1 (M=2.63, SD=1.34) and List 2 (M=2.87, 
SD=1.34) was not present for the chronic cocaine users in 
rehabilitation (p = 0.39). Importantly, the interaction List x 
instructions was significant [F (1, 36) = 21.35, p < 0.001, η2p = 
0.37]. Post hoc Newman-Keuls analyses showed the typical DF effect 
with less List 1 items recalled in the forgetting condition (M=2.71, 
SD=1.56) than List 2 items in the remember condition (M=4.55, 
SD=2.13) [p < 0.01]. The three way interaction instructions x List x 
group was significant [F (1, 36) = 4.61, p = 0.039, η2p = 0.11]. To 
further analyze this interaction, we performed post hoc Newman-
Keuls procedure for the cocaine-free controls and chronic cocaine 
users groups to explore cost and benefit effects.  
First, we analyzed the costs of instructions to forget on List 
1. These comparisons indicated, first, that cocaine-free controls’ 
recall for the List 1 items of the forget condition (M=3.16, SD=1.8) 
was significantly lower than the recall of List 1 items in the 
remember condition (M=4.58, SD=1.43) [p < 0.01], whereas 
chronic cocaine users in rehabilitation did not forget significantly 
more List 1 items in the forget task (M=2.26, SD=1.15) than in the 
remember task (M=3, SD=1.45) [p = 0.27] (see figure 2). Similarly, 
comparisons of recall from List 1 items in the forget condition 
relative to List 2 items in the forget condition was significant for 
the control group [p < 0.01], whereas the chronic cocaine users in 
rehabilitation did not show this difference [p = 0.17]. Finally, we 
analyzed the benefits of forgetting. This comparison showed that 
cocaine-free controls recalled more List 2 items in the forget 
condition (M=6.11, SD=1.63) than in the remember condition 
(M=4.79, SD=1.72) [p < 0.01]. However, for the chronic cocaine 
users in rehabilitation the recall of list 2 items in the forget 
condition (M=3, SD=1.25) as compared to the remember 
condition (M=2.74, SD=1.45) was not significantly different [p = 
0.51]. 
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Discussion 
Experiment 1 aimed to test the hypothesis that chronic 
cocaine users in rehabilitation might not be able to intentionally 
forget no-longer relevant information when instructed to do so, 
even when instructions stressed that this information might 
interfere with recall of relevant information. Results show that 
while cocaine-free controls show the typical memory suppression 
effects associated with the directed forgetting procedure, the 
chronic cocaine users in rehabilitation do not show these effects. 
That is, they did not show the usual impairment of List 1 items 
relative List 2 when instructed to forget or the diminished recall of 
List 1 items in the forget condition relative to List 1 in the 
remember condition. In addition, chronic cocaine users in 
rehabilitation did not show the benefit of forgetting. They were not 
able to benefit from forgetting of List 1. Thus, recall of List 2 in 
forget and recall conditions was similar for the users, whereas the 
cocaine-free controls showed better recall of list 2 in the forget 
than in the remember condition. Presumably, chronic cocaine users 
were not able to suppress information from List 1 as instructed, 
and they were not able to benefit from it, possibly because List 1 
forgetting might not have been strong enough to produce this 
benefit so that chronic users still suffer from proactive interference. 
In order to assess whether other cocaine users that do not 
qualify as chronic cocaine users, but often consume cocaine for 
recreational purposes, would more clearly show intentional 
forgetting deficits, we conducted a new experiment with the same 
materials and procedure as experiment 1, but testing recreational 
cocaine polydrug users’ ability to forget non-relevant memories. 
Experiment 2 
Participants 
Forty-four healthy adults (21 men and 23 women) served 
as participants for partial fulfillment of course credits or a financial 
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compensation. These constituted both the recreational cocaine 
polydrug users and cocaine-free controls. We recruited the 
participants via notes posted on community bulletin boards and by 
word of mouth. Recreational cocaine polydrug users met the 
following criteria: 1) a monthly consumption (1 to 4 grams) by 
snorting for a minimum of two years; 2) no axis I or Axis II 
psychiatric disorders [DSM-IV; (American Psychological 
Association 2000)], including substance abuse other than cocaine 
and tobacco; 3) no clinically significant medical diseases; 4) no use 
of prescription medication. Cocaine-free controls met the same 
criteria except they reported no history of past or current cocaine 
use. Participants were selected by means of a phone interview using 
the MINI (Lecrubier et al. 1997), a brief diagnostic tool that screens 
for several psychiatric disorders. The sample was obtained from a 
pool of approximately 50 potential volunteers who responded to 
the advertisements for studies conducted in our lab over a period 
of six months. Within this pool of potential participants, the most 
common reason for excluding an individual from the study was 
meeting criteria for psychiatric disorders (psychotic symptoms, 
anxiety and depression), alcohol abuse or medication. Furthermore, 
to ensure intact verbal and memory functioning the participants 
performed a Boston naming test (Kaplan et al. 1983), a modified 
version of VFT for native Spanish speakers from SCIP (Pino et al. 
2006) and the memory span test (Daneman & Carpenter, 1980). 
Participants were asked to refrain from taking all 
psychoactive drugs for at least two days, not to consume alcohol on 
the night before the experimental session and to have a normal 
night rest. To encourage participants’ compliance with the 
instructions, saliva samples were obtained (not further analyzed) at 
the beginning of the experiment (cf. Colzato, Erasmus and 
Hommel 2004). 
In the six months prior to participation, thirteen 
recreational cocaine polydrug users smoked cannabis while 
seventeen recreational users reported having used MDMA (ecstasy) 
and eleven reported using ketamine. Participants in the two groups 
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were matched on race, age and IQ (Raven, et al., 1988)]. All 









N (M:F) ns 22 (10:12)  22 (11:11) 
Age (years) ns 25.1 (3.3)  23.7 (2.7) 
Raven IQ ns 102.7 (7.0)  103.2 (8.8) 
Cigarettes (unit/day) * 9 (7.3)  1 (2.0) 
Alcohol (units /weeks) ** 15.2 (10.0)  4.7 (3.7) 
Monthly cannabis (joints) ** 8.5 (8.6)  0 
Years using cocaine 4.4 (2.7)  0 
Monthly exposure (grams) 3.8 (3.9)  0 
Maximum amount in a  12-h 
period (grams) 
1.1 (0.6)  0 
Mean days in abstinence  15.8 (18.3)  0 
Monthly spent money (EUR) 94.5 (61.2)  0 
MDMA (grams/ last 6 
months) 
1.75 (2.0)  0 
Table 3. Demographical characteristics and self-reported use of cocaine and 
other psychoactive drugs in experiment 2. 
 
Notes. Raven IQ: IQ measured by means of the Raven’s standard 
progressive matrices, MST: Memory span test 
nsNon-significant difference 
*Significant group difference; p< 0.05; ** p < 0.01 
  








BNT ns 50.6 (4.2) 50 (5.51) 
VFT ns 43.5 (10.0) 41.3 (10.0) 
MST ns 2.9 (0.7) 3.2 (0.7) 
Table 4. Mean neuropsychological test performance scores in Experiment 
2. 
 




Demographics and drug use statistics are provided in Table 
3. No significant group differences were obtained for intelligence, 
t(42) = 0.18, p = 0.85; memory span test, t(42) = 1.40, p = 0.47; 
Boston naming task, t(42) = -0.36, p = 0.71 or verbal fluency, t(42) 
= -0.72, p = 0.47. Table 4 shows performance on the intelligence 
and neuropsychological tests. We performed an overall ANOVA 
with group (recreational cocaine polydrug users and controls) as a 
between-participant factor, and instructions (forget and remember) 
and List (List 1 and List 2) as a within-participants factors (see 
Figure 3). A significant main effect of group [F (1, 42) = 6.44, p < 
0.01, η2p= 0.13] indicated that the control group remembered more 
items (M=5.17, SD=2.64) than the group of  recreational cocaine 
polydrug users (M=3.93, SD=1.94). The main effect of  List was 
significant [F (1, 42) = 5.74, p < 0.05, η2p= 0.12] showing that List 2 
recall was better (M=4.88, SD=2.42) than List 1 recall (M=4.21, 
SD=2.31). The main effect of  instructions was not significant 
(F<1), but the interaction between List and group reached 
significance [F (1, 42) = 4.29, p < 0.05, η2p= 0.09]. Post hoc 
Newman-Keuls analyses showed that the control group 
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remembered fewer List 1 items (M=4.54, SD=2.52) relative to List 
2 items (M=5.79, SD=2.62) [p < 0.01], whereas this difference 
between List 1 (M=3.88, SD=2.00) and List 2 (M=3.97, SD=1.87) 
was not present for the recreational cocaine polydrug users (p = 
0.81).  The interaction between List and instructions was significant 
[F (1, 42) = 27.42, p < 0.001, η2p= 0.39]. Post hoc Newman-Keuls 
analyses showed the typical DF effect, with fewer List 1 items being 
recalled in the forgetting condition (M=3.65, SD=2.29) than in the 
remember condition (M=4.77, SD=2.17) [p < 0.01]. The interaction 
between instructions, List and group was significant [F (1, 42) = 
13.02, p < 0.001, η2p= 0.23]. To further analyze this interaction, we 
performed additional post hoc Newman-Keuls analyses for the 
cocaine-free controls and recreational cocaine polydrug users 
groups to explore cost and benefit effects.  
First, we analyzed the costs of the instruction to forget List 
1. These comparisons indicated, first, that cocaine-free controls’ 
recall for the List 1 items of the forget condition (M=3.68, 
SD=2.47) was significantly less than the recall of List 1 items on the 
remember task (M=5.40, SD=2.32) [p < 0.01], whereas  recreational 
cocaine polydrug users did not forget significantly more List 1 
items on the forget task (M=3.63, SD=2.15) than on the remember 
task (M=4.13, SD=1.85) [p = 0.24]. Similarly, comparisons of recall 
from List 1 items in the forget condition relative to List 2 items in 
the forget condition was significant for the control group [p < 
0.01], whereas the recreational cocaine polydrug users did not show 
this difference [p = 0.86]. Finally, we analyzed the benefits of 
forgetting. This comparison showed that cocaine-free controls 
recalled more List 2 items at the forget condition (M=6.90, 
SD=2.22) than in the remember condition (M=4.68, SD=2.57) [p < 
0.001]. However, for the recreational cocaine polydrug users the 
recall of list 2 items in the forget condition (M=4.1, SD=1.94) 
compared to the remember condition (M=3.86, SD=1.83) was not 
different [p = 0.61]. 
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Finally, no significant Pearson’s correlations were found 
between the individual lifetime cocaine exposure, alcohol 
consumption, speed, cannabis and ketamine and the DF effect. 
Figure 3. Mean number of recalled words as a function of group, 




Experiment 2 aimed to investigate whether recreational 
cocaine polydrug users showed impaired intentional inhibitory 
processes during episodic memory retrieval. Results clearly indicate 
that recreational cocaine polydrug users do not show the usual 
memory suppression effect associated with the directed forgetting 
procedure. Thus they did not show the usual impairment of List 1 
items relative to List 2 when instructed to forget List 1 items in the 
forget condition relative to List 1 in the remember condition. 
Similarly, they did not show the benefit of forgetting so that recall of 
List 2 items in the forget condition was similar to the recall of List 
2 items in the remember condition. As the DF effect is usually 
interpreted as the result of intentional forgetting mechanisms 
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(Anderson & Hanslmayr, 2014; Bjork, 1989), this pattern of results 
suggests that recreational cocaine polydrug users are not able to 
intentionally suppress List 1 items to prevent interference from List 
2 items. The results show that although recreational cocaine 
polydrug users do not use the drug on a daily basis, their monthly 
continuous small amounts of cocaine (M=3.80, SD=3.90) seems to 
impact inhibitory processes engaged in the suppression of irrelevant 
information in episodic memory. 
General Discussion 
This study investigated for the first time the dynamics of 
intentional forgetting in chronic users in rehabilitation and 
recreational polydrug users of cocaine, who were carefully screened 
and matched to cocaine-free control participants performing a 
directed forgetting task. Different methods have been used to elicit 
the DF effect (see Basden & Basden, 1998; MacLeod, 1999). In the 
present research we used the list method to elicit the inhibitory 
processes engaged during remembering. Several lines of research 
have proposed inhibition as the mechanism underlying this effect 
(Bjork et al., 1998; Bjork, 1989; but see Sahakyan & Kelley, 2002 
for a non-inhibitory account). In addition, there is evidence 
supporting the impairment of inhibitory processes in chronic and 
recreational cocaine users (Ersche et al., 2012; Fillmore & Rush, 
2002; Goldstein & Volkow, 2002; Rosselli, Ardila, Lubomski, 
Murray, & King, 2001; Volkow et al., 2010; Colzato & Hommel, 
2009; Colzato et al., 2007). Given the recruitment of inhibitory 
mechanisms in intentional forgetting and the impairment of these 
mechanism due to cocaine use, it creates a perfect scenario to test 
the relationship between them by focusing on the performance of 
chronic in rehabilitation and recreational cocaine polydrug users 
and a cocaine-free control group on their ability to actively inhibit 
irrelevant information in their episodic memory. 
 The control group in both experiment 1 and 2 replicated 
the typical directed forgetting effect observed in seminal studies 
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(Bjork et al., 1998; Bjork, 1989), showing a decrease in the recall of 
List 1 items under the forget instructions and the typical cost and 
benefit effects. In experiment 1, we found that chronic cocaine users 
attending a rehabilitation program do not show a reliable directed 
forgetting effect, indicating that they were not able to intentionally 
suppress information from memory. Similarly, in experiment 2 
recreational cocaine polydrug users were not able to intentionally 
suppress information and they did not show reliable directed 
forgetting effects. These results suggest that cocaine consumption 
is related to a deficit in intentional forgetting. In addition, the 
results of the reduced directed forgetting effect in recreational 
cocaine polydrug users, compared to the control group, allow us to 
speculate that even the use of small amounts of cocaine results in 
poor performance in effectively triggering the inhibitory 
mechanism. 
Given the relationship between cocaine abuse and reduced 
functioning of prefrontal cortex (Herster and Garavan, 2004; 
Morein-Zamir at al., 2013; see Goldstein and Volkow, 2011 for a 
review) and dopamine D2 (DAD2) receptors (Volkow, Fowler, & 
Wang, 1999), its neuromodulatory effect (Previc, 1999; Robbins & 
Roberts, 2007), the role of inhibitory processes in lateral prefrontal 
cortex (LPFC), anterior cingulate (ACC) and orbitofrontal cortex 
(Posner & Raichle, 1994) and the role of dLPFC and ACC in 
memory suppression (Anderson et al., 2004), the presence of the 
aforementioned memory suppression deficit was expected. And, 
therefore, the results are in line with those investigations that 
suggest that even small amounts of cocaine used regularly are 
connected to deficits in executive control processes (Colzato, 
Huizinga, & Hommel, 2009; Colzato & Hommel, 2009; Colzato, et 
al., 2007). In addition, the results of the reduced directed forgetting 
effect in recreational cocaine polydrug users, compared to the 
control group, allow us to speculate that the continuous and 
ongoing use of cocaine results in poor performance in effectively 
triggering the inhibitory mechanism.  
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The apparent link between cocaine abuse and this deficit in 
memory suppression highlights the variety of inhibitory processes 
that may be altered by the abuse of stimulant drugs that act on the 
catecholaminergic synapses in brain areas that regulate and control 
executive processes. Our results cannot be explained by several 
potentially confounding factors, since our participants were 
screened for several psychiatric disorders (schizophrenia, ADHD 
or obsessive-compulsive disorder) that have been associated with 
dopaminergic alterations (Davis, Kahn, Ko, & Davidson, 1991; 
Pooley, Fineberg, & Harrison, 2007; Tripp & Wickens, 2008). 
Given that MDMA is associated with impairments in working 
memory processes, and cannabis leads to dysfunction in cognitive 
flexibility (Verdejo-García, López-Torrecillas, Aguilar de Arcos, & 
Pérez-García, 2005), both drugs are unrelated to the production of 
impairments in inhibitory control. Hence, we doubt that our results 
can be attributed to the consumption of cannabis or MDMA. In 
addition, since our groups were matched on age, it cannot explain 
our results even though the directed forgetting phenomenon 
appears to diminish in populations thought to suffer deficits in 
executive control, such as in the elderly (Aguirre et al., 2014, Zacks 
& Hasher, 1994) or due to the decline of inhibitory efficiency 
associated with aging (Williams, Ponesse, Schachar, Logan, & 
Tannock, 1999). Particularly important was the screening of alcohol 
consumption in both experiments due to the impairing effect of 
acute alcohol on inhibitory control (Fillmore & Vogel-Sprott, 2000; 
Fillmore, 2007; Noël, et al., 2009). A possible impairment of non-
chronic alcohol users is undetermined. Notwithstanding, given that 
impaired inhibitory control could promote excessive drinking, it is 
reasonable that individuals who experience a greater malfunction of 
inhibitory control should be likely to drink alcoholic drinks more 
excessively (Weafer & Fillmore, 2008).  
It is interesting to note that both chronic in rehabilitation 
and recreational cocaine users showed an overall memory deficit, 
and this deficit does not seem to recover after a short period of 
abstinence since it is still present in the chronic in rehabilitation 
group. This is consistent with prior research with both recreational 
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and abstinent chronic in rehabilitation users that shows persistent 
impairments in verbal learning efficiency, which results in deficits in 
memory storage and recall (Ardila, et al., 1991; Beatty, et al., 1995; 
Manschreck, et al., 1990; Mittenberg & Motta, 1993; O'Malley & 
Gawin, 1990; Reske, et al., 2010; Rosselli & Ardila, 1996; Vonmoos, 
Hulka, Preller, Jenni, Baumgartner, et al., 2013). Some studies 
reported improvement of cognitive processes in cocaine users after 
cessation of the drug consumption (De Oliveira et al., 2009; Di 
Sclafani, 2002; Vonmoos et al., 2014; but see Bauer, 1996; van 
Gorp et al., 1999 for persistent neuropsychological impairment). 
These studies showed that while cocaine clearly has a significant 
effect on cognitive functions, cocaine users can eventually return to 
a normal brain functioning and avoid any permanent damage to 
their cognitive abilities. Because chronic cocaine use produces 
neuroadaptations in dopamine systems (Letchworth, Nader, Smith, 
Friedman, & Porrino, 2001; Nader et al., 2002), the reversibility of 
cognitive deficits after sustained abstinence suggests that 
neuroplastic adaptations might occur if the repeated 
pharmacological stimulus is discontinued. However, the chronic 
cocaine users in rehabilitation in experiment 1 did not show a 
recovery of cognitive functions after cocaine cessation suggesting 
that neuroadaptations may be a slow process that needs time to 
show its effects. 
Finally, this study has certain methodological limitations 
that are common to many neuropsychological studies in the area of 
substance abuse. First, particularly important was the screening of 
alcohol consumption in both groups so that participants selected 
for the study reported an average long-term consumption below 
the criteria for high alcohol use (280 g/week for men and 
168g/week for women). In addition, although participants in 
experiment 1 were undergoing regular urine toxicology screens as 
part of the treatment, some participants in experiment 2 may have 
actively used either alcohol or cocaine within 24 to 48 hours prior 
to the experimental session, potentially affecting the performance 
in the directed forgetting task. Although with caution, the fact that 
the impairment appeared in both recreational and chronic users 
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(urine tested) suggests that this might not have been the case. 
Second, the design of our study allows us to reject alternative 
accounts of our observations in terms of age, IQ, and sex since the 
two user groups were matched with the controls in these variables. 
Similarly, the present results cannot be explained by factors 
regarding pre-existing psychiatric disorders which are known to 
affect response inhibition (Rosenberg et al. 1997; Schachar and 
Logan 1990; Thoma et al. 2007) since we performed a wide 
screening using the MINI to exclude preexisting psychiatric 
disorders (e.g. ADHD). Nevertheless, the results of this study for 
both groups do not allow us to completely rule out an account of 
their deficit in terms of preexistent underlying neurocognitive 
endophenotypes for stimulant drug addiction that may contribute 
to task performance (Ersche et al. 2012 a, b; Verdejo-Garcia et al. 
2008). Furthermore, although we interpret the unreliable DF effects 
for both groups as a deficit in memory suppression due to cocaine 
consumption, this conclusion must be interpreted with care due to 
the cross-sectional design of this study and should be replicated 
through longitudinal studies focusing on this issue.  
Another possible shortcoming of our study is that given 
the abuse rate of other drugs when consuming cocaine among 
recreational users (Grov et al. 2009; Kelly and Parsons 2008), it is 
difficult to separate the cognitive deficit produced by cocaine use 
from the effect of the use of other drugs. We tried to minimize this 
fact by selecting a predominant cocaine users’ sample and avoiding 
as much as possible selecting people that also abuse other stimulant 
drugs. We based our selection on self-report measures since 
previous studies have shown that self-reports of drug abuse are 
quite reliable and strongly correlated with objective measures of 
drug abuse (Glintborg et al. 2008; Zaldívar Basurto et al. 2009). 
Since our participants reported very low consumption of cannabis 
and MDMA, we doubt that our results may be attributed to the use 
of any of these two drugs. Moreover, studies that have examined 
the effect of MDMA and cannabis on executive functions have 
provided conflicting results. Whereas deficits in working memory 
appear to be likely consequences of chronic MDMA and 
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impairments in cognitive flexibility due to cannabis use (Verdejo-
García et al. 2005), less consistent results were found in studies 
investigating inhibitory control in the abuse of both substances 
(Crean et al. 2011; Kalechstein et al. 2007).  Despite these 
limitations and suggestions for further research, our study clearly 
suggests that impairments in memory suppression may be 
associated with cocaine consumption. Cocaine use seems to be 
associated with a low performance in inhibiting the ability to 
suppress irrelevant information. In summary, the results found in 
chronic in rehabilitation and recreational cocaine users are 
worrying, given that a dysfunctional adaptive mechanism of 
forgetting may be responsible for a variety of memory distortions in 
terms of updating information, which affects learning and recall in 
everyday behavior. This distortion can be translated to poor 
efficacy in forgetting information, causing a misconception of the 
acquirement of learning or affecting the ability to forget negative 
autobiographical memories. 
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In line with the general aim of this thesis, we investigated 
whether the use of khat and cocaine impacts particular mechanisms 
that underlie the control of thoughts and actions. With this purpose 
we carried out several experiments to observe the performance of 
khat users on tasks that tap into cognitive control functions, namely 
inhibitory control, mental flexibility, working memory updating, 
and interference control. Moreover, we specifically assessed 
inhibitory control in cocaine users through tasks that tap into the 
ability to overcome semantic interference during verbal production 
and to suppress inappropriate memories at encoding and retrieval 
of information. In addition, we reviewed in this dissertation the 
behavioral and physiological effects of the natural psychomotor 
stimulant khat and the cathinone-derived designer drug 
mephedrone. We paid special attention to the pharmacokinetics 
and pharmacodynamics and its potential to produce withdrawal and 
dependence. The principal outcomes of this investigation are the 
following. 
First, in chapter two we reviewed the historical and 
geographical backgrounds and mechanisms of the khat alkaloid 
cathinone and the designer drug mephedrone. We addressed an 
emerging consensus about their toxicity and the liability potential, 
as well as the effect of producing abuse and dependence. Available 
scientific evidence agrees that the use of these substances may be 
harmful and requires further and extensive research, especially 
mephedrone, which is more dangerous due to its availability and 
the lack of information about it. 
Second, the data reported in chapters three and four 
suggest that khat users, compared to khat-free users show 
deficiencies in the three major functions of cognitive control. The 




users and non-users are comparable in terms of response execution, 
but khat users needed significantly more time to inhibit prepotent 
responses than non-users; 2) khat use may be associated with 
impairments in working memory updating. This implies that khat 
users were less efficient at discriminating which information is old 
and no longer relevant, which means that no longer relevant 
information is more likely to enter in working memory and 
interfere; and 3) khat users, as compared to controls, needed more 
time to shift between mental sets, as indicated by a higher switching 
cost. These results suggest that khat use may be associated with a 
broad and general impact on human cognition. Taking into account 
the chemical and action resemblance between cathinone and 
amphetamine, our results are in line with those of previous studies 
of humans that show impairments in cognitive control functions as 
a consequence of long-term amphetamine and methamphetamine 
abuse (Baicy & London, 2007; Daumann et al., 2003, 2004; 
Monterosso et al., 2005; Nordahl et al., 2003; Rubia et al., 2011; 
Salo & Leamon, 2003; Salo et al., 2009a, 2009b, 2009c; van der Plas 
et al., 2009). We suggest that these impairments may be due to the 
long term use of khat, which leads to dysfunctions in prefrontal 
cortex and fronto-striatal dopaminergic receptors. 
Third, in chapter five, we presented evidence of the impact 
of long-term use of khat on the emergence and resolution of 
interference by measuring performance on a Simon task (Simon, 
1969). In line with studies showing the impact of acute and long-
term use of amphetamines and methamphetamines on this 
cognitive process (Fillmore, Rush, & Abroms, 2005; Rubia et al., 
2011; Salo et al., 2009a, 2009b, 2009c), we showed that long-term 
users were more strongly affected by stimulus-induced response 
conflict, showing a slower and poorer performance on the 
interference task. The stimulant effect of cathinone may act as a 
cognitive enhancer during acute consumption, supporting the view 
of khat as a “natural amphetamine” (Kalix, 1992). However, in the 
long–term it may impair the mechanisms underlying the control of 
interference in response conflict, possibly by altering the dopamine 
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pathways and prefrontal areas that play a key role in resolving 
response conflict (Botvinick, 2007; Cools, 2006). 
Fourth, in chapters six and seven, we presented evidence 
that supports the idea of impaired inhibitory control in the domain 
of language and memory. Previous research shows that the chronic 
and recreational use of cocaine impacts the correct functioning of 
executive control, notably affecting inhibitory processes in the 
cognitive non-verbal domain (Colzato, van den Wildenberg, & 
Hommel, 2007; Fillmore & Rush, 2002; Verdejo-García, Perales, & 
Pérez-García, 2007). In our experiments we assessed chronic and 
recreational cocaine users through a blocked-cycled naming task 
(Belke, Meyer, & Damian, 2005; Damian, Vigliocco, & Levelt, 
2001) and a directed forgetting procedure (Bjork, 1970, 1989) 
where inhibitory mechanisms are engaged to suppress and reduce 
interference in language production (Roelofs & Piai, 2011; Shao, 
Meyer, & Roelofs, 2013) and in episodic memory retrieval 
(Anderson, 2003), respectively. We tapped into the inhibitory 
mechanisms that act selectively to suppress semantically-related 
competitors during lexical selection in users of cocaine and drug-
free controls. Chronic and recreational cocaine users showed 
substantially larger vulnerability to semantic interference as 
compared to cocaine-free controls. This is probably due to 
inefficient performance of verbal inhibitory processes. Moreover, 
we used the directed forgetting procedure to observe the ability to 
suppress recently learned information that becomes irrelevant due 
to instructions to forget. We found that inhibitory mechanisms 
acting on the self-initiated forgetting may be impaired due to the 
use of cocaine. Chronic cocaine and recreational cocaine users’ 
ability to suppress non-relevant memories was inefficient. To 
explain the results, we suggest that chronic long-term usage of 
cocaine and even small but continuous amounts of cocaine usage is 
connected to a hypoactive prefrontal cortex and a relative state of 
dopaminergic dysfunction, which may impair the cognitive 
processes engaged in episodic memory. Notwithstanding, the 
cessation of cocaine use makes a partial-recovery of cognitive 




Garavan, 2012; Sclafani, Tolou-Shams, Price, & Fein, 2002; 
Vonmoos et al., 2014), but this process needs time and complete 
abstinence to show its effect. 
Lastly, this work, together with previous research, has 
considerable implications for the understanding and treatment of 
drug abuse. The findings of these studies are rather worrying 
because, first, many real-life situations require correct cognitive 
control, as it plays an important role in the interaction between our 
inner and external world. The use of stimulant drugs such as khat 
or cocaine may lead to a marked deterioration of psychophysical 
functions, affecting everyday behavior ranging from car driving to 
work performance and social behavior. Second, defining the nature 
of impaired cognitive control will be an important step for the 
development of future therapeutic targets, improvement of the 
detoxification process, and the encouragement of drug abusers to 
achieve and maintain abstinence. 
In summary, the mechanisms that control thought and 
action vary with the fluctuating and dynamic nature of both internal 
physiological states and external environmental constraints. In 
addition, we suggest that the abuse of stimulant drugs like khat or 
cocaine somehow impact cognitive control processes. There are 
currently limitations and unresolved issues associated with the 
performance of these stimulant drugs on the body and mind that 
will need to be addressed in future investigations. We hope that 
other investigators who are interested in cognitive control and drug 
abuse will join in these research efforts in understanding the 
relationship between them.  
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Samenvatting 
Het onderzoek dat in dit proefschrift wordt beschreven  is 
toegespitst op de vraag of het gebruik van khat en cocaïne bepaalde 
mechanismen beïnvloedt die aan de basis liggen van ons denken en 
handelen.  Hiertoe hebben we verschillende experimenten 
uitgevoerd. Wij hebben khat gebruikers taken laten uitvoeren op 
het gebied van cognitieve hersen functies en  observeerden hierbij 
hun gedrag. Deze taken hadden vooral betrekking op het 
onderdrukken van acties (inhibitie),  mentale flexibiliteit, het 
updaten van het werkgeheugen, en controle met betrekking tot de 
interferentie van acties.  Meer  specifiek hebben we met name het 
inhibitievermogen bij cocaïne gebruikers beoordeeld door middel 
van taken die aansluiten op het vermogen om semantische 
interferentie tijdens verbale productie te  overwinnen. Daarnaast 
hebben we taken gebruikt die gericht zijn op het onderdrukken van  
ongepaste of misplaatste herinneringen bij het coderen en 
terughalen van informatie. Aanvullend hebben we in deze 
dissertatie gekeken naar gedrags- en psychologische effecten van de 
natuurlijke psychomotorische stimulant  khat, en de uit cathinone 
verkregen designer drug mephedrone. Onze aandacht ging specifiek 
uit naar de rol die farmacokinetiek en farmacodynamica spelen bij 
onthouding en afhankelijkheid.  Hieronder volgen de belangrijkste 
resultaten.  
Ten eerste  blikten wij in hoofdstuk twee terug op de 
historische en geografische achtergronden en mechanismen van de 
khat alkaloïde cathinone en de designer drug mephedrone. Wij 
richten ons op de ontstane consensus betreffende toxiciteit en de 
mogelijk verantwoordelijke effecten die leiden tot misbruik en 
afhankelijkheid. Het reeds beschikbaar wetenschappelijk  bewijs 
komt overeen met onze hypothese dat het gebruik van deze stoffen 
schadelijk kan zijn en dat dit meer en uitgebreider onderzoek 
behoeft. Dit geldt met name voor mephedrone, deze stof is 
namelijk gevaarlijker omdat het makkelijk  verkrijgbaar is en er 
bovendien weinig informatie over beschikbaar is.  
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Ten tweede blijkt uit de resultaten uit hoofdstuk drie en 
vier dat khat gebruikers in vergelijking met  niet- gebruikers 
deficiënties in de drie belangrijkste functies van cognitieve controle 
laten zien  (Miyake, 2000). De onderzoeksresultaten in de 
verschillende taken en experimenten tonen het volgende aan:  1) 
Hoewel khat gebruikers en niet-gebruikers vergelijkbaar zijn wat 
betreft het uitvoeren van een actie, blijken khat gebruikers 
significant meer tijd nodig te hebben  om  dominante acties te 
onderdrukken dan niet-gebruikers. 2) Het gebruik van khat kan in 
verband gebracht worden met  tekortkomingen in het  
werkgeheugen.  Dit houdt in dat khat gebruikers minder efficiënt 
onderscheid kunnen maken met betrekking tot  oude en irrelevante 
informatie; deze informatie komt  daardoor makkelijker in het 
werkgeheugen en  interfereert met nieuwe en relevantie informatie. 
3) Khat gebruikers hadden, vergeleken met de controle groep,   
meer tijd nodig om te schakelen tussen mind-sets, zoals blijkt uit  
een hogere ‘switch cost’, die ontstaat wanneer mensen moeten 
schakelen tussen twee taken. Deze resultaten doen vermoeden  dat 
khat geassocieerd is met een negatieve impact op de algemene 
menselijke cognitie. Wanneer men daarbij kijkt naar de gelijkenis 
tussen de algemene en chemische werking van cathinone en 
amfetamine, dan zijn onze resultaten in lijn met die van vorige 
studies, die beschadigingen aantonen in de cognitieve 
controlefuncties bij mensen  als gevolg van langdurig gebruik van 
amfetamine en methamfetamine (Baicy & London, 2007; Daumann 
et al., 2003, 2004; Monterosso et al., 2005; Nordahl et al., 2003; 
Rubia et al., 2011; Salo & Leamon, 2003; Salo et al., 2009a, 2009b, 
2009c; van der Plas et al., 2009).  Wij gaan er dan ook van uit dat 
deze beschadigingen het gevolg zouden kunnen zijn van langdurig 
khat gebruik, hetgeen leidt  tot disfuncties in de prefrontale cortex 
en fronto-striatale  dopaminerge receptoren . 
Ten derde hebben wij in hoofdstuk vijf  bewijs 
aangedragen met betrekking tot de impact die  langdurig gebruik 
van khat heeft op zowel het opkomen als verdwijnen van 
interferentie bij de uitvoering van een Simon taak (Simon, 1969). 
Lange termijn gebruikers worden sterker beïnvloed door conflicten 
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in reacties die ontstaan door de presentatie van een stimulus. 
Hierbij laten lange termijn gebruikers namelijk een slechtere en 
langzamere uitvoering van de taak zien. Op de lange termijn kan 
khat gebruik leiden tot beschadigingen aan mechanismen die ten 
grondslag liggen aan de controle die men heeft over het uitvoeren 
van de juiste actie wanneer er een conflict ontstaat, wellicht  
doordat zich wijzigingen voordoen in de bestaande dopaminerge 
banen en prefrontale gebieden die een sleutelrol spelen bij het 
oplossen van zo’n conflict  (Botvinick, 2007; Cools, 2006).  
Ten vierde hebben wij in de hoofdstukken zes en  zeven 
bewijs gevonden voor het idee dat de cognitieve functie met 
betrekking tot het inhiberen van acties is beschadigd in zowel het 
taal- als geheugendomein. Eerder onderzoek toont aan dat het 
chronisch gebruik van cocaïne, evenals recreatief gebruik, een 
negatief effect heeft op de cognitieve controle met betrekking tot 
het uitvoeren van acties. Met name wordt het vermogen om actie te 
stoppen in het cognitieve, non-verbale domein aangetast  (Colzato, 
van den Wildenberg, & Hommel, 2007; Fillmore & Rush, 2002; 
Verdejo-García, Perales, & Pérez-García, 2007).  In onze 
experimenten hebben we chronische en  recreatieve gebruikers van 
cocaïne beoordeeld aan de hand van een blocked-cycled naming task 
(Belke, Meyer, & Damian, 2005; Damian, Vigliocco, & Levelt, 
2001) en een directed forgetting procedure  (Bjork,  1970, 1989). In deze 
taken zijn inhibitie mechanismen betrokken die conflicten in 
taalproductie en het terughalen van episodische herinneringen 
onderdrukken en verminderen (Roelofs & Paiai, 2011; Shao, Meyer, 
& Roelofs, 2013) (Anderson, 2003).  We hebben vooral gekeken 
naar de inhibitiemechanismen die selectief betrokken zijn bij het 
onderdrukken van semantisch gerelateerde concurrenten tijdens 
lexicale selectie, bij cocaïne gebruikers en een drugs-vrije 
controlegroep. Chronische en recreationele gebruikers van cocaïne 
toonden  een substantieel hogere kwetsbaarheid voor semantische 
interferentie, vergeleken met  niet-gebruikers.  Mogelijkerwijs is dit 
te wijten aan de ondoelmatige  uitvoering van verbale 
inhibitieprocessen. Bovendien gebruikten wij de directed forgetting 
procedure, deze heeft als doel de vaardigheid  met betrekking tot het 
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onderdrukken van recent opgenomen informatie, die  irrelevant is 
geworden als gevolg van de instructie, te vergeten. Wij ontdekten 
dat inhibitie mechanismen, werkzaam bij het door de persoon zelf-
geïnitieerde- vergeten, beschadigd kunnen zijn tijdens cocaïne 
gebruik. Het vermogen van recreationele gebruikers van cocaïne 
om niet relevante herinneringen te onderdrukken was onvoldoende. 
Hoewel chronische cocaïne gebruikers blijk gaven van een slechtere 
geheugenonderdrukking dan de controle groep, bleken zij succesvol 
in het opzettelijk afremmen van ongewenste herinneringen. De 
vraag blijft hoe dit mogelijk is. Om de onderzoeksresultaten te 
verklaren, suggereren wij dat zelfs kleine maar continu toegediende 
hoeveelheden cocaïne in verband gebracht worden met een 
hypoactieve prefrontale cortex en een relatieve staat van 
dopaminergisch dysfunctioneren. Deze kunnen de cognitieve 
processen beschadigen die  betrokken zijn bij de werking van het 
episodische geheugen.  Toch kan het beëindigen van cocaïne 
gebruik cognitieve functies deels herstellen  (Connolly, Foxe, 
Nierenberg, Shpaner, & Garavan, 2012; Sclafani, Tolou-Shams, 
Price, & Fein, 2002; Vonmoos et al., 2014).  
Als laatste willen wij benoemen dat ons werk, samen met 
het reeds gedane wetenschappelijk onderzoek, belangrijke 
implicaties heeft voor het begrip en de behandeling van drugs 
misbruik. De uitkomsten van deze studies zijn zeer zorgwekkend. 
Ten eerste omdat vele situaties in het dagelijks leven vragen om 
efficiënte en juiste cognitieve controle, wat een belangrijke rol  
speelt in de interactie tussen onze innerlijke  en uiterlijke wereld. 
Het gebruik van stimulerende drugs zoals khat of cocaïne kunnen 
leiden tot een aanzienlijke verslechtering van de psychofysische  
functies die het dagelijks gedrag beïnvloeden.  Denk hierbij aan een 
scala van activiteiten die variëren van autorijden tot het uitvoeren 
van werkzaamheden en sociaal gedrag. Ten tweede zal het 
definiëren van de aard van beschadigde cognitieve controlefuncties 
een belangrijke stap zijn in zowel de ontwikkeling van 
therapeutische doelen als voor het aanbrengen van verbeteringen in 
het detoxificatie proces en het aanmoedigen van druggebruikers, 
opdat onthouding wordt bereikt en behouden.  
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Samenvattend: de mechanismen die gedachten en acties 
sturen en controleren variëren als gevolg van het  fluctuerende en 
dynamische karakter van zowel interne, psychische toestanden als 
externe, beperkende omgevingsfactoren.  Bovendien willen wij erop 
wijzen dat misbruik van stimulerende drugs zoals khat of cocaïne 
op de een of andere manier cognitieve controlefuncties beïnvloedt. 
Momenteel bestaan er nog onopgeloste kwesties die in verband 
gebracht worden met de werking van deze stimulerende drugs op 
zowel lichaam als geest, waar toekomstig onderzoek nader op in zal 
moeten gaan. Wij hopen dan ook dat onderzoekers die eveneens 
zijn geïnteresseerd in cognitieve controle  en misbruik van drugs 
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Resumen 
El control cognitivo es una característica extraordinaria de 
la mente humana. Este control consiste en la configuración de los 
propios mecanismos mentales en el desempeño y ejecución de 
tareas específicas a través de los ajustes apropiados en la selección 
perceptual, las tendencias de las respuestas y en el mantenimiento 
continuo de la información contextual (Botvinivk, 2001). Además, 
esta tesis pretende subrayar que desde una perspectiva psicológica y 
neurológica hay un consenso en entender que, en la adicción, la 
alteración de los procesos ejecutivos que controlan el 
comportamiento juega un papel central. 
Las investigaciones realizadas hasta la fecha sobre las 
habilidades cognitivas de los consumidores de cocaína presentan un 
escenario en el que los procesos de control que median en la toma 
de decisiones, atención, memoria y aprendizaje se encuentran 
alterados. Muchos de estos procesos cognitivos  necesitan de 
participación de regiones prefrontal dorsolateral y orbitofrontal, 
vías ricas en dopamina y regiones con importantes papeles en las 
funciones ejecutivas, y todas ellas, parecen estar mal reguladas 
cuando se consume cocaína. Muchos investigadores de este campo 
señalan las incidencias que tiene el consumo de sustancia 
estimulantes como la cocaína en los procesos inhibitorios que se 
ven seriamente dañados en quienes la consumen (Colzato, van den 
Wildenberg, & Hommel, 2007; Fillmore & Rush, 2002; Verdejo-
García, Bechara, Recknor, & Pérez-García, 2006). 
Aunque se ha realizado un importante progreso para 
entender la actuación de la cocaína sobre los procesos mentales, 
solo un reducido número de estudios han investigado las 
características sociales y psicológicas de los consumidores de khat. 
Precisamente la inexistencia de estudios que pongan el foco en los 
mecanismos neurobiológicos de esta droga, o de otros que se 
centren en la investigación sistemática del efecto en el consumo 
agudo y a corto y medio plazo, demuestra que se adolece de ese 
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análisis social y psicológico. Sin embargo, dada la similitud entre el 
principio activo de la planta khat (catinona) y las anfetaminas en 
estructura y actividad farmacológica tiene sentido asumir que el 
consumo agudo y las consecuencias del consumo a largo plazo de 
khat afectan al mismo sistema de neurotransmisores y regiones 
cerebrales que las anfetaminas. 
De acuerdo con el objetivo principal de esta tesis, he 
investigado si el consumo de khat y cocaína altera mecanismos 
específicos que subyacen en el control del pensamiento y de la 
acción. Con este propósito he llevado a cabo varios experimentos 
encaminados a observar el rendimiento de consumidores de khat  
ejecutando tareas que acceden a procesos de control cognitivo, 
principalmente control inhibitorio, flexibilidad mental, actualización 
de la memoria de trabajo y en el control de la interferencia. 
Además, de forma específica he evaluado el control inhibitorio en 
consumidores de cocaína a través de tareas experimentales que 
acceden en la habilidad para controlar interferencias semánticas en 
la producción de lenguaje y la habilidad para suprimir trazos de 
memoria irrelevantes durante la codificación y la recuperación de 
los recuerdos. Igualmente, en esta tesis hemos revisado los efectos 
fisiológicos y comportamentales del psicoestimulante natural khat y 
la droga de diseño derivada de la catinona, Mefedrona. He puesto 
especial atención en los procesos de farmacocinética y 
farmacodinámica y en el potencial de estas sustancias para producir 
síndrome de abstinencia y dependencia.  Los principales resultados 
de esta investigación son los siguientes: 
Primero, en el capítulo dos he revisado la literatura que 
analiza el aspecto histórico y geográfico del alcaloide de la planta 
khat (catinona) y la droga de diseño mefedrona. Examino estas 
sustancias sabiendo que hay un cierto consenso sobre su toxicidad y 
el potencial dañino, además de la potencia de estas drogas para 
producir abuso y dependencia. La literatura científica sobre estas 
sustancias coincide en que su consumo  puede ser dañino y sería 
necesario investigar más al respecto, especialmente acerca de la 
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sustancia mefedrona, la cual, es aún más peligrosa debido a su fácil 
disponibilidad y la falta de información sobre ella. 
 Segundo, los datos presentados en los capítulos tres y 
cuatro señalan que consumidores de khat, en comparación con no 
consumidores, muestran deficiencias en las tres principales 
funciones de control cognitivo (Miyake, 2000). Los resultados en 
las diferentes tareas y experimentos muestran que i) los 
consumidores de khat y no consumidores son similares en términos 
de ejecución de respuesta, sin embargo, los consumidores de khat 
en comparación con los no consumidores necesitan más tiempo 
para inhibir las respuestas prepotentes; ii) el consumo de khat 
parece estar asociado  con problemas en la actualización de 
memoria de trabajo. Los consumidores de khat son menos 
eficientes  en la discriminación de qué información es antigua y no 
relevante. Esto significa que la información no relevante tiene 
mayor posibilidad de entrar en memoria de trabajo y convertirse en 
interferencia, y iii) los consumidores de khat, comparados con el 
grupo de control, necesitaban más tiempo para cambiar entre 
configuraciones mentales, indicado esto por un mayor índice de 
coste de cambio.  Estos resultados indican que el consumo de khat 
puede tener un impacto amplio y general sobre la cognición. 
Además, teniendo en cuenta la similitud farmacológica entre 
catinona y anfetamina, nuestros resultados están en línea con 
estudios anteriores que muestran daños en las funciones de control 
cognitivo como consecuencia del consumo a largo plazo de 
anfetaminas (Baicy & London, 2007; Daumann et al., 2003, 2004; 
Monterosso et al., 2005; Nordahl et al., 2003; Rubia et al., 2011; 
Salo & Leamon, 2003; Salo et al., 2009a, 2009b, 2009c; van der Plas 
et al., 2009). Este estudio señala que estos daños en las funciones de 
control cognitivo pueden deberse al consumo a largo plazo de khat 
debido a disfunciones en los receptores dopaminérgicos de áreas 
fronto-estriatales y la corteza prefrontal. 
Tercero, en el capítulo cinco, se demuestran pruebas del 
impacto del consumo a largo plazo de khat en la aparición y 
resolución de interferencia medida a través de la observación de los 
Summary in Spanish ─ 220 
 
 
participantes un una tarea Simon (Simon, 1969). De acuerdo con 
algunos estudios que muestran el impacto del consumo agudo y a 
largo plazo de anfetamina y metanfetamina en este proceso 
cognitivo (Fillmore, Rush, & Abroms, 2005; Rubia et al., 2011; Salo 
et al., 2009a, 2009b, 2009c), se muestra cómo el consumo agudo de 
khat a largo plazo altera la habilidad de inhibir información 
irrelevante y seleccionar la respuesta correcta en la aparición de 
conflicto inducido por incompatibilidad de respuesta, mostrando 
una pobre ejecución en la tarea de interferencia. Por un lado, el 
efecto estimulante de la catinona actúa como un potenciador 
cognitivo a nivel agudo mientras se consume, apoyando de este 
modo la idea del khat como una “anfetamina natural” (Kalix, 1992). 
Por otro lado, el consumo a largo plazo de khat puede producir un 
efecto nocivo sobre los mecanismos cognitivos que subyacen al 
proceso del control de la interferencia en la respuesta de conflicto, 
posiblemente debido a la alteración de las vías dopaminérgicas y las 
áreas prefrontales que tienen un papel muy importante en la 
resolución de conflicto de respuesta (Botvinick, 2007; Cools, 2006). 
Cuarto, en los capítulos seis y siete, he presentado los datos 
que apoyan la hipótesis de los posibles daños en el control 
inhibitorio en los dominios del lenguaje y la memoria. Existen 
investigaciones previas que muestran que los consumidores de 
cocaína, tanto recreativos como crónico, muestran alteraciones en 
el correcto funcionamiento del control ejecutivo notablemente, 
afectando procesos inhibitorios del dominio no verbal de funciones 
cognitivas (Colzato et al., 2007; Fillmore & Rush, 2002; Verdejo-
García, Perales, & Pérez-García, 2007). En estos experimentos se 
evalúo a consumidores crónicos y recreativos de cocaína usando 
una tarea de bloqueo semántico en el nombrado (Belke, Meyer, & 
Damian, 2005; Damian, Vigliocco, & Levelt, 2001) y una tarea 
experimental mediante el procedimiento de olvido dirigido (Bjork, 
1970, 1989) en la que los mecanismos inhibitorios son requeridos 
para suprimir y reducir la interferencia  en la producción de 
lenguaje (Roelofs & Piai, 2011; Shao, Meyer, & Roelofs, 2013) y en 
la recuperación de memoria episódica (Anderson, 2003) 
respectivamente. En los experimentos del capítulo siete he usado la 
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tarea de bloqueo semántico para observar los mecanismos que 
selectivamente suprimen competidores semánticamente 
relacionados durante el proceso de selección léxica en 
consumidores de cocaína y no consumidores de la sustancia. Los 
consumidores crónicos y recreativos de cocaína mostraron una 
vulnerabilidad a la interferencia semántica en comparación con los 
grupos controles no consumidores de cocaína. Esto, 
probablemente, puede que sea producido por una ejecución 
ineficiente de los procesos inhibitorios en el ámbito de la 
producción verbal. Además he usado el procedimiento de olvido 
dirigido para observar la habilidad de suprimir información 
recientemente aprendida que se convierte en información 
interferente debido a instrucciones de olvidar. En los experimentos 
que he llevado a cabo observo que los mecanismos que actúan 
durante olvido auto-iniciado pueden estar dañados durante el 
consumo de cocaína y la habilidad para suprimir trazos de memoria 
no-relevantes es ineficiente en consumidores crónicos y recreativos 
de cocaína. Este resultado sugiere que, además de un consumo 
crónico y continuado, pequeñas cantidades de cocaína consumidas 
continuadamente está asociado con una hipofunción de la corteza 
prefrontal y un estado relativo de disfunción dopaminérgica que 
puede alterar los procesos cognitivos implicados en la recuperación 
de la memoria episódica. No obstante, hay diversos estudios que 
demuestran que el cese de consumo de cocaína parece favorecer 
una recuperación parcial del funcionamiento cognitivo (Connolly, 
Foxe, Nierenberg, Shpaner, & Garavan, 2012; Sclafani, Tolou-
Shams, Price, & Fein, 2002; Vonmoos et al., 2014), aunque se 
necesita tiempo y abstinencia para pueda manifestarse alguna 
mejoría. 
Por último, este trabajo, junto con la investigación previa 
sobre el tema, hace varias consideraciones sobre el funcionamiento 
y el tratamiento cuando se abusa de sustancias adictivas. Los 
resultados de esta serie de investigaciones son de notable 
preocupación; primero, muchas situaciones de la vida diaria 
requieren un correcto funcionamiento de control cognitivo que 
juega un papel muy importante en la interacción entre nuestro 
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fuero interno con el mundo exterior. El uso de drogas estimulantes 
del comportamiento como el khat o la cocaína conducen al 
deterioro de funciones psicológicas y físicas que influyen en el 
comportamiento diario, desde la conducción de un vehículo al 
desempeño de actividades laborales o el comportamiento en 
sociedad; segundo, definir la naturaleza del posible daño del control 
cognitivo es un paso importante en el desarrollo de los objetivos 
terapéuticos, así como la mejora del proceso de desintoxicación y 
alentar a los consumidores de estas sustancias  a lograr y 
mantenerse en abstinencia.  
En conclusión, sostengo que los mecanismos que 
controlan el pensamiento y la acción varían en la fluctuante y 
cambiante naturaleza de los estados fisiológicos internos y en las 
limitaciones ambientales externas y además apunto que el consumo 
de sustancias psicoestimulantes como el khat o la cocaína, de alguna 
manera, impactan más en estos proceso de control cognitivo. Sin 
embargo, siguen habiendo una serie de limitaciones y aspectos poco 
conocidos acerca de cómo actúan estas sustancias en el cuerpo y en 
la mente que a mi juicio deben ser estudiados en futuras 
investigaciones. Espero que otros investigadores interesados en los 
procesos de control cognitivo y el consumo de drogas se sumen al 
esfuerzo de entender la relación existente entre ambos.
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